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PEPTIDE-BASED DESIGNED BIOMATERIALS FOR MEDICAL 
APPLICATIONS THROUGH BIOMIMETIC APPROACH 
SUMMARY 
Biomaterials used in implants have traditionally been selected based on their 
mechanical properties, chemical stability and biocompatibility. Titanium and 
titanium alloys are current widely used biomaterials for dental and orthopedic 
implants due to their superior properties. Although, they are the most preferential 
materials in implantation, improper implant–tissue integration into surrounding bone 
often occurs due to unwanted biological response includes bacterial colonization 
subsequently bacterial infection and fibrous capsule formation. Biological response 
at the implant-tissue interface is a surface phenomenon. Surface properties such as 
topography, morphology and chemistry play a major role in determining both the 
biological response to implants and the material response to the physiological 
condition. Hence, surface engineering focuses on modifying the surface properties of 
titanium to control the interaction between the implants and its biological 
surroundings by altering cell attachment, growth and tissue formation. Due to the 
ultimate role of surface properties on the rate and quality of implant–tissue 
integration or osseointegration, a variety of surface modification approaches 
including physical, chemical and biological ones have been utilized. Among them, to 
create biologically active surfaces that are mimicking natural environment and 
organization of bone tissues is emerged as a current approach to induce controlled, 
guided and rapid cellular response.  
In course of implantation; a competition occurs between integration of the material 
into the surrounding tissue and adhesion of bacteria onto the implant surface. These 
two concurrent events followed by mineralization are critical steps for the successful 
osseointegration. Thus, biological surface modifications have a potential to bring 
solutions for better implant materials firstly in designing nonfouling and 
antimicrobial surfaces, secondly in creating bioactive surfaces that enhance short and 
long term cellular response subsequently mineralization at implant-tissue interface. 
To design surfaces with targeted goal, various biomolecules have been immobilized 
on to implant surfaces via different immobilization techniques. Depending on current 
design parameters under biological surface modifications for nonfouling and 
antimicrobial surfaces, PEO, PEG and antimicrobial peptides are the most favorable 
biomolecules to prevent bacterial adhesion that is primary cause of implant failures. 
In case of bioactive surfaces, engineered peptide motive arginine-glycine-aspartic 
acid (RGD) derived from cell adhesive proteins present in the extracellular matrix 
(ECM) of bone, (such as fibronectin, bone sialoprotein, and osteopontin), have been 
immobilized on implant materials. Besides, Ca-P coatings and its combination with 
organic molecules such as albumin, collagen, BMPs, biphosphate and amlogenins 
due to their similar composition with bone and its extracellular environment, are 
another type of biological surface modifications to trigger mineral formation for 
optimal osseointegration.  
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The success of biological surface modifications relies on the choice of 
immobilization methods (i.e. physical or chemical) which control functionality, 
stability of biomolecules. Physical immobilization with simple adsorption principle 
is lack of controlling amount and density of adsorbed molecules. Covalent 
attachment as a chemical immobilization method utilizing self assembled monolayers 
(SAMs) is often applicable only to a limited range of materials and requires the 
presence of specific functional groups  which are themselves non-specific to surfaces 
and synthetic pathways which requires extensive chemistry. Both of the techniques 
are poor to control orientation, structural conformation that effect function of 
molecule to fully retain biological activity. Controlling the bio-material interfaces is 
the common major challenge in all of these surface treatments.  
There is a need for a new generation of molecular linkers that can induce controlled 
and predictable interactions at bio-material interface with high material binding 
affinity, specificity. These properties can only be achieved with material recognition 
capability for desired surface that allow us precise control density, functionality, 
accessibility of biomolecules. Molecular recognition is the basis of biological 
interactions, therefore molecular biomimetics approch offers unique premises to 
generate biological molecules, which are truly self assembled, can be genetically 
programmable, and have molecular recognition properties. Genetically engineered 
peptides for inorganics (GEPI) can be designed as novel alternative biomolecular 
linkers to immobilize biological molecules onto implant surfaces. Their high binding 
affinity and specificity towards inorganic surface, high conjugation capability with 
biomolecules to produce mutlifunctional molecular probes, easy production are 
unique features to be implemented in restorative medicine.  
In this dissertation, we first generated a set of sequence that have affinity to titanium 
dental implant surface (cp Grade 4) via cell surface display and then each of the 
selected  titanium binding peptides (TiBPs) was characterized semi-quantitatively via 
fluorescence microscopy (FM) for binding to their respective titanium surface. 
Peptides with strong binding affinity (TiBP1 and TiBP2) and weak binding affinity 
(TiBP60) were further subjected to quantitative binding characterization via quartz 
crystal microbalance (QCM) as well as analysis of the molecular conformation 
properties by protein structure interrogation techniques. The high binding subset of 
TiBPs (TiBP1 and TiBP2) were then examined for their material selectivity and 
cytotoxicity properties. Next, their potential applicability for biological surface 
modifications as peptide based molecular linker was shown with three examples that 
are critical for osseointegration.  
In the first approach, bi-functional peptides were designed in conjugation with two 
different titanium binding peptides (TiBP1 and TiBP2) and integrin binding domain 
Arg-Gly-Asp-Ser (RGDS) for bioactive surface modifications. Effects of two bi-
funtional peptides on cell viability, adhesion and spreading were examined on 
different implant surfaces with distinct surface roughness and topography such as cp 
Grade 4, cp Grade 1 titanium dental implant and titanium coated glass surfaces in the 
presence of osteoblast and fibroblast. Cell adhesion and spreading assays 
demonstrated that bi-functional peptide within single peptide domain preserved its 
dual functionality effectively while peptide facilitating the titanium surface 
functionalization, also kept its functionality as a recognition site for cells. The 
increase in cell number and spreading on three different surfaces also supports us 
utilization of the TiBPs as a molecular linker for bioactive surface modfications. 
  
xxvii 
 
In the second approach, to bring a new surface modification metdology in the area of 
implant infections, TiBP and antimicrobial peptide (AMP) were conjugated as a bi-
functional peptide to impart the bacterial resitance or antimicrobial properties to 
titanium surface.  Two bi-functional (TiBP1-AMP and TiBP2-AMP) peptides were 
designed based on their charge, binding affinity and structurual properties and then 
evaluated detail in terms of their binding and antimicrobial activity. To evaluate 
efficiency of the method as a biological surface modification, in solution and on the 
surface antimicrobial activity were examined against Streptococcus mutans, 
Staphylococcus epidermidis, and Escherichia coli. Modified surfaces with two 
different bi-functional peptides were found to significantly reduce bacterial adhesion 
on titanium against all three bacteria. The results indicate us surface modification 
with conjugated molecules consisting of antimicrobial and titanium binding peptides 
is a promising approach to prevent bacterial infection on implant surfaces. 
In the third approach, utilization of GEPI`s for mineral deposition on the implant 
surface which is one of the major challenge in osteointegration were shown. To 
achive to induce and control mineral formation, molecular linker and material 
synthesizer capability of GEPIs` were combined in a bi-functional peptide. TiBP2 
with two different  de novo designed peptides (ADP5 and ADP7), which are very 
well characterized in terms of their binding affinity to hyrodxapatite (HA) with 
controllable mineralization capability, were conjugated to create a bi-functional 
peptide. After performing complete characterization of the bi-functional peptides for 
inorganic binding, real time monitoring of the CaPO4 biomineralization were 
successfully achieved on the surface of titanium via QCM. The mineral morphology 
and crystal structure were examined with Transmission Electron Microscopy (TEM) 
and Scanning Electron Microscopy (SEM).  This part of work indicates that GEPI 
may provide the ways for genetic control on biomineralization from tissue restoration 
to regeneration. In vitro studies reveal that the bi-functional peptides form 
hyrodxapatite (HA) on the implant surface while promoting the cell adhesion on 
titanium surface.  
In scope of this thesis, the remarkable potential of GEPIs were shown in controlling 
not only cell-surface interactions through controlled immobilization of peptide based 
multifunctional molecular linkers on the implant surfaces but also controlled mineral 
formation was demonstrated addressably at implant-tissue interphase. 
Titanium binding peptides can be a candidate to serve as biomolecular linker to 
functionalize implant surfaces by providing modular domains that ease their 
conjugation to biologically active signaling molecules while retaining their 
remarkable binding and selectivity to the solid substrate with the absence of 
cytotoxicity properties. Since material surface binding peptides can be conjugated 
with a variety of bioactive molecules that can enhance cell attachment, cell 
proliferation, cellular spreading and other fundamental properties of cell behavior, 
the TiBPs studied here offer a unique utility for tissue engineering studies. The 
proposed peptide based surface coating is universal and can be applied to induce 
various desired biological activity on any implant material from dental to orthopedic 
surgery using an easily adaptable single-step biologically relevant condition. 
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BĐYOMĐMETĐK YAKLAŞIMI ĐLE PEPTĐD BAZLI BĐYOMALZEMELERĐN 
MEDĐKAL UYGULAMALAR ĐÇĐN GELĐŞTĐRĐLMESĐ 
ÖZET 
Đmplantlarda kullanılan biyomalzemeler geleneksel olarak mekanik özellikleri, 
kimyasal kararlılıkları ve biyouyumluluklarına göre seçilirler. Titanyum ve titanyum 
alaşımları ortopedik ve diş implantları için seçkin özellikleri dolayısıyla günümüzde 
oldukça kullanılmaktadır.   Titanyum ve alaşımları, implantasyon da çok tercih 
edilen malzemeler olmalarına rağmen; bakteriyel kolonizasyon ve sonrasındaki 
bakteriyel enfeksiyonu, fibroz kapsül oluşumunu içeren, istenmeyen biyolojik cevap 
dolayısıyla implantın çevredeki kemik dokusuyla uyumsuzluğuna çok sık 
rastlanmaktadır. Implant-doku ara kesitindeki biyolojik cevap yüzey olgusudur. 
Yüzey topografisi, kimyası ve morfolojisi gibi özellikler, implanta karşı biyolojik 
cevabın ve fizyolojik ortama malzemenin cevabının belirlenmesinde önemli rol 
oynamaktadırlar. Yüzey mühendisliği; implant ve biyolojik çevresinin arasındaki 
etkileşimi, titanyumun yüzey özelliklerini değistirerek ve böylelikle hücre 
bağlanması, büyümesi ve doku oluşumunu etkileyerek kontrol etmeyi 
hedeflemektedir. Yüzey özelliklerinin; implat–doku uyumunun oranı ve hızına olan 
temel etkisi dolayısıyla; fiziksel, kimyasal ve biyolojik olan çok farklı yüzey 
modifikasyonları  kullanılmaktadır. Bunlar arasında, kemik doğal ortamına benzeyen 
biyolojik aktif yüzeyler günümüzde kontrollü, yönlendirilmiş ve hızlı hücre cevabına 
neden olan yaklaşımlar olarak ortaya çıkmaktadır. 
Đmplantasyon sırasında, malzemelerin çevresindeki doku ile uyumu ve bakterilerin 
yüzeye tutunması arasında yarışmacı bir durum oluşur. Eş zamanlı ve akabinde 
mineralizasyonun gercekleştiği bu iki olay; etkin osseointegrasyon için kritik olan 
aşamalardır. Böylelikle, biyolojik yüzey modifikasyonları ilk olarak; antimikrobiyel 
yüzeylerin, ikici olarak; hücrelerin kısa ve uzun süreli cevabını ve sonrasında 
implant-doku ara kesitindeki mineralizasyonu arttıran biyoaktif yüzeylerin 
oluşturulmasına daha iyi implant mazlemeler için çözümler getirme potensiyeline 
sahiptir. Hedef  odaklı  malzeme tasarlamak için, çok çesitli biyomoleküller implant 
yüzeyler üzerine farklı immobilizasyon yöntemleri ile tutturulmuşlardır. Günümüzde 
antimikrobiyel ve kirlenmemiş yüzeyler için biyolojik yüzey modifikasyonlarının 
tasarım kriterlerine bağlı olarak; implant başarısızlıklarının temel sebebi olan 
bakteriyel yapışmayı engelemek amacıyla PEO, PEG ve antimiktobiyel peptitler en 
çok tercih edilen moleküller arasındadırlar.  Biyoaktif  yüzeyler için,  kemik hücre 
dışı matriksinde bulunan  hücre etkileştirici proteinlerden (fibronektin, kemik 
sialoprotein ve osteopontin) türetilerek tasarlanmış arjinin-glisin-aspartik asit (RGD) 
peptit motifi implant malzemeler üzerine immobilize edimişlerdir. Bunun dışında, 
Ca-P kaplamaları ve bunların albumin, kologen, kemik morfogenetik proteinleri, 
bifosfat ve amelojenin gibi kemik yapısına ve hücre dışı ortamına benzerlikleri olan 
organik moleküllerle bileşimi optimal osseointegrasyon için mineral oluşumunu 
tetikleyen diğer bir biyolojik yüzey modifikasyon çeşididir. 
  
xxx 
 
 
 
Biyolojik yüzey modifikasyonlarının başarısı, biyomoleküllerin kararlılığını, 
fonskiyonelliğini kontol eden immobilizasyon yöntemlerine (örneğin fiziksel ve 
kimyasal yöntemler) bağlıdır. Basit adsorpsiyon prensibine bağlı olan fiziksel 
immobilizasyon, adsorplanan biyomoleküllerin miktarını ve yoğunluğunu kontrol 
etmekten yoksundur. Kovalent bağlanma, kendiliğinden oluşan tek tabakaları 
kullanan kimyasal bir immobilizayon yöntemi olarak özgün foknsiyonel gruplar ve 
sentetik yollar gerektirir, çoğunlukla sınırlı sayıda malzemelerle uygulanır. Her iki 
teknik de biyomolekülün fonksiyonunu etkileyen yönelim ve yapısal 
konformasyonun kontrolü zayıftır. Fiziksel ve kimyasal immobilizasyonun 
eksiklerinin gösterilmesi, hedef yüzey için yüksek bağlanma, özgünlük ve tanıma 
kapasitesi olan ve biyomolekülün fonksiyonelliği erişilebilirliği, yoğunluğunu 
kontrol edilebilmesine izin veren yeni moleküler bağlayıcıların geliştirilmesine 
ihtiyaç vardı. Tüm yüzey modifikasyonlarında doku-malzeme ara kesitinin kontrol 
edilmesi başta gelen sorunlardan biridir. 
Doku-malzeme ara kesitinde, kontrol edilebilir etkileşimini tetikleyecek malzemeye 
yüksek bağlanma ilgisi ve özgünlüğü olan yeni bağlayıcı moleküllere ihtiyaç vardır. 
Bu özellikler sadece biyomoleküllerin yoğunluğunu, fonksiyonelliğini ve 
ulaşılabilirliliğini kontrol edebilmeye izin veren ve istenilen yüzeye özgü moleküler 
tanıma kapatitesi sayesinde elde edilebilir.  Moleküler tanıma biyolojik etkileşimlerin 
temelinidir ve böylelikle moleküler biyomimetik yaklaşımı da kendiliğinden oluşan, 
genetik olarak programalanabilen ve moleküler tanıma özelliklerine sahip olan 
biyolomoküllerin oluşturulmasında özgün bir yol oluşturmaktadır. Genetik olarak 
tasarlanmış peptitler (GEPI), biyolojik moleküllerin implant yüzeylerine 
immobilizasyonu için moleküler bağlayıcı olarak alternatif bir method olabilirler.   
GEPI`lerin inorganik yüzeylere yüksek bağlanma ilgisi, özgünlüğü, biyomoleküllerle 
yüksek konjugasyon kapasitesi, kimyasal yapısını kesin olarak kontrolüne izin veren 
kolay üretimi diğer immobilizasyon metodları üzerine dikkat çekici özellikleridir.  
Moleküllerin bu özellikleri implantasyon alanında uygulanmasına sebep olmaktadır. 
Bu tez çalışmasında, ilk olarak  titanyum diş implant yüzeyine (cp Grade4) ilgisi olan 
peptitleri hücre yüzey gösterim teknolojisi ile elde ettik ve sonrasında her bir 
seçilmiş titanyuma özgül olarak bağlanan peptitler yarı kantitatif olarak floresan 
mikroskopu (FM) methodu ile titanyum yüzeyine bağlanma ilgilerine göre 
karakterize edildiler. Yüksek bağlanma ilgisi olan (TiBP1 ve TiBP2) ve zayıf 
bağlanma (TiBP60) ilgilisi olan peptidlerin bağlanma ilgileri, kuvars kristal 
mikroterazi (QCM) methodu ile kantitatif olarak ve aynı zamanda moleküler 
konformasyonu da protein yapısı analiz methodlari ile karakterize edildi.  Yüksek 
bağlanma ilgisi olan gruptaki TiBP1 ve TiBP2`nin malzemeye seçici bağlanma 
ilgileri ve sitotoksite özellikleri açısından incelendi. Sonrasında, peptidlerin biyolojik 
yüzey modifikasyonları için moleküler bağlayıcı olarak potensiyel uygulanabilirliği 
osseointegrasyon için kritik olan üç farklı örnekle gösterilmiştir. 
Đlk yaklaşımda, titanyum`a bağlanan iki farkli peptitle (TiBP1 ve TiBP2) ve integrin 
bağlanma bölgesi RGDS`nin birleştirilmesiyle biyoaktif yüzey modifikasyonları için 
çift fonkisyonlu peptit tasarlammıştır.  Đki çift fonskiyonlu peptidin hücre canlılığı, 
bağlanması ve yayılması üzerine etkisi yüzey pürüzlülüğü ve topografisi farklı olan 
iki cp Grade 1 ve cp Grade 4 diş implant yüzeyleriyle, titanyum kaplanmış cam 
yüzey üzerinde osteoblast ve fibroblast hücreleri ortamında incelendi. Hücre 
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bağlanma ve yayılma deneyleri çift fonsiyonlu peptidin tek bir parça içersinde 
titanyum yüzeyini fonksiyonelleştirme ve hücre tanıma özellikleri gibi iki farklı 
fonksiyonu barındırdığını göstermiştir.  Üç farklı yüzey üzerinde hücre sayısında ve 
yayılmasındaki artış TiBP`lerin moleküler bağlayıcı olarak biyoaktif yüzey 
modifikasyonlarında kullanılabileceğini desteklemektedir. 
Đkinci yaklaşımda, implant enfeksiyoları alanına yeni yüzey modifikasyon methodları 
getirmek için TiBP ve antimikrobiyal peptidler (AMP) titanyum yüzeyine 
antimikrobiyal özellik kazandırmak ve bakteriye karşı dirençli hale getirmek 
amacıyla birleştirilip çift fonksiyonlu peptit oluşturuldu.  Çift fonksiyonlu (TiBP1-
AMP ve TiBP2-AMP) peptitler her bir peptidin yük, bağlanma ilgileri ve yapısal 
özelliklerine bağlı olarak tasarlandı ve sonrasında yüzeye bağlanma ilgileri ve 
antimikrobiyal özelliklerı açısından değerlendirildi. Metodun biyolojik yüzey 
modifikasyonu olarak etkinliğini değerlendirmek için peptidin hem solusyon içindeki 
hem de yüzeydeki aktivitesi Streptococcus mutans, Staphylococcus epidermidis, and 
Escherichia coli`e karşı incelendi. Đki farklı çift fonksiyonlu peptitle modifiye olmuş 
yüzeylerde üç bakteriye karsı, hücre tutunmasında önemli bir azalma görülmüştür. 
Sonuçlar antimikrobiyal ve titanyuma bağlanma özelliği olan birleşmiş peptitlerin 
implant yüzeylerde bakteriyel enfeksiyonu önlemek için yüzey modifikasyonlarında 
kullanılabileceğini gösterir.  
Üçüncü yaklaşımda, osseointegrasyonda önemli bir sorun olan implant yüzeylerinde 
mineral depolanmasında GEPI`lerden nasıl yararlanılacağı gösterilmiştir. Mineral 
oluşumunu implant yüzeyinde tetiklemek için, GEPI`lerin moleküler bağlanma ve 
malzeme sentezleme kapasitesi tek bir çift fonksiyonlu peptidi tasarlanmıştır. TiBP2, 
de novo methodu ile tasarlanmış kontrol edilebilir mineralizasyon yapabilme  
kapasitesi ve hidroksiapatit yüzeyine yüksek bağlanma ilgisi açısından iyice 
karakterize edilmiş iki farklı peptit ile (ADP5 ve ADP7) ile birleştirilerek çift 
fonksiyonlu peptit oluşturulmuştur. Çift fonksiyonlu peptidin anorganiklere 
baglanma karakterizasyonunun tamamlanmasının ardından, gerçek zamanlı olarak 
CaPO4 mineralizasyonu QCM kullanılarak gözlenmiştir. Mineral morfolojisi ve 
kristal yapısı TEM ve SEM kullanılarak incelenmiştir. Bu kısımdaki çalışmayla, 
GEPI`lerin doku onarımından ve yenilenmesine kadar olan alanlardaki mineral 
oluşum sürecinin genetik olarak kontrol edilebilir olduğu gösterilmektedir. In vitro 
çalışmalarda implant yüzeyinde çift fonksiyonlu peptidlerin hücre adhezyonu 
tetiklerken aynı zamnada HA mineralizasyonu da yapabileceğini göstermektedir.  
Bu tezin kapsamında, GEPI`lerin moleküler bağlayıcı olarak dikkat çekici 
potensiyeli implant-doku ara kesitinde, hücre-yüzey arasındaki ilişkinin yanısıra 
mineralizasyonunu da fonkiyonel moleküllerin immobilzasyonuyla kontrol 
edebildiği gösterilmiştir. 
Titanyuma bağlanan peptitler biyolojik olarak aktif sinyal molekülleri ile kolay 
birleşebilen ve birleşirken de hücre toksitesileri olmayan, katı yüzeylere olan belirgin 
bağlanma ve seçiciliklerini koruma özelliklerinden dolayı biyomoleküler bağlayıcı 
olarak implant yüzeylerin fonksiyonelleştirilmesinde kullanılmaya adaydırlar. 
Malzemeye bağlanan peptidler, hücre bağlanması, yayılması, proliferasyonunu ve 
hücre davranışının diğer  temel özelliklerini arttıran çok çeşitli biyoaktif moleküllerle 
birleşebilirler. Burada çalısılan TiBP`lerin doku mühendisliği çalışmaları için özgün 
bir yararlılığı olacaktır. Önerilen peptid bazlı kaplamalar, diş implantlarından 
ortopedik implantlarin yüzeyine kazandırılması istenilen biyolojik aktivite için 
yaygın şekilde ve kolaylıkla tek basamakta biyolojik olarak uygun koşullarda 
uygulanabilecek bir tekniktir. 
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1 INTRODUCTION  
1.1. Bionanotechnology and Biomaterials  
Nanotechnology, a new focus in the area of biomedical research, involves 
visualization, manipulation, and fabrication of materials on the smallest scales, in 
dimensions of 1 µm down to 10
◦
A [1-3]. The range below 100 nanometers is 
important because at this small size, the classic laws of physics change. The 
result is novel properties that enable researchers to produce new materials with 
the exact characteristics they desire: smaller, stronger, and tougher than current 
materials.   
Nature enables to produce materials with unique features applying proper 
nanotechnology since at the beginning of the life.  The biological systems in cells 
and in nature contain examples of many nanoscale systems. Firstly, proteins, 
nucleic acids, lipids and carbohydrates are the building block of life and they are 
the examples of materials that possess unique properties determined by size, 
folding and patterns at the nanoscale [4-6]. Specifically, bone and tooth are 
composed of numerous nanostructures, such as collagen and hydroxyapatite, 
which provide a unique nanostructure for protein and bone cell interactions in the 
body [7-12] (Figure1.1). 
Most of the current macro- or micro fabrication techniques are unable to create 
these sophisticated structures. Recent paradigm shifts from these fabrication 
techniques to nano-enabled techniques have significantly enhanced our ability to 
design new materials for various fields [13].  However, this unique feature and 
ability of nanotechnology requires an integrated understanding of and 
collaboration between multiple scientific fields, including biology, physics, 
chemistry, materials science, computer science, mechanical engineering, and 
electrical engineering [14, 15].  
Biomimetics can be considered as a promising way for realizing nano and 
bionanotechnology by taking inspiration from  mother nature`s biological 
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structures to design practical materials and systems for engineering [16].  
Traditionally, biomimetics have focused on imitating biosystems using mostly 
synthetic components and conventional approaches [17].With a growing 
understanding of the processes involved in biology, novel routes were created in 
material assembly and fabrication for technological applications [15]. Recent 
advances in molecular biology with merging engineering disciplines open a new 
route in biomimetics. The new emerging field as molecular biomimetics shifts 
biomimetic material science to the molecular level [9]. 
All accumulated knowledge in various fields as described above thorugh 
nanotechnology can lead fabrication of new nanomaterials from metals, ceramics, 
polymers to composite materials, which demonstrate novel properties compared 
to conventional materials due to their nanoscale features [18, 14, 19, 20, 8]. 
 
Figure 1.1: a) Mammalian tooth is a hierarchical multimaterial system composed 
of enamel (E), dentin (D), pulp (P), cementum (C) and periodontal 
ligaments (PDL) [9].b) The nanostructured hierarchal self-assembly 
of bone[8]. c) Plywood-like structure present in lamellar bone (left), 
Radial fibril arrays (right) [10]. 
At the nanoscale, materials possess several novel properties including extremely 
high surface area, tunable optical emission, enhanced mechanical properties, and 
super paramagnetic behavior, which contrast the properties that are important 
when working with the bulk parent materials [21, 8]. 
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In recent years, bionanotechnology, as a branch of nanotechnology for 
application of biology, can be broadly defined an area, which utilize molecular 
tools and knowledge of the human body for diagnosis, treatment and prevention 
of diseases [22]. Applications of bionantechnology and/or nanomedicine can be 
roughly classified into diagnostics, imaging, nanobiomaterials, 
nanodevices/implants, novel drug delivery systems [22-24]. Several biomaterials 
in the form of self-assembled nanofibers/nanoparticles, electrospun nanofibers 
and nanocomposites and hydroxapaptite are also being used as a part of 
biomedical devices to enhance their performance (Figure 1.2) [23, 12].  
 
Figure 1.2: Nanotechnology and implant applications [12]. 
Nanobiomaterials have an increased number of atoms and crystal grains at their 
surfaces and possess a higher surface area to volume ratio than conventional 
microscale biomaterials. Novel physiochemical properties of nanobiomaterials 
dramatically change after decreasing material size into nanoscale by creating 
different surface topographies [13, 25]. They have been proposed as the next 
generation of improved implant materials, with the aim of improving surface 
properties to create an environment more conducive for osteoblast function and bone 
ingrowth  [26]. Nanotubes, building blocks for macro nanostructures, are about one-
sixth the weight and nearly 100 times stronger than steel. For example, 
nanostructured ceramics can reduce friction and wear problems associated with joint 
replacement components [27]. Biologically active molecules, added to the implant 
surface via nanotechnology for the guided interfacial osteogenesis. Nanostructured 
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titanium implant surfaces promote bone cell responses leading to accelerated calcium 
deposition improving integration with surrounding bone compared to conventional 
titanium surfaces [18, 28, 20, 29, 30]. But bone is not the only application of 
nanobimaterials in nanomedicine. For cartilage applications, nano-structured 
polylactic- co-glycolic acid (PLGA) surfaces have been shown to accelerate 
chondrocyte adhesion and proliferation, as well as extracellular matrix production 
[31-33]. Furthermore, vascular graft (PLGA) and stent (titanium) surfaces with 
nanometer surface roughness values improve endothelial (inner vessel cells) cell 
functions as compared to nanosmooth polymer and titanium surfaces [34-38]. In 
addition to the incorporation of nanometer surface features on conventional 
biomaterials, intrinsic nano-sized materials such as carbon nanotubes (hydrophobic) 
[39-42] and helical rosette nanotubes (hydrophilic) [43] are under intense 
investigation in regenerative medicine. Both types of these novel carbon based 
nanomaterials promote cellular interactions over currently implanted materials. Such 
data strongly supports the hypothesis that nano surface topography, in addition to 
surface chemistry, dictate initial protein adsorption and bioactivity (since initial 
protein interactions mediate cellular adhesion) as well as subsequent cellular 
adhesion [44]. 
1.2 Implant Materials for Tissue Restoration   
Biomaterials are artificial or natural materials and they have role to restore the 
function of lost and diseased biological structures. Thus biomaterials help to enhance 
the quality of life and longevity of human beings.  The field of biomaterials has 
shown rapid increase to keep with the demands of an aging population [45]. Many 
synthetic materials are used in the medicine for a variety of applications ranging 
from total replacement of hard or soft tissues (such as bone plates, pins, total joint 
replacement, dental implants, intra-ocular lenses, etc.), repair, diagnostic or 
corrective devices (such as pacemakers, catheters, heart valves, etc.) [46].  
The material or system of materials were chosen for the appropriate mechanical 
properties such as elasticity, yield stress, ductility, toughness, wear resistance, etc. 
[47]   depending on desired function. Further it should be amenable to being formed 
or machined into different shapes, at relatively low cost and be readily available. A 
proper design of an implant material is aimed to provide the requisite durability, 
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functionality and biological response. Durability and functionality are governed by 
the bulk properties of the material, whereas biological response depends on the 
surface chemistry, surface topography, surface roughness, wettability, surface 
charge, and surface energy [48-51]. Biocompatibility can be defined as the 
acceptance of the implant material by the surrounding tissues without any adverse 
response from the body and vice versa. Therefore, a biocompatible implant material 
should be nontoxic, noncarcinogenic, with little or no foreign body reaction and be 
chemically stable or corrosion resistant [51, 52, 47]. Depending on required 
parameters that listed above, various types of synthetic materials have been 
developed in order to fulfill with its function. They belong to the following main 
material classes [52]: 
i. Metals- titanium, titanium alloys, stainless steel, cobalt–chromium   
alloys. 
ii. Ceramics- aluminum oxide, carbon, calcium phosphates, glass–
ceramics. 
iii. Polymers- silicon, poly (methylmethacrylate), poly lactide, poly 
(urethane), ultra high molecular weight poly ethylene. 
iv. Composites- ceramic coating on metal implants, or ceramic-
reinforced polymers. 
v. Natural materials 
The choice of one material above another will depend on the application and the type 
of function that needs replacement. Unfortunately, none of the existing biomaterials 
can meet all of the requirements. The following section explains utilization of each 
material based on their required function. 
1.2.1 Metallic materials 
Metallic materials are most commonly used for load bearing implants and internal 
fixation devices.  The properties of metals can be determined processing method and 
purity of the materials. Some featured properties of a metallic material are its high 
tensile strength, high yield strength, resistance to cyclic loading (fatigue), resistance 
to time dependent deformation (creep) and its corrosion resistance. They generally 
find applications in the fabrication of implant devices such as hip joint prosthesis, 
knee joint prosthesis, dental implants, cardiovascular devices, surgical instruments, 
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etc. The most commonly used metals and alloys for medical device applications 
include stainless steels, commercially pure titanium and its alloys, and cobalt-based 
alloys [52, 45-47]. 
1.2.1.1 Titanium and its alloys  
Titanium as a pure metal is a well-tolerated material especially compared to stainless 
steel and Co–Cr based alloys under in vivo conditions. The two most commercially 
used specifications for implants are pure Ti (ASTM F67) and Ti–6Al–4V (ASTM 
F136). These alloys have driven a lot of interest for load bearing implants because of 
their superior mechanical properties (tensile strength and fatigue strength), chemical 
stability (corrosion resistance), and biocompatibility under in vivo conditions [53-
57]. Commercially pure Ti is one of the preferable materials for applications where 
corrosion resistance is much important than its mechanical properties.  
In the recent past, however there has been a great concern about the dissolution of 
aluminum and vanadium ions into the body fluid and the possibility of any toxic 
effect, as a result of the passivation layer break down during wear in Ti–6Al–4V. 
Figure 1.3 and Figure 1.4 shows the different types of Ti-based implants. Although 
titanium and its alloys are very promising in various fields, their bone-bonding 
activity is insufficient compared to other ceramic based materials. Thus a large 
amount or research in recent decades has been focued to surface modification of 
implant materials [47, 51]. 
 
 
Figure 1.3: a) A dental implant b) A replacement heart valve [52]. 
 
a) b) 
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1.2.1.2 Stainless steel 
Despite having a high content of Ni – a metal that provokes a strong dermatological 
allergic reaction in many people – and Cr, which in one of its oxidation states is a 
human carcinogen, stainless steel is surprisingly biocompatible and has been used for 
many decades as a permanent surgical implant material [46]. The type of stainless 
steel that is normally used for implants is 316L. It achieves its biocompatibility by 
being highly corrosion-resistant due to the formation of a thin protective chromium 
oxide layer on its surface. The environment that stainless steel must deal with in the 
body is, however, rather complex and, if corrosion occurs, release of potentially 
harmful material could ensue [52]. Due to the fact that stronger and more corrosion-
resistant materials are available and also that a growing number of people are 
displaying Ni sensitivity (apparently due to the increasing practice of body piercing), 
other alloys are now usually preferred for permanent prosthetic devices. 
 
 
Figure 1.4: Orthopedic Implant devices used for load bearing applications: (a) hip 
implant (b) knee implant (c) shoulder implant and (d) elbow [52]. 
Stainless steels are more suitable for nonpermanent implants and are still employed 
for permanent implantation in certain circumstances [47, 58]. 
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1.2.1.3 Cobalt chromium alloys  
CoCr alloys have excellent mechanical properties and are widely used in orthopaedic 
implants. The alloys are generally CoCrMo or CoNiCrMo, and may also include 
other elements such as tungsten or iron (Fe).Bedises these elements, Ni can be 
avoided in the formulation, CoCr alloys have advantages over stainless steel in terms 
of better corrosion resistance and somewhat better mechanical properties for certain 
applications. Both wrought and cast CoCr alloys are used in prosthetic devices, each 
version having distinct properties. They are often used as components in modular 
prosthetic devices such as hip or knee joints, being the most suitable for bearing 
surfaces (often against ultra-high-molecular-weight polyethylene) [46, 52, 58]. 
1.2.1.4 Ceramics  
Ceramics are inorganic compounds of metallic or nonmetallic materials, with 
interatomic bonding as ionic or covalent and which are generally formed at elevated 
temperatures. A class of such materials used for skeletal or hard tissue repair is 
commonly referred to bioceramics. These bioceramics may be bioinert (alumina, 
zirconia), bioresorbable (tricalcium phosphate), bioactive (hydroxyapatite, bioactive 
glasses, and glass ceramics), or porous for tissue in growth (hydroxyapatite coating, 
and bioglass coating on metallic materials) [59, 60]. Their success depends on their 
ability to induce bone regeneration and bone in growth at the tissue–implant interface 
without the intermediate fibrous tissue layer. The featured clinical applications 
include their use in orthopedics as (a) bone plates and screws, (b) total and partial hip 
components, (c) coatings on metal prosthesis for controlled implant or tissue 
interfacial response, (d) space fillings of diseased bone [61, 52]. 
1.2.2 Polymers  
Polymers are long chain molecules consisting of large number of small repeating 
units known as monomers. They belong to the family of macromolecules and 
represent the largest class of biomaterials. Polymers can be derived either from 
natural sources or from synthetic organic sources. The different types of polymers 
and their corresponding medical applications are listed in Table 1.1 
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Table 1.1: Examples of polymers used as biomaterials [62, 52, 63]. 
Applications  
 
Polymer  
Knee, hip, shoulder  joints  Ultrahigh-molecular-weight polyethylene 
Finger joints Silicone 
Sutures Polylactic and polyglycolic acid 
Tracheal tubes Silicone, acrylic,nylon 
Heart Pacemaker Acetal, polyethylene, polyurethane 
Blood vessels Polyester,polyetrafluroethylene,PVC 
Gastrointestinal segments Nylon, PVC, silicones  
Facial Prostheses Polydimethyl siloxane,polyurethane,PVC 
Bone Cement Polymethylmethacrylate 
 
Figure 1.5 shows the use of UHMWPE as a bearing material for hip joint and knee 
joint prostheses. Some advantages associated with polymers, for use as biomaterials 
can be listed as follows: 
• Polymers can be easily fabricated to various complex shapes and structures. 
• Provide wide range of bulk compositions and physical properties. 
• Surface properties can be easily tuned. 
On the other hand their disadvantages include: 
• Difficulty in sterilization. 
• Easily absorb water and biomolecule from the surroundings and thereby alter 
the surface chemistry. 
• Being soft materials may undergo mechanical wear and breakdown. 
• May leach some harmful compounds to the body under in vivo conditions. 
1.2.3 Composites  
A composite defines as combination of two or more materials each with distinct 
physical or chemical properties. It is designed to have best characteristic of each 
component materials. Biomedical composites are often designed to provide superior 
mechanical and biological compatibility. They can be classified based on the matrix 
material or on the bioactivity of the composites. Considering matrix material as the 
basis for classification, there are three different types of biomedical composites [64]: 
• Polymer matrix composites, e.g., carbon/PEEK (polyetheretherketone), 
HA/HDPE. 
• Metal matrix composites, e.g., HA/Ti, HA/Ti–6Al–4V. 
• Ceramic matrix composites, e.g., stainless steel/HA, glass/HA. 
  
10 
 
Considering bioactivity of the composite as the basis for classification, there are 
three different types of biomedical composites. 
 
Figure 1.5: Illustrating the use of UHMWPE as a bearing metal for (a) hip joint and 
(b) knee joint prosthesis [52]. 
• Bioinert composites, e.g., carbon/carbon, carbon/PEEK. 
• Bioactive composites, e.g., stainless steel/bioglass, HA/HDPE, HA/Ti–6Al–
4V. 
• Bioresorbable composites, e.g., tricalcium phosphate (TCP)/polylactic acid 
(PLA), TCP/polyhydroxybutyrate (PHB). 
The various factors that affect the performance of a biomedical composite material 
can be listed as follows [64]: 
• shape, size and distribution of reinforcement; 
• reinforcement properties and volume percentage; 
• bioactivity of the reinforcement; 
• matrix properties such as molecular weight and grain size; 
• reinforcement-matrix interfacial state. 
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1.2.4 Natural materials  
Natural polymers such as collagen and glycosaminoglycans are the most commonly 
used natural materials for clinical applications [65, 63, 66, 67]. Collagen is a fibrous 
protein that connects and supports other bodily tissues such as skin, bone, tendons, 
muscles, and cartilage. It is the most plentiful available protein present in the bodies 
of mammals, including humans. Glycosaminoglycan is the most abundant 
heteropolysaccharide present in the body. Glycosaminoglycans occur primarily on 
the surface of the cells or in the extracellular matrix (ECM). The advantages 
associated with these natural biomaterials can be listed as follows: 
• These materials being similar to the macromolecular substances get easily 
recognized by the biological environment and therefore deal metabolically. 
• Problems of toxicity, chronic inflammation, and lack of recognition by cells 
which occurs mostly with synthetic materials can be avoided. 
•  These materials are biodegradable, and therefore it can be used for 
applications where it is desired to deliver a specific function for a temporary 
period of time [52]. 
 
1.3  Performance Factors for Implant Materials  
The design and selection of biomaterials depend on the function of the implant which 
allows researchers to create new materials with desired pyhical, chemical and 
biological properties. Thus, development of new biomaterials often requires a 
collaborative work between diffent disciplines from  material scientists, engineers to 
clinicians [45]. 
It is well established that the bulk and surface properties of synthetic biomaterials, 
determine their long-term performance and stability under in vivo conditions. The 
bulk properties of an implant material can be characterized by its mechanical 
behavior and chemical stability under in vivo conditions. Based on the intended 
application and normal activity of the patient, an implant material may fail due to 
yielding, plastic deformation, rupture, fatigue, creep, corrosion, wear, and impact 
fracture. Further, since the atoms at the surface are highly unstable and drive most of 
the biological reactions at the tissue–implant interface, characterization and 
evaluation of surface properties plays an important role in determining its 
 biocompatibility to the surrounding 
that dictate the biological response
morphology, wettability, chemical composition, charge, crystallinity,
heterogeneity (Figure 1.6).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: Surface composition, roughness, topography, and energy are interelated 
surface characteristics tha
implanted device [45]
1.3.1 Chemical composition 
The chemical composition and charges on implant surfaces can be different 
depending on their bulk composition as well as surface treatments. It is well known 
that the composition and charges 
attachment. The surface chemical composition of 
of the implant surface [68].   
Commercially pure titanium or titanium alloys
orthopedic implants. Commercia
purity (graded from 1 to 4). This purity is 
content. Most dental implants are made from grade 
grades. Titanium alloys are mainly co
with greater yield strength and fatigue properties than pure titanium 
the effect of chemical composition
hydrophobicity, contact angle measurements of titanium implant surface
from 0
◦
 (hydrophilic) to 140
◦
 (hydrophobic)
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environment. The various surface parameters 
 to surfaces include surface roughness, surface 
 
t dictate the biological response to an 
. 
are critical for protein adsorption and cell 
implants affects the hydrophilicity 
 are preferred materials for dental and 
lly pure titanium (cpTi) has various degrees of 
characterized by oxygen, carbon and iron 
4 cpTi as it is stronger than other 
mposed of Ti6Al4V (grade 5 titanium alloy) 
[69, 70]. Due to 
 and various surface treatments on surface 
 is ranging 
. Highly hydrophilic surfaces seem to be 
and 
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more desirable than hydrophobic ones because of their interactions with biological 
fluids, cells and tissues [71-73]. Recent studies was shown in an animal model that a 
hydrophilic sand-blasted, acid-etched (SLA) implant surface yielded higher bone-to 
implant contact than a regular SLA surface [71].  
1.3.2 Mechanical behavior  
 The mechanical properties are one the major issue to decide the type of material for 
a specific application.  There are various parameters need to be consired such as 
hardness, tensile strength, modulus and elongation to design implant for proper 
function.  Among them, the fatigue strength of the material that is directly related the 
material response mostly determined by the repeated cyclic loads or strains. This 
feature determines the long-term success and usability of the implant that is 
subjected to cyclic loading. If an implant fractures due to poor strength or mismatch 
in mechanical property between the bone and implant, then this is referred to as 
biomechanical incompatibility. The implant material replaced for bone is expected to 
have a modulus equivalent to that bone. The bone modulus varies in the magnitude 
from 4 to 30 Gpa depending on the type of the bone and the direction of 
measurement [74, 45]. The current applicable implant materials shouldn`t have 
higher stiffness than bone. Higher stiffness prevents the needed stress being 
transferred to adjacent bone. The problem ended in bone resorption around the 
implant and consequently to implant loosening. This biomechanical incompatibility 
that cause to death of bone cells and this phenomena is called as ‘‘stress shielding 
effect” [75]. Thus a material with excellent combination of high strength and low 
modulus closer to bone has to be design for implantation due to the prevention   
loosening of implants and higher service period  for revision of  surgery [52]. 
1.3.3 Corrosion 
Corrosion is the weaknees of a material as a result of chemical and electrochemical 
reactions with its surrounding environment. It is a fact that most pure metals and 
alloys are chemically unstable in many everyday environments due to their tendency 
to corrosion. Gold is the obvious exception to this rule in typical terrestrial 
environments. In the complex environment of the human body, alloys are subject to 
electrochemical corrosion mechanisms, with body fluids acting as an electrolyte. 
Implant materials used inside a human body are generally exposed to a harsh 
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aqueous environment containing various anions (Cl
-
, HCO3
-
, HPO4
2-
), cations (Na
+
, 
K
+
, Ca
2+,
 Mg
2+
), organic substances, and dissolved oxygen [76, 77]. Hence metallic 
implant materials are prone towards aqueous corrosion. The metallic components of 
the alloy are initially oxidized to their ionic forms and release a free electron. The 
dissolved oxygen presents in the aqueous environment then react with the water 
molecules and free electron to form hydroxyl ions. These hydroxyl anions then react 
with the metallic cations to form a corrosion product [52].  
Corrosion resistance of the implants in the body fluid ended up the releasing of metal 
ions by the implants into the body. The released ions are caused allergic and toxic 
reactions which makes the implants as noncompatible materials [78, 79]. 
Development of implants with high corrosion resistance is emerged for the longevity 
of the material in the human system [45]. 
1.3.4 Surface characteristics  
Implant surface characteristics is one of the implant design factor affecting the rate 
and extention of osteointegration. The process of osteointegration is now well known 
both histologically and at the cellular level [80-82]. When an implant material is 
inserted into the living tissue, an interface is created between the surface of the 
foreign implant material and surrounding tissues. The surrounding tissue consists of 
water molecules, oxygen, negative and positive ions, proteins and other biomolecules 
that will attack the implant surfaces and they may further trigger to build larger 
structures such as cells and cell membranes. On the other hand, the surfaces of a 
foreign material may consist of individual atoms, molecules or large polymeric 
structures. Hence the surface of an implant is a termination of extended, three-
dimensional structure and thus generally represents broken bonds with higher surface 
energy. Because of thermodynamic and kinetic reasons, when implant surface comes 
in to the contact with the biological environment, it reacts immediately to form new 
bonds and compounds to lower the surface energy. The nature of implant surfaces 
plays a major role in thermodynamic process at implant-tissue interface. Therefore 
surface characteristics of implant materials such as chemistry, topography, 
roughness, wettability and energy may influence the cell interaction and 
consequently tissue integration [83, 52, 68].  
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1.3.4.1 Surface chemistry  
Implant surface chemistry plays an important role in protein adsorption and 
subsequent cell adhesion. Although several studies have provided insights into the 
relationships between surface chemistry and protein adsorption, many of these 
experimental systems suffer either from a lack of surface homogeneity or 
uncharacterized surface properties. For instance, polymeric surfaces can undergo 
conformational rearrangements in response to environmental conditions and can 
exhibit differences in surface roughness and chemistry depending on processing or 
surface modifications [84, 85]. To address these limitations, recent work has focused 
on model substrates with well-controlled properties [86-88]. In particular, self-
assembled monolayers (SAMs) of alkanethiols on gold have provided a useful model 
system to systematically investigate the effects of surface chemistry without altering 
other surface properties such as roughness. Recent studies using alkanethiol SAMs 
have demonstrated that surface chemistry can modulate cell adhesion, spreading and 
adhesion strength [89-91]. The same has been observed for titanium. For example, 
the surface oxide layer of titanium has many qualities regarded as important for 
promoting bone growth. This oxide layer of titanium can be manipulated chemically 
and there has been speculation whether the biological properties of the oxide surface 
may then be changed and even improved. The significance of titanium surface 
chemistry can be illustrated by the various cellular responses reported for different 
titanium alloys, different grades of c.p. titanium, and different bulk metals [92]. 
Specifically, chemical modification of titanium surfaces through their treatment in 
simulated body fluid, covalent attachment of biological molecules, changes in the 
surface ion content, and alkali soaking have all been reported to influence cellular 
responses (but to different degrees) [92]. An electrochemical method known as 
anodization or anodic oxidation is a well-established surface modification technique 
for titanium that produces protective layers. Anodization has been successfully used 
as a surface treatment for orthopedic implants and has some new advances recently 
reported to increase bone growth when possessing nanometer features [93]. Other 
strategies for improving the biocompatibility and osteogenic capacity of metal 
implants include surface modification with inorganic mineral coatings, particulates, 
or cements containing a diversity of calcium salts (mainly calcium phosphates, 
sulfates or carbonates) [94]. The idea behind all of these strategies is to make the 
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metal surface more acceptable to bone cells and, by doing so, trick the body into 
rapid integration of the implanted structure rather than fibrous encapsulation. An 
emerging area, still at the experimental stage to change chemistry to promote bone 
growth, is the use of photolithography to produce micro- and nano-fabricated 
surfaces. Such surfaces, made of silicon and titanium, incorporate intentional surface 
chemical and topographical features in the nano- and micrometer scales to provide 
greater opportunities to promote cell behavior [95, 96, 21]. 
1.3.4.2 Surface hydrophobicity (wettability) 
Surface wettability is considered as a one of the important criteria that can control 
the biocompatibility of the implant materials due to its possible effect on protein 
adsorption followed by attachment of cells to the implant surface. The three most 
important factors that affect the wettability of the surface are its chemical 
composition, micro and nano structural topography and surface charge [52, 95, 97].  
Contact angle measurements indicate whether the surface is hydrophilic and 
hydrophobic. If the contact angle is high (> 90
0
) then the surface considered as a 
nonwetting or a hydrophobic surface. If the contact angle is small, then the surface is 
considered as wetting or a hydrophilic surface [98, 52, 99-101] (Figure 1.7). 
 
Figure 1.7: Schematic illustration of (a) a hydrophobic or non wetting surface (b) a 
hydrophilic or wetting surface [52]. 
In the literature, several studies have implied the interaction between different cell 
types or blood proteins and various solid substrates having different wettabilities to 
correlate the relationship between surface weattability and cell or blood 
compatibility. The surface of hexamethyldisiloxane were modeled to different 
degrees of wettability and thereby studied its effect on cell attachment, cell 
proliferation and cell morphology [52]. Cai et al investigated effect of titanium films 
shared the same surface chemistry but exhibited very different topographies on 
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protein adsorption and cellular growth [102]. On the other hand, Webster et al. 
demonstrated that the role of nano-topographies on different materials such as 
ceramics, polymer composites and metals on cellular response by increasing surface 
wettability. They also reported that adsorption of vitronectin and fibronectin which 
stimulates osteoblast adhesion on nanophase ceramics with greater wettability [103]. 
It is widely observed that cell adhesion and subsequent activity are generally better 
on hydrophilic surfaces [104, 105]. Therefore it is not surprising that materials for 
example titanium and hydroxyapatite with its hydrophilic character have high ability 
for osteointegration. Depending on all accumulated knowledge on surface 
wettability, the topographical features like roughness, energy and wettability modify 
cell behavior and alter the function of cells in the initial mechanism of 
osteointegration. Feng et al observed that, besides surface characteristics, the number 
of hydroxyl groups on implant surfaces influence the cell behavior [106, 97]. They 
also observed that the greater roughness, the larger surface energy and the higher 
number of hydroxyl groups, the greater number of adhered cells and cell activity. 
1.3.4.3 Surface topography and roughness 
It is well established that morphological features such as surface roughness and its 
topography can strongly affect the protein adsorption, cell attachment, cell 
proliferation, contact guidance, and differentiation.  Hence, it controls the rate and 
quality of new tissue formation at the interface [52, 95, 81]. Surface roughness is a 
vastly studied subject by numerous investigators with the goal of enhanced 
performance factors of implants and it is commonly divided, depending on the 
dimension of the measured surface features, into macro-, micro- and nano-roughness. 
Typically, these different roughness features are related to distinct effects during 
wound healing and osseointegration [68]. 
Macro-roughness comprises features in the range of millimeters to tens of 
micrometers. This scale directly relates to implant geometry, with threaded screw 
and macro-porous surface treatments.  The evidence exist that primary implant 
fixation and long-term mechanical stability can be improved by an appropriate 
macro-roughness. The underlying mechanism thereby is the mechanical interlocking 
between the macro-rough features of the implant surface and the surrounding bone 
profile [107, 108]. 
  
18 
 
Micro-roughness is defined as being in the range of 1–10 mm. This range of 
roughness maximizes the interlocking between mineralized bone and implant 
surface. Specifically, compared with smooth surfaces, micron surface roughness on 
titanium substrates created by sandblasting, etching, machining and the use of 
micron-sized metal bead coatings has enhanced osteoblast functions such as 
adhesion, proliferation, production of alkaline phosphatase, and deposition of 
calcium-containing mineral [109]. Many of these techniques are currently being 
incorporated into the orthopedic marketplace. In fact, improved osteoinduction of 
titanium was observed on microporous structures compared with non-microporous 
titanium which did not induce bone formation at all [110]. Several studies have 
further suggested that other microstructural features (such as grain and particle size) 
promote osteoblast functions compared with smooth surfaces. However, the type of 
micro-roughness created in these studies does not match the roughness that 
osteoblasts are naturally accustomed to in the body. Since bone is composed of 
constituent nanostructures, it is clear that instead of formulating surfaces with micron 
roughness, emphasis should be placed on techniques that create nanometer 
roughness; that is, indeed, the role nanophase materials can play in universally 
increasing the efficacy of orthopedic implants [111, 21, 96, 97]. 
1.3.4.4 Surface porosity  
Other design criteria to achieve successful implantation with best match the behavior 
of the bone is porous structure of implant materials. Implant material as mentioned 
above should be strong enough and durable to withstand the physiological loads 
placed upon it over the years.  Suitable balance between strength and stiffness has to 
be found similarity with bone structure. One consideration to achieve this has been 
the development of materials that exhibit substantial surface or total bulk porosity in 
medical applications [112]. 
The fabrication of porous materials has been actively researched since 1943, when B. 
Sosnik attempted to introduce pores into aluminium by adding mercury to the melt.  
Numerous investigations into porous materials where subsequently initiated in the 
early 1970s involving porous ceramic, polymeric, and metallic materials, which 
showed in animal studies to be potential candidates for porous implants that would 
enable bone ingrowth [113-116]. Although ceramics portray excellent corrosion 
resistance, the general opinion is that porous ceramic structures, as they are available 
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today, cannot be employed as load bearing implants, due to their intrinsic brittleness. 
Likewise, porous polymeric systems cannot sustain the mechanical forces present in 
joint replacement surgery. This led researchers to focus on porous metals, based on 
orthopaedic metallic materials, as a consequence of their superior fracture and 
fatigue resistance characteristics, which are required for load-bearing applications. 
A major problem concerning metallic implants in orthopaedic surgery is the 
mismatch of Young’s modulus between bone (10–30 GPa) and bulk metallic 
materials (between 110 GPa for Ti and 230 GPa for Co–Cr alloys). Due to this 
mechanical mismatch, bone is insufficiently loaded and becomes stress shielded, 
which eventually leads to bone resorption. It has been suggested that when bone loss 
is excessive, it can compromise the long-term clinical performance of the prosthesis 
[117]. 
The clinical literature of the past 30 years records a variety of approaches to this end 
and several researchers have performed studies aimed at clarifying the fundamental 
aspects of interactions between porous metals and hard tissue. Porous materials in 
implantation are increasingly attracting the widespread interest of researchers as a 
method of reducing stiffness mismatches and achieving stable long-term fixation by 
means of full bone ingrowth and there have been a number of previous reviews on 
the many different porous coatings and fully porous matrices that have been 
developed [118, 119]. 
1.3.5 Biocompatibility  
The materials used as implants are probable to be highly non toxic and should not 
cause any inflammatory or allergic reactions in the human body. The success of the 
biomaterials is mainly based on the biococompatibility of a material which can be 
defined the reaction of the human body to the implant [120]. The two main factors 
that influence the biocompatibility of a material, the one is the host response induced 
by the material and another one is the materials reponse or degradation induced by 
the environment around the implant. Depending on two main factors, materials can 
be subdivided into three different classes such as biotolerant, bioactive, and 
bioresorbable [45]. 
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Table 1.2 Classification of biomaterials based on their interaction with its 
surrounding tissue [45]. 
 
Classification Response Examples Effect  
Biotolerant  
Materials 
Formation of thin 
connective tissue 
capsules (0.1-
10µm) and the 
capsule does not 
adhere to the 
implant surface   
Polymer-poly tetra 
fluorethylene (PTFE), 
polymethyl metha 
acralyte(PMMA),Ti,Co-
Cr, etc. 
Rejection of the 
implant leading 
to failure of the 
implant  
Bioactive  
Materials 
Formation of bony 
tissue around the 
implant material 
and strongly 
integrates with the 
implant surface  
Bioglass, synthetic 
calcium phosphate 
including hydroxyl 
apatite (HAP) 
Acceptance of 
the implant 
leading to 
success of 
implantation  
 
Bioreabsorbable 
Materials  
 
Replaced by 
autologous tissue 
 
Polylactic acid and 
polyglycolic polymers 
and processed bone 
grafts, composites of all 
tissue extracts or 
proteins and structural 
support system 
 
Acceptance of 
the implant 
leading to 
success of 
implantation 
 
The classification of biomaterials based on the reaction against to the human body is 
given in Table 1.2. Bioactive materials are highly preferred due to their high 
integration capacity with surrounding bone; however, biotolerant implants are 
available for production of implant materials. When implants are exposed to human 
tissues and fluids, several reactions take place between the host and the implant 
material. The acceptability of these materials by our system were determined by 
these reactions [83]. Resorbable biomaterials are another type of material that 
degrade gradually over a period of time and are replaced by the natural host tissue. 
This leads to a very thin or nonexistent interfacial thickness.  There are various 
complications in the development of resorbable biomaterials such as maintenance of 
strength, stability of the interface during the degradation period, and matching 
resorption rates to the repair rates of the body. The concept of bioactive materials 
holds intermediate position in between resorbable and bioinert materials. All of the 
bioactive materials produce specific biological response and form an interfacial bond 
with adjacent tissue. Although they have wide ranges of bonding capacity with 
surrounding tissue,  bonding time, strength, and mechanism is changeable form one 
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material  type to another [121, 59].  There are two major issues with regard to 
biocompatibility. The one is thrombosis, which involves blood coagulation and 
adhesion of blood platelets to biomaterial surface, and the other second is the fibrous 
tissue encapsulation of biomaterials that are implanted in soft tissues. 
1.4 Biomaterials Induced Biological Response at Implant-Tissue Interface 
 
1.4.1 Material-host interactions  
Scientists are continuously investigating novel materials which can promote 
desirable responses from surrounding cells for better osteointegration. There are two 
important factors to produce implant materials with high compability with the human 
body. The first one is correct chemistry that has a role to support or stimulate an 
appropriate host response and the second one is geometric structure of an appropriate 
scaffold. Ideal implant material should also interact with the host tissue and even 
promoting differentiation of osteogenic cells, rather than acting as passive stage for 
the performance of any itinerant cells. Implant material performance on cell response 
subsequently bone apposition is critical for rapid integration [95]. However, 
frequently implant materials are not preferentially compatible with bone cells, which 
is responsible for bone formation. They have tendency to promote the formation of 
undesirable soft connective tissue by other cells such as fibroblasts. Fibrous soft 
tissue has been shown improper fixation into surrounding tissue which leads implant 
failure. Excessive fibrous tissue formation hinders osteoblast/osteoclast activities 
and, thus, less new bones regeneration between an implant and juxtaposed bone 
results. Osteoblasts and osteoclasts form and resorb bone, respectively [92]. 
It is clear that to design better orthopedic implant materials, one needs to concentrate 
on cellular processes that lead to efficient new bone growth. Positive responses from 
osteoblasts, including increased initial adhesion, proliferation, and differentiation 
from non-calcium depositing to calcium depositing cells are essential. In addition, 
coordinated activities between osteoblasts and the bone–resorbing cells, osteoclasts, 
are needed to maintain healthy bone surrounding the implant. Poor communication 
between these cells will lead to necrotic (or dead) bone juxtaposed to the implant 
which is much weaker and will lead to fracture in the bone surrounding the implant. 
Due to the importance of these specific cellular events, understanding cellular 
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recognition of implant surfaces in order to create biomaterial surface properties that 
maximize initial cellular interactions leading to more bone formation is required 
[122].  
A sequence and strongly interrelated events takes place at the implant surface after 
implantation of the material (Figure 1.8). Immediately after implantation, water 
molecules bind to the surface and form a water mono- or bilayer in nanoseconds. The 
arrangement of water molecules depends on the implant surface properties at the 
atomic scale.  Blood proteins and tissue specific proteins adsorb and desorb to and 
from the surface [123]. This adsorption process is strongly dependent on the implant 
surface features, such as its physicochemical, biochemical and topographic 
characteristics. Inorganic, physicochemical stimuli, such as release of Ca
2+ 
and PO4
- 3
 
ions from calcium phosphates, can positively affect the cellular response. Implant 
surfaces that have protrusions, cavities, gullies, etc., on a micro- and/or nanoscale 
will induce biological interactions different from those with a flat surface.  Indeed 
some studies provided evidence that in implant surface energy; surface chemical 
composition and topographical features influence the type and concentration of 
adsorbed proteins. For example, previous studies indicate that fibronectin 
preferentially adsorbs on calcium-phosphate coated bioactive glass compared with 
untreated bioactive glass and stoichiometric bioactive glass [124, 125]. Additionally, 
implants biochemically modified with biomolecules immobilized on the surface, 
such as growth factors or cell adhesion motifs, will induce certain cell responses in 
the physiological surrounding by specific cell signaling pathways. As a result, both 
the exact mixture of adsorbed proteins and their conformational state(s) are largely 
controlled by the implant surface. This surface specific adsorbed biofilm 
subsequently determines cell adhesion, since proteins act as contact for the 
attachment of cells. This is accomplished by means of integrins, which are specific 
transmembrane receptors that bind to adhesive proteins on the biomaterials surface 
and to components of the cytoskeleton through their extra- and intracellular domains, 
respectively. Moreover, it is now well known that osteoblasts preferentially adhere to 
specific amino acid sequences such as arginine- glycine-aspartic acid (RGD) and 
heparin sulfate binding regions in adsorbed proteins.  Accordingly, how specific 
amino acid sequences are exposed in adsorbed proteins to associate with binding to 
  
23 
 
integrin receptors in cell membranes is critical to whether cell adhesion will occur on 
an implant surface [122, 96, 95].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8: An example of biomaterial- tissue interactions, e.g., Implant- bone 
interactions [96]. 
In general, the biocompatibility of bone-replacing implant materials is closely related 
to osteoblast adhesion onto their surface. Osteoblast attachment, adhesion and 
spreading will influence the capacity of these cells to proliferate and to differentiate 
itself upon contact with the implant. These latter processes are quintessential for the 
establishment of a mechanically solid interface with complete fusion between the 
implant surface and bone tissue without any intervening fibrous tissue layer [126-
128]. 
1.4.2 Cell-surface interactions 
1.4.2.1 Protein adsorption  
Proteins adsorb in different quantities, densities, conformations, and orientations 
depending on the chemical and physical characteristics of the surface. Although 
surface-protein interactions are not well understood, surface chemistry has been 
shown to play a fundamental role in protein adsorption [129]. Moreover, the 
properties of protein over-layers can be altered by underlying surface chemistry of a 
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material and this behavior has exciting implications for controlled biocompatibility 
[87, 130-132].  
In here, we address the role of adsorbed proteins in directing cell responses to 
specific surface characteristics and materials. Proteins are highly surface active and 
thus exhibit high affinity for interfaces. Initial adsorption occurs rapidly, effectively 
preventing direct interactions between cells and implant materials. Adsorption may 
be promoted or opposed by a number of potential enthalpic and entropic changes 
within the surface- water protein system. Adsorption may be promoted or opposed by 
a number of potential enthalpic and entropic changes within surface-water-protein 
system. These changes can be summarized into three sections: 
1. Dehydration of protein and surfaces 
2. Redistribution of charged groups in the interface 
3. Conformational changes in the protein molecule 
The relative significance of each process depends on the nature of the protein, 
material surface and solvent [133, 87].  
In complex biological components- surface interaction process, adsorption will 
increase with time and protein concentration in solution until at least the coating 
approaches monolayer coverage. The adsorption rate then decrease in relation to the 
number of available binding sites, becoming progressively more dependent on the 
protein-surface affinity. Such trends however are not necessarily indicative of 
adsorption behavior from mixed solutions, such as blood [92]. 
In implantation, after the initial hydration layer surrounds the material, blood 
proteins and other macromolecules (e.g., lipids and sugars) arrive at the surface. 
Since blood contains many hundreds of different proteins competition for the surface 
ensues. After a complex process of adsorption, desorption and surface 
rearrangement, wherein the protein layer composition changes dramatically over 
time, equilibrium is reached at the interface. It is generally accepted that the more 
abundant small proteins will adsorb first due to their rapid transport to the surface. 
Over time these are then replaced by larger proteins with a greater affinity towards 
the surface. The ‘surface enrichment’ of a protein from the ECM such as fibrinogen 
was first observed by Vroman and Adams and is generally termed the ‘Vroman 
effect’[134, 135]. The protein layer may then subsequently mediate cell attachment 
and progressively the material is integrated into the biological system. 
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Fundamentally, biomaterial responses are governed by the interaction of protein 
molecules on surfaces, involving both binding in the initial stage and subsequent 
unfolding. Residues pointing outwards into solution are available for surface 
interaction whereas those in the core of the protein are not. Unfolding, or denaturing 
of the protein would allow the internal amino acid residues to become accessible to 
the external environment thereby making them available to take part in external 
interactions. Protein deformation may be induced by interaction with a surface and is 
affected by several factors including electrostatic forces and entropic effects, 
hydrophobic interactions and conformational changes [133, 122, 96].  
 
Figure 1.9: Schematic representation of events consecutively taking place at the 
titanium surface after implantation into living bone tissue. Water binds 
to the surface, followed by incorporation of hydrated ions, adsorption 
and desorption of proteins, eventually leading to cell attachment. After 
differentiation, mature osteoblasts produce the extracellular matrix 
(ECM) [122].  
Dehydration of hydrophobic regions both on the substratum and on the external 
protein surface is favourable, which may cause the protein to deform to move its 
hydrophobic sections away from the aqueous environment (Figure 1.9 and Figure 
1.10). Bonding between adsorbed neighbouring protein molecules can allow 
hydrophobic regions to remain shielded from the aqueous phase, due to the increase 
in flexibility of the polypeptide backbone brought about by loss of secondary 
structure. Van der Waals interactions, electrostatic interactions and hydrogen bonds 
can also form between proteins, provided they are enthalpically favourable. Model 
surfaces with varying functionalities have been used to assess protein adsorption 
rates and conformational stability upon adsorption. Proteins adsorb rapidly and 
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become deformed to a greater extent on surfaces with decreasing wettability, 
minimising hydrophobic contact with the aqueous phase as described above [132]. 
Likewise charged protein regions can interact with oppositely charged surfaces 
[136], although electrostatic effects are much weaker than hydroph obic effects when 
dealing with proteins adsorbing from an aqueous phase, due to complications arising 
from the charges being shielded by water molecules [137] and small ions [138]. 
Protein–surface interactions are very important factors when considering the 
adsorbed protein state. Initially protein molecules will adsorb giving the kinetic 
adsorption product, however, if the interaction is very high a deformation of the 
protein to afford an energetically more favourable thermodynamic adsorption 
product occurs. 
 
Figure 1.10: Schematic drawing to represent the protein-biomaterial interactions 
which often guide to conformational changes of adsorbed proteins and 
the subsequent disclosure of hidden proinflammatory epitopes [133]. 
This process, sometimes termed ‘relaxation’ occurs either directly on adsorption or 
some time thereafter, probably involving the protein spreading to increase its 
interaction with the surface and/or to decrease its interaction with the aqueous phase. 
Similarly, differing protein–surface interactions could force protein molecules to 
adopt specific orientations. As a result the protein may lose the specific structure 
required for activity, or functional sites may become obscured due to 
conformational/orientational rearrangements that hinder protein function [92, 96, 
133]. 
1.4.2.2 Cell adhesion  
In a physiological environment cell adhesion always follows protein adsorption. 
Cells are sensitive and responsive to the topography and surface chemistry of the 
material which they interact. Although cell-surface interaction may be affected by 
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several parameters, the interaction mechanism needs to be elucidated [129, 111, 92, 
96, 83, 139].  
Cells in their nature environment are anchored by discrete attachments to proteins in 
extracellular matrix. Osteoblastic cells (and various other cell types) in vitro  have 
been shown to depend primarily on adsorbed vitronectin or fibronection for initial 
adhesion and spreading on implant material [140, 141]. Thus, the ability of materials 
to adsorb such proteins (in an active state) determines their ability to support cell 
adhesion and spreading [142, 143] and, hence, is an important aspect of their 
biocompatibility. 
The primary interaction between cells and adhesion proteins occurs via integrins 
(heterodimeric receptors in the cell membrane), as demonstrated by the decrease in 
cell attachment observed when antibodies are introduced to prevent these 
interactions. Sinha et. al. conclude that differences in integrin expression observed 
on different materials may account for observed variations in cell attachment. 
Integrins are also involved in intracellular signaling and, thus, a diverse range of cell 
functions [144, 145]. Integrins bind specifically to an arginine-glycine- aspartic acid 
(RGD tripeptide) found in cell adhesive proteins such as fibronectin, vitronectin and 
laminin. Moreover, it is now well recognized that osteoblasts preferentially adhere to 
RGD in adsorbed proteins on implant surfaces. Accordingly, how specific amino 
acid sequences are exposed in adsorbed proteins to associate with binding to integrin 
receptors in cell membranes is critical to whether cell adhesion will occur on an 
implant surface (Figure 1.11). 
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Figure 1.11: Initial protein interactions leading to cell recognition of implants [95]. 
Although the initial states of the surface, the cells, and the interface between them 
are critical, we should also consider the dynamic nature of the system. Cells may 
alter their environment and adhesion mechanism by secreting fibronectin, or by 
manipulating the extracellular matrix, as is discussed below. Furthermore, cells adapt 
to their environment. It has been demonstrated that nonadherent fibroblasts reduce 
production and/or secretion of fibronectin and the cell surface expression of its major 
receptor [146, 147]. Cells also adapt by changing the collection of integrins 
expressed, and their distribution, according to the ligands available and the 
differentiation state of the cells. Because of upregulation (and localization) of 
integrins when their preferred ligand is available, it is possible that differential 
integrin expression reflects distinct adsorption profiles characteristic of underlying 
surface properties. This may also account for differences observed in integrin 
expression in bone tissue [148, 146]. 
1.4.2.3 Cell morphology and motility  
Cell spreading is a process related to adhesion and usually involves similar 
extracellular proteins. In addition to their effects on cell adhesion, proteins such as 
vitronectin and fibronectin are required for the formation of focal contacts and 
essential intracellular structures [149]. Massia  et. al. [150] estimated that a ligand 
spacing of 140 nm or less was needed for these structures to form, although response 
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to ligand density may be altered by surface topography. The distribution of ligands 
on the substratum and the availability of the appropriate binding sites are thus 
important in cell adhesion, spreading, and subsequent functions[151]. In addition to 
adaptations relating to integrin expression and fibronectin production, a progressive 
change in the mechanism of anchorage is frequently observed as cells reorganize 
their cytoskeleton, and also the extracellular matrix to which they are anchored 
[152]. As cells spread, contractile forces apply tension to the extracellular matrix; 
these forces may be sufficient to remove adsorbed proteins from a biomaterial 
surface. Fibroblasts were thus able to remove fibronectin from a glass surface. 
Although this could potentially disrupt adhesion, it may assist in extracellular fibril 
assembly, suggesting that there is an upper limit to protein adsorption strength for 
normal cell activity to occur. Cell motility (including migration) also depends on the 
nature of adhesion to the substratum. Adhesive ligands are required for this and may 
provide a haptotactic signal, with a peak in migration being observed at certain 
intermediate ligand concentrations on the surface [153]. The ligand density 
corresponding to this peak is reduced with increasing strength of cell binding 
[154].However, migration rates and cell adhesion strength on various surfaces often 
show opposite trends [155, 156].  Webb et al. also showed an inverse relationship 
between cell migration and spreading [104]. Thus, it is apparent that maximal cell 
motility requires adhesion strength sufficient to maintain substratum contact, but not 
to the extent that release of contacts is inhibited. 
14.2.4. Cell proliferation and differentiation 
It is well established that cell adhesion and morphology influence subsequent activity 
such as proliferation and differentiation [157]. With respect to osteoblasts and 
adsorbed proteins, fibronectin (and its receptors) appears to become progressively 
more important as the cells differentiate [158]. Given that osteoblasts (and most other 
cells) produce their own fibronectin, this may reflect the deposition of an 
increasingly agreeable environment. Furthermore, Altankov et.al. propose that 
reorganization of surface-bound fibronectin is required for fibroblast proliferation 
[159]. Corresponding to the role of fibronectin, the β1 integrin subunit (to which it 
frequently binds, particularly in the α5β1 dimer) is predominant in the progression of 
precursor cells toward differentiated osteoblasts [160] and ligand binding by β1 is 
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required for matrix mineralization[161]. The β1 integrin is also involved in binding 
collagen and laminin. 
The (not exclusively) vitronectin-binding αVβ3 integrin heterodimer also appears to 
be involved in mineralization. The αVβ3 integrin is also a key mediator of 
angiogenesis and osteoclast adhesion to extracellular matrix, suggesting a key role 
for its various ligands in bone repair and remodeling [162].  
Although adhesion is clearly critical in osteoblast development, excessive adhesion 
strength may inhibit subsequent cell activities, as indicated above with regard to cell 
motility. Qiu et al. showed increased marrow stromal cell attachment on positively 
charged surfaces, but these cells also showed reduced spreading and differentiation 
[163]. This emphasizes that cell adhesion alone is not an adequate indicator of 
biocompatibility when a specific function is required. 
Implant surfaces may also contribute to the proliferation and/or differentiation 
promoted by growth factors and other signaling molecules. Adsorbed proteins may 
provide binding sites for other molecules, mimicking storage in the extracellular 
matrix in vivo; for example, insulin-like growth factor II (IGF-II) is stored in bone as 
a complex with IGF-binding protein 5 (IGFBP-5), which in turn binds to bone matrix 
hydroxyapatite [164, 165]. Studies have exploited this concept to use vitronectin as a 
delivery vehicle for insulin-like growth factors [166]. 
 
1.5 Challenges at Implant–Tissue Interface  
1.5.1 Osseointegration 
A goal of current implantology research is to design devices that induce controlled, 
guided, and rapid healing. In addition to acceleration of normal wound healing 
phenomena, endosseous implants should result in formation of a characteristic 
interfacial layer and bone matrix with adequate biomechanical properties. To achieve 
these goals, however, a better understanding of events at the interface and of the 
effects biomaterials have on bone and bone cells is needed. Such knowledge is 
essential for developing strategies to optimally control osseointegration [167]. 
Osseointegration clearly belongs to the category of direct or primary healing. 
Originally, it was defined as direct bone deposition on the implant surfaces. In a 
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more comprehensive way, osseointegration is characterized as “a direct structural 
and functional connection between ordered, living bone and the surface of load 
bearing implant “ [168]. This term was initially defined by Branemark et al. 
Throughout bone to implant contact; specifically, the dynamic cellular and acellular 
processes at the interface at a micro- and nanoscale level are not fully elucidated 
[169]. Additionally, early aspects of the bone/biomaterial interaction in terms of 
seconds and minutes are not well known in the in vivo environment. Recent 
knowledge in both aspects of implant osseointegration is even more limited when the 
process of biomineral formation is under consideration. To gain insight into the state 
of mineralization at implant interfaces, the various levels of bone structure and 
physiology are considered and evaluated in light of the recent knowledge on implant 
osseointegration [170]. 
1.5.1.1 Prerequisites for osseointegration 
Osseointegration shares many prerequisites with primary fracture healing, such as 
precise fitting (anatomical eduction), primary stability (stable fixation) and adequate 
loading during the healing period. In addition, it requires bioinert or bioactive 
material with desired surface properties that are attractive for bone deposition. The 
tissue response to a freshly installed implant greatly depends on the mechanical 
situation. As in direct fracture healing, it requires perfect stability if bone is expected 
to be formed. In a fracture, a stable fixation is obtained by exact adaptation and 
compression of the fragments. The primary stability of implants depends on their 
appropriate design and precise press fitting at surgery. Primary stability must 
counteract all forces that could create micromotion between the implant and the 
surrounding tissues or in other words, it should build up enough preload to 
compensate for functional load. It thus determines not only the size but also the 
direction of the forces that are considered to remain adequate. All these parameters 
must be specified, and this makes it understandable why immediate functional 
loading may be adequate for such systems as bar-connected screws, whereas others 
require a prolonged, unloaded healing period before a supraconstruction can be 
installed. 
Direct bone healing, it occurs in defects, primary fracture healing and in 
osseointegration is activated by any lesion of the pre-existing bone matrix. When the 
matrix is exposed to extracellular fluid, noncollagenous proteins and growth factors 
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are set free and activate bone repair. Once activated, osseointegration follows a 
common stages first, incorporation by woven bone formation; second, adaptation of 
bone mass to load (lamellar and parallel-fibered bone deposition) and third, 
adaptation of bone structure to load [171, 172]. 
In the first stage, primitive type of bone or woven bone tissue characterized by a 
random, felt like orientation of its collagen fibrils, numerous, irregularly shaped 
osteocytes and low mineral density formed. It has an outstanding capacity. It grows 
by forming a scaffold of rods and plates and thus is able to spread out into the 
surrounding tissue at a relatively rapid rate. Woven bone is the ideal filling material 
for an open space and for the construction of the first bony bridges between bony 
walls and the implant surface. It usually starts growing from the surrounding bone 
towards the implant, except in narrow gaps, where it is simultaneously deposited 
upon the implant surface. Woven bone formation clearly dominates the scene within 
the first 4 to 6 weeks after surgery. Following woven bone formation stage, new 
bone formed towards either well known lamellar bone or parallel- fibered bone. 
Deposition of more mature bone on the initially formed scaffold results in 
reinforcement and often concentrates on the areas where major forces and transferred 
from the implant to the surrounding original bone. At the last stage of 
osseointegration is bone remodeling. This stage contributes to an adaptation of bone 
structure to load in two ways: 
1. It improves bone quality by replacing pre-existing, necrotic bone and/or 
initially formed, more primitive woven bone with mature, viable lamellar 
bone. 
2. It leads to a functional adaptation of the bone structure to load by changing 
the dimension and orientation of the supporting elements. 
It has been mentioned already that bone remodeling continues throughout life and 
thus becomes important for the longevity of implants. Continuous replacement of old 
bone by new bone prevents accumulation of microdamage and fatigue as one 
possible cause of aseptic implant loosening [168, 170]. 
1.5.2 Bacterial infection  
Bacterial infection at the site of implanted medical devices presents a serious 
ongoing problem in the biomedical area [173].  Infections associated with surgical 
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implants are generally aggressive and more cumbersome to manage, have a greater 
adverse impact on quality of life, result in primary cause of implant failure, excessive 
prolongation of hospital stays, and incur higher costs [174, 175]. They are very 
common various type of  implants, including prosthetic heart valves, orthopedic 
implants, cardiac pacemakers, intravascular catheters, left ventricular assist devices, 
urinary catheters,  vascular prostheses, ocular prostheses, cerebrospinal fluid shunts 
and contact lenses, and intrauterine contraceptive devices [176]. 2.6 million 
orthopedic implants inserted into humans annually in the United States, 
approximately 4.3% become infected. The annual infection rate for cardiovascular 
implants is even higher (7.4%). When considering all indwelling devices, the number 
of implant-associated infections approaches approximately 1 million per year [177, 
173, 178].  
At the cellular level, implant-associated infections are the result of bacterial adhesion 
to a biomaterial surface. Upon implantation, a competition exists between integration 
of the material into the surrounding tissue and adhesion of bacteria to the implant 
surface. For a successful implant, tissue integration occurs prior to appreciable 
bacterial adhesion, thereby preventing colonization at the implant. However, host 
defences are often not capable of preventing further colonization if bacterial adhesion 
occurs before tissue integration [179]. A 6 h post-implantation ‘‘decisive period’’ has 
been identified during which prevention of bacterial adhesion is critical to the long-
term success of an implant [180]. Over this period, an implant is particularly 
susceptible to surface colonization. At extended periods, certain species of adhered 
bacteria are capable of forming a biofilm at the implant-tissue interface. Biofilms are 
remarkably resistant to both the immune response and systemic antibiotic therapies, 
and thus their development is the primary cause of implant-associated infection. The 
formation of a pathogenic biofilm ensues from the initial adhesion of bacteria to an 
implant surface. Thus, inhibiting bacterial adhesion is often regarded as the most 
critical step to preventing implant-associated infection [181, 173]. 
Implant infections or biofilm formation can be traced to several sources including the 
ambient atmosphere of the operating room, surgical equipment, clothing worn by 
medical professionals, resident bacteria on the patient’s skin, and bacteria already in 
the body [182]. Although sterilization and the use of aseptic techniques greatly 
reduces the levels of bacteria found in hospital settings, pathogenic microorganisms 
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are still found at the site of approximately 90% of all implants [183]. The most 
common pathogens that cause implant infections include Gram-positive 
Staphylococcus aureus and Staphylococcus epidermidis, which are responsible for up 
to 60% of all prosthetic hip implant infections since 1980 [182]. S. aureus infections 
proceed rapidly and are generally more severe than S. epidermidis infections. 
However, S. epidermidis has more accessibility as an opportunistic pathogen since it 
is found ubiquitously on the skin. Other bacteria that have been implicated in 
implant-associated infections include Gram-negative Escherichia coli, Pseudomonas 
aeruginosa, and those from the Proteus group (e.g., P. mirabilis and P. vulgaris) 
[182]. 
A pathogenic biofilm formation occurs in many steps which can also be categorized 
based on time dependent phases and formation of steps. The coating of surfaces with 
a  layer consisting of proteins such as fibronectin, vitronectin, fibrinogen, albumin, 
and immunoglobulins, many of which serve as binding ligands to receptors on 
colonizing bacteria represents the initial step of biofilm formation (Fig.1.12a, Step 
1). Following, bacteria, transported to the substratum (Fig.1.12a, Step 2), adhere 
through either a nonspecific or specific binding reaction (Step 3). These steps can be 
included in phase I (Figure 1.12b). Phase I also involves reversible cellular 
association with the surface over the first 1–2 h post-implantation. This nonspecific 
association is mediated through long (e.g., gravitational, van der waals, and 
electrostatic interactions) and short (e.g., hydrogen bonding, dipole–dipole, ionic, 
and hydrophobic interactions) range forces. If the forces are weak, bacteria may 
desorb into the liquid (Step 4). Once attached firmly to the substratum, bacteria begin 
cell-to-cell signal communications (Step 5) that may control growth, replication, 
plasmid conjugation, secretion of various virulence factors, and secretion of 
extracellular mucopolysaccharides, which can form a three-dimensional gelatinous 
matrix (Figure 1.12a, Steps 6, 7, and 8). These steps can be named phase II (Figure 
1.12b).  It begins approximately 2–3 h later and is characterized by stronger adhesion 
between the bacteria and the foreign material. Irreversible molecular bridging can 
settle down between compounds on the cell and substrate surfaces through the  
specific chemical reactions [184]. Both polysaccharides on and adhesin proteins 
within the bacterial membrane facilitate attachment to substrate surfaces. Beyond 
phase II, certain bacterial strains are capable of forming a biofilm if provided with an 
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appropriate supply of nutrients. During biofilm formation, bacteria secrete an 
exopolysaccharide layer that retains nutrients and protects the microorganisms from 
the immune response [173, 185, 186, 184]. 
 
Figure1.12: a) Biofilm formation [176], b) Representation of bacterial adhesion to a 
biomaterial substrate. Phase I adhesion involves reversible cellular 
association with the surface. During Phase II, bacteria undergo 
irreversible molecular bridging with the substrate through cell surface 
adhesin compounds. After approximately 1d, certain bacterial species 
are capable of secreting a protective exopolysaccharide matrix (biofilm) 
that protects the adhered bacteria from host defences and systemically-
administered antibiotics [173]. 
With the protective polysaccharide coating and sequestered nutrients, bacteria in 
biofilms exhibit extreme resistance to antibiotics. In some cases, it has been found 
that killing bacteria in a biofilm requires roughly 1000 times the antibiotic dose 
necessary to achieve the same results in a suspension of cells [187]. 
In the strategy for the prevention of infections, much has been done to improve the 
operating standards, minimize the possibility of contamination during surgery, 
reduce the establishment of infection by peri-operative antibiotic prophylaxis, and 
confine pathogenic strains by patient isolation [188, 189]. Along these directions 
further improvements can still be made, but little advancements in terms of decreased 
infection rates are being expected in return of this type of efforts [189]. As a 
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consequence, over the last 15 years, increasing attention has progressively been 
focused on the epidemiology and the pathogenesis of the infections, especially those 
associated to implant materials, in order to build knowledge and gain better control 
over this phenomenon. Many effort have been directed to investigate which are the 
most important etiologic agents involved, the pathogenetic mechanisms leading to 
microbial adhesion, colonization of implant surfaces, and evasion of the host 
defenses, the most crucial virulence factors, the nature and properties of microbial 
biofilms and, not last, the progressive alarming appearance of antibiotic resistant 
strains [190]. 
1.5.2.1 Main pathogen bacteria involved in implant Infections 
Organization of bacteria in biofilm that cause implant infections is not random. It is 
quietly depending on implantation site and bacterial communication.  
In orthopedics, it is well established that the vast majority of implant-related 
infections is due to Gram positive aerobes, staphylococci species in first place. Based 
on orthopedic clinical isolates, exclusively from infections associated to prosthetic 
implants (including these: artificial knees, hips, tendons and ligaments, fixation 
systems, and so on), about 16% of the infections are of polymicrobial origin. A very 
large proportion of all implant-related infections are caused by staphylococci 
(roughly four out of five), and two single staphylococcal species, respectively 
Staphylococcus aureus and Staphylococcus epidermidis, account together for two out 
of three infection isolates. They represent, in absolute, the main causative agents in 
orthopedics, while CoNS species other than S. epidermidis, and, especially among 
them, Staphylococcus hominis and Staphylococcus haemolyticus, contribute to an 
additional 13% of the infections (Figure 1. 13). In order of relevance in terms of 
prevalence then there follow Pseudomonas aeruginosa and Enterococcus faecalis. 
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Figure 1.13: Frequency of main pathogenic species among orthopedic clinical 
isolates of implant-associated infections [190]. 
In other words, infections caused by all existing pathogenic microbial species except 
staphylococci represent together only a minority of implant infections, just about 
22%. The Staphylococcus genus therefore acquires a huge importance in implant-
related infections. It comprises important pathogenic species such as S. aureus, at 
times currently even deserving the denomination of ‘‘superbug’’[191], along with a 
broad number of typically saprophytic species capable to become harmful only when 
host defenses are significantly endangered. This holds a series of implications, the 
most important of which is that there are two main similar enemies belonging to the 
same group to defeat: S. aureus and S. epidermidis. Another one is that fully 
understanding the mechanisms underlying staphylococcal virulence and 
pathogenicity [192, 193]  would provide unique clues to tackle the phenomenon of 
implant infection both on a prevention and on a treatment level, with significant 
numeric impact and vast clinical outcomes. As far as this is concerned, the 
comparison of the, at times subtle, differences between saprophytic CoNS species, 
and the more aggressive S. aureus can give important insights [194, 190]. 
In case of dental implant infections, it has been shown that there are specific 
associations among bacteria in dental biofilms. Socransky et al.  examined over 
13.000 subgingival plaque samples from 185 adult subjects and used cluster analysis 
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and community ordination techniques to demonstrate the presence of specific 
microbial groups within dental plaque (Figure 1.14) [195]. Six closely associated 
groups of bacterial species were recognized. These included the Actinomyces, a 
yellow complex consisting of members of the genus Streptococcus, a green complex 
consisting of Capnocytophaga species, Actinobacillus actinomycetemcomitans 
serotype a, Eikenella corrodens and Campylobacter concisus and a purple complex 
consisting of Veillonella parvula and Actinomyces odontolyticus. These groups of 
species are early colonizers of the tooth surface, and their growth usually precedes 
the multiplication of the predominantly gram negative orange and red complexes 
(Figure 1.14). Similar relationships have been demonstrated in in vitro studies 
examining interactions between different oral bacterial species. These studies of oral 
bacteria have indicated that cell-to-cell recognition is not random but that each strain 
has a defined set of coaggregation partners [196].  
 
Figure 1.14: Diagram of the association among subgingival species [196]. 
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1.6 Approaches for Implant-Tissue Integration  
1.6.1 Implant surface modifications for better osseointegration  
Variations in biological activity at the interface between materials and host tissue can 
be correlated with specific surface properties. Chemical composition, energy, 
roughness, and topography [197, 198] are all believed to help determine the activity 
of different cell lines, acting either separately or synergistically. The connections 
between the physico/chemical properties of surfaces and cellular responses are still 
not fully understood. Once they are elucidated, however, they will improve our 
understanding of fundamental biological processes. At the same time, the ability for 
tailoring surfaces to control cellular events and guide the cells along predetermined 
pathways will pave the way for the rational design of a new generation of 
biomaterials that can be integrated in the human body more effectively and 
beneficially.  In the classical conception of conventional biologically, inert or 
biocompatible materials will gradually be replaced by a new generation of ‘‘smart’’ 
materials with intelligent surfaces able to interact decisively with the biological 
environment, and that may even initiate selective reactions in response to differential 
cues. Surface properties of materials can be modified on a range of scales by various 
techniques, [199, 200] with the common aim of collecting information to unravel the 
link between surface cues and cellular response. Straightforward surface treatments 
that have frequently been used to modify the behavior of biocompatible metals 
include polishing, grinding, blasting, and machining and chemical methods such as 
acid etching, alkali etching and anodization [201-203, 52]. Such mechanical 
methods, used either individually or in combination with other treatments, mainly 
cause the formation of different topographies with inhomogeneous micrometric 
features (Figure 1.15) [97]. These features have been demonstrated to have an impact 
on cellular activities and on osseointegration [69, 204, 205, 97, 206]. Another 
approach towards the creation of biologically active implants surface involves the 
application of an additional coating onto the implant surface by means of 
physicochemical and biochemical deposition techniques [207]. 
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Figure 1.15: SEM micrographs of the dental implants surfaces. (A) machined, (B) 
acid etched, (C) sandblasted and (D) anodized [97]. 
1.6.1.1 Chemical surface modifications  
Recent work has established that key biological processes, including protein 
adsorption, cell proliferation, and gene expression, can be controlled to some extent 
by using chemical methods to modify the surface properties of biocompatible 
materials [208]. The most popular and efficient ways to modify surfaces involve 
direct chemical modifications with acids and oxidants. Chemical treatments are 
attractive for large-scale manufacturing because they are simple and provide efficient 
and uniform access to all surfaces, even on multifaceted devices with complex 3D 
shapes such as dental screws and cardiovascular stents. In principle, chemical 
modifications leading to controlled surface functionalization can be also applied to 
other families of materials such as polymers [209], thus extending the scope of the 
technique. For example, it was reported that poly(lactic-coglycolic acid) can be 
nanostructured by chemical etching with NaOH, resulting in a material with novel 
surface features able to enhance the activity of various cell types [85, 32, 210]. 
Together, these characteristics make chemical treatments an advantageous and 
flexible way to modify biomaterials for commercial applications. Different chemical 
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treatments with acids, [211-213] bases and oxidants [214] have been used to create 
micrometer-scale and submicrometer-scale textures on surfaces (Figure 1.16) [207]. 
 
 
 
Figure 1.16: Scanning electron microscopy (SEM) images illustrating various 
microtextures achieved on Ti after etching in 48% H2SO4 at 60
0
C for 
0.25, 0.5, 1, 3, and 8 h. The upper row displays micrographs with higher 
magnification [207].  
Such studies have revealed that chemically treated surfaces can enhance the adhesion 
and proliferation of osteogenic cells, precipitation of apatite, and the expression of 
bone-related genes and proteins [202, 215]. From these observations, surfaces that 
are hydrophilic, microrough, and porous appear to have beneficial effects on various 
biological phenomena. 
Although chemical treatments have yielded a variety of microtextured implants with 
improved clinical outcomes, the demonstration in several laboratories that cell 
respond to nanofeatures has intensified the application of chemical treatments for 
nanostructuring biometals [71, 216]. A particularly effective method for 
nanostructuring titanium-based metals is electrochemical oxidation [217]. By 
adjusting parameters such as the nature of the electrolyte, voltage, and current 
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density, smooth Ti surfaces [218-220] were transformed into nanotubular tructures 
(Figure 1.17), with diameters less than 100 nm [207]. 
Biological studies carried out on these anodized Ti surfaces revealed a general 
increase of in vitro activity, measured by enhanced osteoblastic activit  and mineral 
precipitation [221]. 
 
 Figure 1.17: SEM image of nanotubular structures created by anodization of Ti 
[207].  
Anodization creates nanoscale topographies, yet it also allows control over other 
physical properties such as pore size and the thickness of the oxide layer, [222] thus 
providing a way to conduct targeted experiments (e.g., varying only the dimension of 
surface features) to reveal how each of these parameters affects cellular behavior. A 
different chemical approach for modifying the surface of metals is based on the 
observation that etching with combinations of strong acids and oxidants can generate 
a micro and nanotopography. Mixtures of sulfuric acid (H2SO4) and hydrogen 
peroxide (H2O2) have been shown to reproducibly yield networks of nanometer-sized 
pits around 20 nm in diameter (Figure 1.18) on Ti  [223, 224] , and Ti6Al4V alloy 
[225]. 
Surface morphology, wettability, nanoroughness, and the thickness of the TiO2 
overlayer can be controlled by adjusting the length of exposure to the etching 
solution. It is also possible to vary the density of OH groups on the surface, which is 
believed to influence cell activity [224]. Unlike other methods described so far for 
structuring surfaces, this chemical treatment of Ti and its alloys creates surfaces with 
distinctive discriminatory effects on different cell types.  
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Figure 1.18:  SEM image of the characteristic nanometric sponge-like structure that 
is achieved by treatment of Ti with H2SO4/H2O2 [207]. 
The properties of surfaces can also be modified at the nanometric level by using 
other processes such as sol–gel [226] and chemical vapor deposition (CVD) [227]. In 
vitro biological tests on materials coated in these ways have demonstrated that the 
novel surface features have beneficial effects on bone cell activities, including 
adhesion, spreading, and matrix mineralization. Chemical strategies have been 
efficiently exploited to create nanostructured coatings of materials that are not 
directly used in implantology. Coatings of nanostructured niobium oxide and 
diamond-like carbon, [228] when deposited by sol–gel or CVD on titanium and other 
substrates, have demonstrated significant bioactivity, thus providing additional 
avenues for improved biomaterials. In addition, alkali treatment of bulk niobium has 
resulted in the formation of nanometric fibers (Figure 1.17) that favor precipitation of 
apatite from simulated bodily fluids [229, 230]. 
 
 
 
 
 
 
 
 
 
 
Figure 1.19:  SEM images of rod-like structures resulting from the treatment of Nb 
with NaOH at a) 60
0
C (diameter of the rods in the 100–300-nm range) 
and b) 80
0
C (diameter of the rods in the 50–100-nm range) [207].  
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Electrochemical deposition makes it possible to create coatings comprised of wire 
like nanometric crystals of hydroxyapatite (Figure 1.18), which enhance bone 
remodeling and maturation [231] .Similarly, composite coatings of hydroxyapatite 
and multi-walled carbon nanotubes deposited on titanium have been achieved by 
electrophoretic deposition [207]. 
 
 
Figure 1.20: SEM images of an electrochemically deposited coating of calcium 
phosphate on smooth Ti. a) Microporous structure. b) Crystal grains on 
the nanometer scale [207]. 
1.6.1.2 Physical surface modifications  
The vast majority of surface morphology modifications can be categorized under 
physical surface modifications that have been used  to alter biomaterials and endow 
them with useful new properties, and such alterations have also shown to favor 
diverse biological processes [232, 233]. Electrostatic and plasma spray, as well as 
physical vapor deposition (PVD) techniques such as electron-beam evaporation, 
deposition and grit blasting can yield superficially deposited bioactive layers [52, 97, 
234, 206]. The deposition of TiO2 and hydroxyapatite in this way has been shown to 
enhance the activity of osteoblastic cells and to favor osseointegration in vivo [232, 
235]. Although these methods generally result in modifications on the micrometer 
scale, such physical approaches can also be used to create nanostructures. 
Laser-based approaches have been exploited to produce a coating of calcium 
phosphate on titanium and its alloys. Such coatings have been reported to have 
multiphase compositions ranging from the nano- to mesoscale [236] and to enhance 
in vitro osteogenic cell attachment, growth, and differentiation. A different approach 
based on compaction of metallic nanoparticles (Ti, Ti6Al4V, CrCoMo) has been 
successfully applied to produce nanostructured surfaces. The inherently higher 
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number of particle boundaries in materials prepared from nanoparticles was 
suggested as an explanation for the observed enhanced adhesion of osteoblastic cells 
[53]. Moreover, there was more deposition of calcium and phosphorus from 
simulated bodily fluid, which suggests that mineralization can also be enhanced by 
appropriate nanostructuring [237]. 
1.6.1.3 Biological surface modifications  
In the last few years there has been a major shift in the design criteria for modern 
synthetic biomaterials. An understanding of cell and molecular biology had led 
biologists, chemists and material scientists to design biomaterials equipped with 
molecular cues mimicking certain aspects of structure or function of natural extra-
cellular microenvironments. Hence biological surface modification is aimed at 
controlling cell and tissue response to an implant by immobilizing biomolecules 
representing such molecular cues on the surface of biomaterials. Adsorption, 
entrapment, and covalent attachment are the three mechanisms by which 
biomolecules are immobilized on the surface of a biomaterial [52]. 
Currently available organic coating approaches include (1) immobilization of ECM 
proteins (such as collagen) or peptide sequences as modulators for bone cell 
adhesion; (2) deposition of cell signaling agents (bone growth factors) to trigger new 
bone formation; (3) immobilization of DNA for structural reinforcement; (4) 
enzyme-modified titanium surfaces for enhanced bone mineralization [122]. 
Immobilization of ECM proteins or peptide sequences  
Because of the crucial role of extracellular matrix components in osteoblast 
functions, extensive studies have been performed to functionalize titanium implant 
surfaces with elements of ECM proteins. Contact of cells with other cells and the 
surrounding ECM are mediated by cell adhesion receptors. The cell membrane 
receptor family of integrins is involved in cell adhesion to ECM proteins. These 
integrins bind to specific amino acid sequences within ECM molecules. In particular, 
the amino acid sequence arginine–glycine–aspartic (RGD) has been identified as a 
cell adhesion motif in many ECM proteins, including fibronectin, vitronectin, type I 
collagen, osteopontin and bone sialoprotein. Thus, by immobilizing ECM proteins or 
peptide sequences onto titanium implant materials, bio-functional surfaces are 
produced that bind adhesion receptors and promote cell adhesion. Additionally, the 
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ECM also takes an active part in regulating the cellular processes and responses, 
influencing not only adhesion, but also proliferation, migration, morphological 
change, gene expression and cell survival by intracellular signaling. As such, the 
biological acceptance of implants can be improved by modifying implant surfaces 
with ECM components, thereby mimicking the natural interface and influencing the 
response of osteoblastic cells. 
Although surface immobilization of entire proteins, such as fibronectin and 
vitronectin, is demonstrated to be effective in enhancing cellular attachment [238], 
research has focused on the design of materials representing only short peptide 
fragments of ECM proteins. These peptide sequences can possess similar 
functionalities, for example, receptor specificity, binding affinity, and signaling of 
cell responses, compared to their native proteins.These sequences can be produced 
synthetically, allowing precise control over their chemical composition and avoiding 
issues related to concerns on proteins from animal sources. As compared to the long 
chain proteins, the short peptide sequences are generally more resistant to 
denaturizing agents [239]. Furthermore, an entire ECM protein tends to be randomly 
folded upon adsorption to the biomaterial surface, resulting in a less effective 
availability of the receptor-binding domains as compared to short peptides. The most 
commonly used peptide sequence for surface modification is cell adhesion motif 
RGD. Additionally, various other peptide sequences have been immobilized onto 
implant materials [240]. To provide a stable link, peptide sequences are usually 
covalently attached to the titanium surface, e.g. via functional groups like hydroxyl-, 
amino-, or carboxyl groups. RGD-functionalized materials are reported to improve 
early bone ingrowth and matrix mineralization in implanted constructs and to induce 
more bone contact to the implant [241]. 
Growth factor immobilization  
Growth factors are proteins that serve as signaling molecule to induce an intracellular 
signal transduction system that produces a biological response. Once they release 
from an implant surface can increase the osteoblastic activity of the bone tissue. 
Bone regeneration around implants can be strongly enhanced by immobilizing 
growth factors such as bone morphogenetic protein (BMP), transforming growth 
factorbeta (TGF-β), fibroblast growth factor (FGF), platelet derived growth factor 
(PDGF), and insulin-like growth factor (IGF) to the titanium surface [242]. The most 
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common osteogenic growth factors used for biomedical purposes are the members of 
the TGF-β superfamily, including the BMP family. In particular BMP-2, BMP-7 and 
TGF-β1 are promising growth factors for enhanced bone formation around the 
implant [243]. Growth factors can be adsorbed or covalently bound to the titanium 
surface, but are commonly added to CaP or collagen-coated implants. Growth factors 
immobilized on titanium implants pre-coated with collagen or CaP were found to be 
more effective in inducing bone formation than growth factors bound to untreated 
titanium surfaces [244]. This may be due to a sustained delivery profile or a higher 
stability of the growth factor. Overall, loading implants with growth factors has 
shown to accelerate bone formation and to facilitate the bridging of small gaps 
between implant and surrounding bone. In summary, coating implants with locally 
acting growth factors can improve the remodelling process at the tissue–implant 
interface, and is therefore a promising option for establishing an improved 
integration of implants into healing bone [122]. 
Deoxyribonucleic acid (DNA) coatings 
Another possibility for implant surface modifications is the generation of DNA-
containing coatings. The structural properties of DNA show high potential for this 
unique biomolecule to be used as a biomaterial coating, regardless of its genetic 
information. DNA-based coatings improved the deposition of CaP, favorable for 
direct apposition of bone tissue to the implant surface. Furthermore, DNA-based 
coatings proved to be eligible for functionalization with biologically active growth 
factors, and hence can modulate cell response. These beneficial effects on cell and 
tissue response show potential for DNA-based surface modifications with respect to 
immunology, drug-delivery, and apposition of bone mineral [245, 246]. 
Enzyme coatings 
A novel approach for surface modification utilizes enzyme-modified titanium 
surfaces to enhance bone mineralization along the implant surface. The enzyme 
alkaline phosphatase (ALP) is known to play an important role in the mineralization 
process of bone and cartilage. ALP appears to act both to increase the local 
concentration of inorganic phosphate (Pi), required for physiological mineralization 
of hard tissues, and to decrease the concentration of extracellular pyrophosphate 
(PPi), a potent inhibitor of mineralization. Under physiological conditions, ALP 
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coatings accelerated mineralization onto the titanium surface. These newly 
developed enzyme coatings seem promising for an early and improved implant 
fixation [247]. 
Ca-Phosphate coatings 
Another surface modification of implant surfaces under bioactive coating is Calcium 
phosphate coatings (CaPs). They are often used in the biomedical field due to their 
similarity with the mineral phase present in bone and teeth. Hydroxyapatite, or more 
specifically carbonate apatite, is by far the most abundant inorganic phase in the 
human body. Carbonate apatite comprises a chemical composition closer to bone and 
dental enamel than that of hydroxyapatite. The relation between carbonate apatite 
and hydroxyapatite is important, because carbonate increases the chemical reactivity 
of apatites. This occurs by an increase of the solubility of the product and rate of 
dissolution in acids, and by reducing the thermal stability. Since carbonate is known 
as an effective crystal growth inhibitor, carbonate apatite consists of smaller crystals 
than hydroxyapatite [52, 121]. 
Calcium phosphate (CaP) ceramics are known for their bioactive properties. 
Generally, bioactive materials interact with surrounding bone, resulting into the 
formation of a chemical bond to this tissue (“bone-bonding”). CaP ceramics are too 
brittle for use as bulk material under loaded conditions, which makes that CaP 
ceramics are frequently applied as coatings onto the surface of metallic implant 
materials in order to combine the mechanical strength of metals with the excellent 
biological properties of CaP ceramics. Following utilization of CaP coatings for 
orthopaedic and dental implants, numerous reports have been published about the 
osteoconductive properties of CaP-coated implants (osteoconduction refers to the 
ability of a biomaterial to support the growth of bone over its surface). These CaP 
coatings are described to induce an increased bone-to-implant contact, to improve the 
implant fixation, and to facilitate the bridging of small gaps between implant and 
surrounding bone [248, 124, 122]. 
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CaP-organic coatings  
Since bone is composed of an organic matrix strengthened by an inorganic CaP 
phase, research during the last decade composite coatings made of both biomolecules 
have therefore generated a great deal of interest  for implant surface modifications. 
Due to potential capability of CaPs, Ca-P coatings are the most popularmethod that is 
used to loading therapeutic and bioactive agents in. This allows diffusion of the 
respective agent(s) into the coating after processing. The degree and type of bonding 
of these agents largely depends on the composition, microstructure and properties of 
the finished coating products. For example, a nanoporous biomimetic apatite coating 
adsorbs more serum proteins than the dense plasma-sprayed hydroxyapatite coating. 
The development of a biomimetic coating approach has made it possible to 
incorporate therapeutic agents directly into the Ca-P coating. The molecules of 
interest dissolved in the calcifying solution can be adsorbed or incorporated into the 
forming Ca-P coating during the coating process.  The most applicable embedded 
molecules into Ca-P coatings as carriers are several proteins and therapeutic agents, 
including albumin, collogen, BMPs, bisphosphonates, antibiotics and amelogenin 
[249, 52, 121]. 
Amelogenins and their incorporation in Ca-P coatings 
The use of naturally occurring matrix proteins that regulate mineral crystal growth 
holds promise as one way to biologically regulate bone formation. Amelogenin 
proteins, the principal components of the developing dental enamel extracellular 
matrix, have been postulated to facilitate the elongated and oriented growth of the 
carbonated apatite crystals during enamel formation [249].  
Thus, amelogenin, the predominant protein components of secretory stage in tooth 
enamel, have been using as a good candidate to fabricate biomimetic coating implant 
materials. Furthermore, they have potential signal transduction functions during tooth 
and bone development and can promote the adhesion of several cell type. Based on 
potential signaling the effect of amelogenin and its ability to promote cell adhesion, 
control apatite crystal morphology and organization can be good candidate for 
biomimetic coating that would not only improve the implant integration but also 
promote bone tissue engineering [250].  
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1.6.2 Strategies to prevent implant infections  
Implant-associated infection is still one of the most serious complications in implant 
surgeries due to the existence of immune depression in the peri-implant area.  Many 
approaches with understanding of pathogenesis of implant-associated infections have 
been applied to prevent implant infections. In this section, current strategies such as 
systemic and local antibiotic treatment, nonfouling surfaces, utilization of 
antimicrobial agents and peptides have been explained with advantages and 
disadvantages for implant infection treatment.  
1.6.2.1 Antibiotic treatment  
One of the most applied conventional treatments to prevent implant associated 
infection is antibiotics which are chemical compounds that inhibit or abolish the 
growth of microorganisms, such as bacteria, fungi or protozoans. The main goal of 
treating various types of infections should be reduce the bacterial load in the wound 
to a level at which wound healing processes can take place. Conventional systemic 
delivery of antibiotics entails poor penetration into ischemic and necrotic tissue and 
can cause systemic toxicity with associated renal and liver complications, which 
result in a need for hospitalization for monitoring. Alternative local delivery of 
antibiotics by either topical administration or by a delivery device may enable the 
maintenance of a high local antibiotic concentration for an extended duration of 
release without exceeding systemic toxicity [251, 252]. Hence, controlled release of 
antibiotics from the implant or medical devices shows many advantages over 
systemic treatments, such as increasing the local dosage of antibiotics, as well 
avoiding systemic side effects [178, 253, 175, 177]. 
For nondegradable implants, such as central venous catheters, urinary catheters and 
stents, surface coating is doubtless a simple method, which can maintain the bulk 
properties of the implants as well as increase the antibacterial ability of the surface. 
Owing to the structure of antibiotics, which normally have a molecular weight of less 
than 1000, direct coating through solvent dipping is obviously not suitable. The 
retention of drugs on the surface is limited and the release rate cannot be controlled. 
However, many antibiotics are synthetically designed as anionic derivatives with 
carboxylate, phosphate or sulfate substitutes [254]. Thus, the immobilization of 
antibiotics on the surface can be facilitated by an electrostatic force. Besides 
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immobilization of antibiotics onto implant surfaces, an alternative method is to first 
blend the antibiotics into the coating materials and then coat the mixture on the 
surface. The options for the coating materials include biodegradable or non-
degradable polymers. For the nondegradable polymer coating, normally polyurethane 
[255-257], the release of the antibiotics is entirely through diffusion.  
The release profile can be also controlled through the coating strategy. For example, 
another thin layer can be coated on the top of the layer loaded with antibiotics, thus 
providing a barrier to restrict the fast initial burst of the release [258]. Controlled 
release can also be approached through creating a coating with a concentration 
gradient of loaded antibiotics; for example, with a higher concentration in the inner 
layer and a lower concentration in the outer layer. Biodegradable polymer coating is 
also applicable [259-261]. The release of antibiotics is not only through diffusion, 
but also influenced by the degradation rate and mechanism of the coating. FDA-
approved biodegradable polymers include PLA, PGA, PLGA, polyanhydride, and so 
on. All of these show great potential as matrixes for the release of antibiotics [262, 
263]. 
Antibiotics are also incorporated into non-degradable PMMA bone cement and beads 
for prophylaxis and treatment of total joint arthroplasty infection, treatment of 
chronic osteomyelitis  and prophylaxis of infections in open fracture repair [264]. 
Although these have been put into clinic application, the release of most antibiotics 
from the PMMA cements or beads are far from satisfactory [265, 266]. For example, 
for gentamicin, less than 50% was observed to be released from implants after 4 
weeks, and no continuous release was found after that, which may be due to the 
solid, glassy, non-swelling properties of the PMMA matrix. Thus the antibiotic-
loaded biodegradable implants show great potential [267-270]. Unlike PMMA, 
biodegradable implants degrade over time, eliminating the need for a second surgery 
to take them out, and thereby preventing the possibility of re-infection during second 
surgery. Moreover, the loaded antibiotics can be totally released out of the implants 
once they degrade. The degradation rate can be tuned through the selection of the 
biodegradable chemical structure and through building up a concentration gradient in 
the implants.  
Antibiotics are also combined with bioactive ceramics as a coating for metal 
implants. The utilization of a bioactive ceramic coating containing hydroxyapatite 
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(HA), calcium phosphate and other osteo-conductive materials as antibiotic carriers 
offers the added value of providing the physiochemical environment and structural 
scaffold required for bone-implant integration. In vitro release of antibiotics from 
hydroxyapetite coated implants has been reported for chlorhexidine, vancomycin, 
gentamicin, tobramycin and several other antibiotics [252, 271]. 
In all application of antibiotic treatment, the main concern with all of these 
antibiotics is the development of resistant bacteria. Many important pathogens, S. 
aureus in first line among them, have long been recognized to exhibit always more 
alarming levels of antibiotic resistance [272, 273]. Moreover, bacteria forming 
biofilms on prosthetic surfaces are per se particularly resistant to antimicrobials and 
tend to survive to aggressive chemotherapy even in the absence of specific antibiotic 
resistance factors. In consideration of this, it may result clear how important is to 
survey the presence of antibiotic resistant strains at clinical setting, not uniquely with 
the scope to decide the patient treatment regimen [190]. 
The mechanisms of resistance to antibiotics in bacterial biofilms are beginning to be 
elucidated [274].  Figure 1.21 shows three main hypotheses. The first hypothesis is 
the possibility of slow or incomplete penetration of the antibiotic into the biofilm. 
Measurements of antibiotic penetration into biofilms in vitro have shown that some 
antibiotics readily permeate bacterial biofilms [275]. There is no generic barrier to 
the diffusion of solutes the size of antibiotics through the biofilm matrix, which is 
mostly water [276]. 
 Figure 1.21: Three hypotheses for mechanisms of antibiotic resistance in biofilms
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the antibiotic. The hypothesis of a spore-like state entered into by some of the 
bacteria in a biofilm provides a powerful, and generic, explanation for the reduced 
susceptibility of biofilms to antibiotics and disinfectants of widely different 
chemistries [181]. 
In addition these mechanism steps, a number of studies have reported the existence 
of a strong association between genomic DNA mobile elements termed transposons 
and important virulence factors as well as most of the genes for the resistance to anti-
microbials. The importance of this association relies on movement of  transposons 
across the microbial population, transferring clusters of genes, crucial to the ability 
of bacteria to do harm and to survive to medical treatments, not only among strains 
of the same species, originating new dangerous clones, but even across different 
species [190, 280]. 
1.6.2.2 Antimicrobial agents  
An attractive alternative to using antibiotics would be to use an antiseptic, such as 
chlorhexidine or quaternary ammonia compounds, since antiseptics tend to have 
broad spectrum activity against Gram-positive and Gram-negative bacteria. 
Chlorhexidine is commonly used in surgical scrub, hand wash, and to clean wounds, 
but has been used in association with external fixator pins [281], polymeric coatings 
on titanium [282], and other indwelling implants [283, 284]. There are disadvantages 
reported for using chlorhexidine in association with implants, including the toxicity 
of the antiseptic to host cells. In vitro, chlorhexidine diacetate has been reported to be 
lethal to fibroblasts [285], probably because chlorhexidine diacetate lyses the host 
cell membranes in the same way as it does bacterial cell membranes. Hypersensitive 
reactions are also known to occur when patients are exposed to chlorhexidine 
diacetate [286, 287]. A second disadvantage is that chlorhexidine diacetate resistance 
has been observed in various staphylococci and Gram-negative bacteria, particularly 
with antibiotic-resistant bacteria [288]. Quaternary ammonia compounds (QAC) has 
also been studied for use, through covalent binding of the antimicrobial directly onto 
the implant surface [289]. QAC works by disrupting the cell membrane of both 
Gram-positive and Gram-negative bacteria [290].  
Other alternative method is silver ion- and silver nitrate-based coatings on implants, 
since silver is known to have broad spectrum antibacterial properties. Silver-based 
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coatings have been studied in association with polymer andmetal implants, 
particularly on external fixation pins [291, 292]. Coating stainless steel pins with 
silver has been found to decrease the adhesion and colonization of S. aureus, S. 
epidermidis, E. coli, and P. aeruginosa around the coated implant [293, 294]. 
However, there are reports that silver is toxic to host cells, causing severe 
inflammatory responses [295]. Due to the toxicity of silver, “NanoSilver”, which is a 
new form of silver consisting of silver particles (5−50 nm), has been tested and in 
vitro results have shown that it was effective against several type of  bacteria and 
have indicated that it is not cytotoxic due to its higher porosity and active surface 
[294]. 
Another possible solution to the development is to use lysostaphin instead of 
conventional antibiotics. Lysostaphin is an antibacterial enzyme that cleaves 
pentaglycine bridges in the cell wall of staphylococci. A study by Wu et al [296] 
found that applying lysostaphin to S. aureus and S. epidermidis biofilms not only 
killed the bacteria, but also disrupted the extracellular polysaccharide matrix 
surrounding the bacteria [262]. 
1.6.2.3 Nonfouling surfaces  
An important step in preventing infections is to inhibit the adhesion of proteins, 
biomolecules, and bacteria onto the implant surfaces. PEO or PEG and its derivatives 
represent a class of hydrophilic polymers that can be used to create anti-adhesive 
surfaces [26, 262, 297, 298, 178]. These hydrophilic polymers have highly dynamic 
chain structures that, when locating on surfaces, present large exclusion volumes in 
an aqueous environment (such as in circulation) by retaining a surrounding hydrous 
layer, thereby repelling the adhesion of molecular species [299], cells [300], and 
bacteria from the surfaces. 
PEO or PEG type of polymers can be introduced onto surfaces via physical or 
chemical approaches. Using physical approaches, PEG is coated onto material 
surfaces by direct deposition such as dipping. However, PEG layer formed by 
physical approaches is unstable in an aqueous environment due to the good solubility 
of PEG in water and poor wettability with the surface. Alternatively, PEG may be 
chemically linked to surfaces by crosslinking or grafting. PEG can be crosslinked by 
argon radio frequency (RF)-plasma after spin coating on a stainless steel (SS) surface 
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[301] or by using dicumyl peroxide (DCP) as a crosslinking agent on the surface of a 
polyurethane-containing PEO segment [302]. The crosslinked PEG surface was 
shown to have decreased bacterial adhesion. PEG with a functional end group can be 
chemically grafted onto the substrate surface, such as polyurethane, glass, silicon and 
poly(ethylene terephthalate). The coating density and PEO chain length greatly 
influence the antibacterial ability. When the density of PEO is high enough, the 
molecules are forced to stretch out and form a layer called “molecular brush”. 
Generally speaking, higher coating density and longer PEO chain length attain better 
anti-bacterial ability [178] . 
Various derivatives of PEG have been testing their effectiveness against different 
bacteria type, osteoblast, fibroblast. For example, cell adhesion and spreading of 
osteoblast and fibroblast on metal oxide surfaces coated with PLL-g-PEG is strongly 
reduced in comparison to uncoated oxide surfaces [303]. In vitro PLL-g-PEG 
coatings are also effective at inhibiting S. aureus, S. epidermidis, P. aeruginosa and 
Streptococcus mutans [297, 304, 303, 305]. A biofunctionalized version of PLL-g-
PEG copolymer with the cell-adhesive peptide Arg−Gly−Asp (RGD) motif has been 
synthesized and used to induce specific attachment of fibroblasts and osteoblasts to 
surfaces [306, 303]. The RGD motif is present in proteins such as fibronectin, 
vitronectin and fibrinogen. It is known to interact specifically with a number of 
integrin cell receptors, while being resistant to the adsorption of non-specific 
biomolecules. The advantage of this coating is that it enhances fibroblasts and 
osteoblasts, but remains inhibitory to S. aureus, S. epidermidis, P. aeruginosa, and 
Streptococcus mutans adhesion. Such surfaces (PLL-g-PEG and PLL-g-PEG/RGD) 
are believed to have potential as implant coatings, but they currently need 
improvement in the coating adhesion strength to the implant surface [262]. 
 
1.6.2.4 Antimicrobial peptides  
A novel class of peptides, the antimicrobial peptides (AMPs), has received 
considerable attention over the last few decades due to their potential use as 
therapeutic treatments.  AMPs are an evolutinary conserved constituent of the innate 
immune response and have been found in all walks of life including insects, plants, 
and animals [307-310]. Due to the wide distribution and characteristics of AMPs, it 
is difficult to categorize them except broadly on the basis of their secondary stucture 
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and aminoacid composition. The fundemental structural principle underlying all 
classes is the ability of the molecule to adapt a shape based on hydrophobic and 
cationic amino acid spatial organization (Figure 1.22) [309].  
 
 
 
  
 
 
 
 
 
Figure 1.22: Clustering of cationic and hydrophobic amino acids into distinct 
domains in several antimicrobial peptides of different structural classes. 
This `amphipathic' design is evident in many, but not all, antimicrobial 
peptides. Red, basic (positively charged) amino acids; green, 
hydrophobic (`oily') amino acids. Other amino acids are not shown. 
Magainin is depicted in its a-helical configuration [309]. 
Depending on structural features, they have been divided into four major classes: β-
sheet, α-helical, loop, and extended peptides. Of these classes,  β-sheet and α-helical 
appear to be the most common in nature [307].  Several idealized peptides have been 
synthesized since the explosive interest in the class of peptides as a therapeutic target
 
[311, 312]. AMP characteristics and their antimicrobial peptide activity and 
specificity against wide specturum of  organisms are influenced by the size, 
sequence, charge, conformation and structure, hydrophobicity, and ampipathicity of 
the peptide [308]. 
The precise mechanism of action for matimicrobial peptides has not been understood 
yet. Nevertheless, most AMPs are believed to target the negatively charged cell 
membrane of bacteria, (and possibily the embedded lipids bearing phospholipid 
head-groups), and mediate killing by membrane disruption or pore formation [309, 
307, 308].  For some AMPs an intracellular target has been proposed that may be the 
sole mechanism of action of the peptide, or may work synergistically with membrane 
disruption
 
[307].   
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According to described variety of mechanisms on antimicrobial peptide activity, 
these peptides have targeted clearly the difference in design of membranes of 
microbes and multicellular animals. Bacterial membrane are organized in leaflet of 
lipid bilayer. The surface exposed to the outer world is heavily populated by lipids 
with negatively charged phosholipid headgroups. In contrast, the outer leaflet of the 
membranes of plants and animals is copmposed of principally of lipids with no net 
charge; most of the lipids with negatively charged headgroups are segregated into the 
inner leaflet, facing the cytoplasm (Fig. 1.23) [309].  
 
Figure 1.23: The membrane target of antimicrobial peptides of multicellular 
organisms and the basis of specificity [309]. 
A model that explains the activity of most antimicrobial peptides is the Shai-
Matsuzaki-Huang (SMH) model (Figure 1.24). The model proposes the interaction of 
the peptide with the membrane, followed by displacement of lipids, alteration of 
membrane structure, and in certain cases entry of the peptide into the interior of the 
target cell. The presence of cholesterol in the target membrane in general reduces the 
activity of antimicrobial peptides, due either to stabilization of the lipid bilayer or to 
interactions between cholesterol and the peptide. Similarly, it is believed that 
increasing ionic strength, which in general reduces the activity of most antimicrobial 
peptides, does so in part by weakening the electrostatic charge interactions required 
for the initial interaction [309]. 
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Figure 1.24: The Shai-Matsuzaki-Huang model of the mechanism of action of an 
antimicrobial peptide. An alpha-helical peptide is depicted. a, Carpeting 
of the outer leaflet with peptides. b, Integration of the peptide into the 
membrane and thinning of the outer leaflet. The surface area of the outer 
leaflet expands relative to the inner leaflet, resulting in strain within the 
bilayer (jagged arrows). c, Phase transition and `wormhole' formation. 
Transient pores form at this stage. d, Transport of lipids and peptides 
into the inner leaflet. e, Diffusion of peptides onto intracellular targets 
(in some cases). f, Collapse of the membrane into fragments and 
physical disruption of the target cell's membrane. Lipids with yellow 
headgroups are acidic, or negatively charged. Lipids with black 
headgroups have no net charge [309]. 
Many hypotheses have been presented on the actual mechanism of antimicrobial 
peptide to kill the microbes which include:  fatal depolarization of the normally 
energized bacterial membrane; the creation of physical holes that cause cellular 
contents to leak out; the activation of deadly processes such as induction of 
hydrolases that degrade the cell wall; the scrambling of the usual distribution of 
lipids between the leaflets of the bilayer, resulting in disturbance of membrane 
functions; and the damaging of critical intracellular targets after internalization of the 
peptide [313, 314]. 
AMPs are an exciting class of antibiotics because they are effective against a broad 
range of microorganisms [315-318], including multidrug resistant bacteria, can work 
independently or synergistically with classical antibiotics, neutralize endotoxin, and 
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are active in animal models [307]. The ability of AMPs to inhibit and/or kill 
multidrug resistant bacteria increase their importance as a therapuetic agent, as there 
is a high need for new treatment options against such epidemeological pathogens.  
Another advantage of AMPs is their ability to work synergestically with classical 
antibiotics, possibly facilitating access of antibiotics to the infection site, and thus 
providing an avenue for a more aggressive treatment approach against biofilms. 
The use of AMPs in therapeutical approaches is vast underway.  Appendini et. al. 
covalently liked an AMP onto the surface of polystyrene resin beads that had 
polyethyleneglycol (PEG) grafted onto them and found it to be microcidal against 
several microorganisms [317].  Etienne et al developed a way to insert an AMP into 
polyelectrolyte multilayer films that was reported to effectively inhibit Micrococcus 
luteus and Escherichia coli D22 when 10 antimicrobial peptide layers were applied 
[318].  Kwakman et.al. locally administered an AMP along the site of insertion of a 
catheter in a murine model and found the peptide to have a broad in vivo potentency 
against microorganisms and reduced inflammed tissue [319].  The list goes on with 
exciting new applications of AMPs being published frequently; for a review of 
AMPs as therapeutics see Guliane et al. (2007). 
During the past two decades it has become evident that increasing bacterial drug 
resistance has created an urgent need for new classes of antibiotics. Even if a 
superbug epidemic has not yet hit and the panel of traditional antibiotics can still 
manage drug resistant pathogens, at the moment, AMPs seem to represent one of the 
most promising future strategies for defeating this threat. This statement is well 
represented by the fact that AMPs are subject to an increasing number of academic 
studies. At industrial level, several companies worldwide are focused on the 
development of AMPs with several molecules both at the preclinical and clinical 
stage. This demonstrates that despite the first clinical trials failing (Pexiganan and 
Iseganan), there is still a lot of general optimism for their use in future clinical 
practice. Some of the challenges facing the development of peptidic drugs have 
already been overcome, starting from the industrial production of T-20 peptide 
(Fuzeon) at the multi-ton scale production, incredibly boosting the production of new 
peptides on a large scale with beneficial effects on the cost of all starting materials. 
Other challenges are common to other class of molecules that may be defined as 
innovative. Several strategies have been devised to optimize AMPs with promising 
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activity, ranging from inclusion of non-natural aminoacids and a new method 
applicable to high-throughput screening to multimerization of linear sequences. Even 
if we cannot exclude the fact that resistance may evolve whenever bacterial 
populations are consistently exposed to elevated levels of AMPs, this concern should 
not discourage their further study and development; instead, they may help us to 
rationalize their use in future, for example preventing the big mistake made in the 
past of distribution of large amounts of antibiotics, and thereby minimizing the 
emergence of resistant organisms [307-309, 312, 313, 310]. 
1.7 Biomolecule Immobilization Approaches to Functionalize Implant Surfaces   
Biological surface modifications are one of the emerged fields to overcome 
limitations for implant–tissue integration. In the previous sections, the role of 
immobilized various biomolecules on implant surfaces for successful integration 
were explained in detail. In this following section, principles of immobilization 
techniques for biofunctionalization of implant surfaces will be mentioned. The major 
principle of immobilization increased stability and functionality of biomolecules. 
However, activity of biomolecules can be reduced due to the random orientation and 
structural deformation during the attachment. In fact, the immobilization techniques 
shouldn`t effect conformation and function of the molecule to fully retain the 
biological activity [320]. Physical and chemical immobilizations are two major 
techniques for biomolecule functionalization of implants. 
1.7.1 Physical immobilization  
Physical immobilization or adsorption is a very simple immobilization method 
performed under mild conditions, and therefore hardly disruptive to the 
biomolecules. However, by dipping titanium implants into a solution of proteins, 
biomolecule linkage is highly dependent on experimental parameters such as pH, 
temperature and solvent. Basically adsorption occurs at surfaces via intermolecular 
forces, mainly ionic bonds and hydrophobic and polar interactions. Mostly, the 
resulting layer is to be heterogeneous and randomly oriented, since each molecule 
may have different optimum conformation to minimize the repulsive forces from the 
surface and previously attached protein, during the adsorption [320]. However, 
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it should be also noted that the physical adsorption of proteins constitutes the first 
step of chemical immobilization involving covalent bonding of proteins at the 
surface as a second step.  
During protein adsorption at a surface, the net free energy change must be negative, 
that may be caused from enthalpic or entropic origins. For example, many proteins 
undergo conformational changes and generally, their ordered structural content is 
decreased at the adsorption process. This fact yields an entropic gain and may act as 
an adsorption-driving force [321]. From an enthalpic point of view, the adsorption 
driving force may be originated from the interactions between the protein and the 
surface. The most important ones are van der Waals, hydrophobic, electrostatic 
interactions and hydrogen bonding [320, 321]. 
Surface properties of the inorganic materials directly affect the physical attachment 
of protein; also surface modification may be needed to increase the protein 
adsorption. The surface hydrophobicity is one of the surface properties that one can 
control over a wide range. Furthermore, hydrophobic interactions between the solid 
surface and the protein would be expected to be more favorable comparing to 
hydrophilic interactions in terms of protein adsorption. This is also frequently, but 
not always, observed experimentally [321, 322]. As an example, the preferential 
adsorption of fibrinogen at a hydrophobicity gradient surface was demonstrated by 
Elwing et al. 
Electrostatic interactions between the inorganic surface and the protein may also 
enhance the protein adsorption. For example, the adsorption of bovine pancrease 
ribonuclease at a (hydrophobic) negatively charged polystyrene surface was found to 
be high at both above and below the protein isoelectric point. This indicates us there 
is interplay among hydrophobic and electrostatic interactions.  
For the proteins undergoing large conformational changes on adsorption, e.g. BSA, 
nonelectrostatic driving forces considerably take roles. Hence, the adsorption usually 
does not follow the electrostatic interactions. Moreover, the adsorption is governed 
also by other effects, such as van der Waals and hydrophobic interactions [323]. 
Especially in biomedical applications, PEG derivatives are mostly used reagents in 
the literature to prevent the protein adsorption at a solid surface [324, 325]. If the 
PEG chains are sufficiently long and molecule density is high enough at the surface, 
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PEG modified surfaces display very low protein adsorption. The main reason of the 
efficient repulsive characteristics of the PEG layer is two-fold [326, 324]. Firstly, 
dense and thick layer of the PEG derivatives maintain a strong streic hinderance for 
the proteins [326]. Secondly, the adsorption driving forces are absent. For example, 
since the typical PEG-layers are uncharged, electrostatic interactions are insufficient 
for the protein attachment [326]. Also, PEG molecules can interact with the water 
molecules, preventing van der Waals interactions between the surface and the protein 
[30]. Under these conditions, it is really hard for a protein to attach to the PEG-
modified surface unless it can penetrate through the PEG layer and reach the bare 
surface. 
In adsorption, surface loading is very low compared to methods as covalent coupling. 
In addition, biomolecules desorb from the surface in an uncontrolled manner. Using 
the approach of physical entrapment of biomolecules, the biomolecule is retained by 
a barrier but not chemically bound to it. Therefore, this technique is extremely mild 
and universal for any biomolecule. However, barriers are often fragile, and tearing or 
eroding can cause loss of biomolecules. Besides, this method is mostly used to 
biosensor applications [327]. For the delivering of biomolecules to the implant 
interface, biomolecules are incorporated into coatings made of materials such as 
poly(D,L-lactide) (PDLLA), ethylene vinyl acetate (EVAc) and collagen [328, 329].  
In this way, biomolecule release from the implant surface can be controlled, which 
makes it an attractive approach for the immobilization of bone growth factors. 
1.7.2 Chemical immobilization 
Covalent attachment is widely used for the immobilization of peptides, enzymes and 
adhesive proteins onto implant surfaces, even though this approach is more 
complicated and time consuming than other immobilization methods.  Major 
limitations of this methodology, especially when immobilize the proteins, include the 
loss of protein mobility on the surface which is directly effected by possible 
repsentation of unfamiliar protein conformation on the surface.  Other drawbacks of 
this technique, remains of toxic monomer residue on the surface may cause 
biocompatibility problems in the area of implantation. Issues in task of chemical 
immobilization can be addressed by physical adsorption techniques, which usually 
involve dip coating a material to form a film with desired properties on the surface. 
While physical adsorption may help reduce toxic monomer residues, issues while 
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binding between the materials and immobilized molecules mainly retain as an 
unsolved problem which is directly caused by the  instability of the molecules on the 
surface [133]. 
Due to the limatations in chemical and physical modification, self-assembled 
monolayers (SAMs) were developed as a method to control the density and 
conformation of a single or multiple specific functional groups on a surface precisely 
[330]. The general process of producing SAMs requires two major steps. Firstly, the 
bulk material surface needs to be activated by SAMs, then graft polymerize onto the 
activated surface.  At the end of the two major steps, flat and chemically well defined 
surfaces can be provided through the SAMs  [331].  Additional benefits of applying 
SAMs are obtaining closely packed, well-ordered functionalities near 
thermodynamic equilibrium on the surface.   
SAMs tend to provide functionalities with control over pattern and densities. 
Selection of terminal group can also provide a site for further functionalization of the 
coated surface. Surface functionality via SAMs have been used to investigate in vitro 
cell responses and in vivo inflammatory and foreign body responses of implanted 
biomaterials [332] as well as many other processes, giving insight into how a 
particular functional group effects a particular process. However, application of 
SAMs are limited the type of materials. The most common materials that SAMs 
easily funtionalize its surface is gold and silver. These surfaces can be derivatized 
into reactive groups, such as amino groups or aldehyde groups [234].  
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Figure 1.25: Standard approaches for creating SAMs on noble metal and oxide 
surfaces using alkanethiol and silane chemistry [331]. 
1.8 Genetically Engineered Peptides for Inorganics (GEPI) in 
Bionanotechnology 
In recent years, genetically engineered peptides for inorganics (GEPIs) is remarkable 
in various application areas taking advantage of molecular biomimetics where 
different disciplines such as material science and molecular biology are utilized to 
understand the interactions between materials and biomolecules by taking lessons 
from the nature [16, 4]. 
Molecular biomimetics is the application of methods and systems found in nature to 
the study, design and engineer materials. The biological world has long been a source 
of inspiration for engineering design. The popularity of designs that mimic natural 
systems is due, in large part, to advantages in performance.  
In the past, drawing ideas from nature was limited to macroscopic engineering 
problems [5].  Advances in analytical techniques over the past several decades have 
opened the door to understanding the materials’ structure and properties at the 
molecular level and have provided a better understanding of the potential of the 
nanotechnology. However, the realization of the full potential of nanotechnological 
systems has so far been limited due to the difficulties in their synthesis and 
subsequent assembly into useful functional structures and devices. Biological 
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materials, on the other hand, are highly organized from the molecular to the nano- 
and macro scales, often in a hierarchical manner, with complex nano-architectures 
[333, 334]. One key aspect of this process is the participation of biomacromolecules 
such as glycoproteins and phosphoproteins. Therefore the next-generation 
biomimetic engineering systems should include proteins in synthesis, assembly or 
function [5, 335, 17]. 
The interaction of proteins with inorganic surfaces is a fundamental process, which 
has great impact on biotechnological and biomedical applications such as biomaterial 
design, biosensing, biominerilization, and tissue engineering. Especially, specific 
interactions between proteins and inorganics promise new application areas in the 
field of nano- and bionanotechnology. In biological organisms proteins controls the 
formation of different hard tissues like tooth, bone and many other hard tissues 
occurring in different organisms. Bionanotechnological applications focuses on 
utilizing proteins in order to create multifunctional nanomaterials, self assembled 
supramolecular structures that could be applicable in the fields of nanomedicine 
(drug delivery, cancer probing, implantation), nanoelectronics, nanophotonics, nano- 
and microelectromechanical systems (NEMS/MEMS) [16, 336, 337, 4, 338]. 
Integration with protein functionality and materials science can offer a new way for 
explosive growth in medical implants research area.  
Our overarching aim has stem from the various inherent capabilities of GEPIs. The 
aspect is to develop biomimetic implant materials using GEPIs. This includes 
creating biocompatible and/or non-fouling surfaces for implant material applications 
using the molecular recognition and binding capabilities of GEPIs and creating 
biomimetic restorative materials and cell free tissue engineering systems using the 
morphogenic and synthetic capabilities of GEPIs.  
1.8.1 Biocombinatorial selection of GEPIs 
Progress in development of combinatorial selection techniques created a major tool 
for a myriad of biotechnological applications including antigen-antibody, peptide-
ligand interactions, and drug and vaccine development [339]. Phage display [340] 
and cell surface display [341-343] are two well-adapted techniques based on 
screening of peptides against to target. The basic principles of each technique rely on 
the link between phenotype and genotype of the organism. DNA sequence of random 
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peptides is inserted into genome of organisms where they will express within the 
context of proteins localized on the surface of phage or the cell. Random peptides as 
a chemic protein display in lipoprotein, flagellar protein of cell or major or minor 
coat protein of phage [344, 340, 345]. 
Recently, adaptation of these techniques in the area of molecular biomimetics with 
isolation of peptides that are specific inorganic materials opens up new avenues for 
the design and utilization of multifunctional molecular systems with the wide range 
of applications, from tissue engineering, and biosensors to nanomedicine [9, 346-
349].  
The first example of identifying peptide that bind to inorganic surface was shown by 
S. Brown.  The peptides were selected against to Fe2O3 substrate by using cell 
surface display technique [350]. Afterwards, Belcher and coworkers utilized the 
phage display technique for the first time in the selection of semioconductor 
materials [351]. These initiative works was example for utilization of combinatorial 
biology techniques to select and identify sequences that have high affinity to other 
materials systematically.
 
 
By applying two major techniques, short amino-acid sequences peptides have been 
selected to various materials including noble metals (Au, Pd, Pt, Ag) [352-355, 4, 
356, 357], oxides (Al2O3, SiO2, ZnO, Cu2O, TiO2) [358-360, 4, 16, 361-364], 
semiconductors (GaN, ZnS, CdS, GaAs) [351, 365, 366], minerals [367-370] 
polymers [371], zeolites [372] and carbon nanotubes [373]. In vitro selection of 
GEPIs are carried out by biopanning step where the library of phage or cell clones, 
displaying a vast population of randomized peptides on their surfaces, exposed to 
desired inorganic material as target (Figure 1.23). Following the binding step, the 
unbound clones are washed away and the bound one eluted by physical or chemical 
methods [368]. Subsequently, amplification step was carried out to increase 
population of bound clones. Generally, the biopanning cycle is repeated, usually 3-5 
times to enrich the population of clones that have affinity to desired surface. In the 
final step, selected individual clones isolated and their DNA sequence was identified 
[374, 4, 9, 368]. 
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Figure 1.26: Schematic diagram for phage and cell-surface display techniques [16]. 
Although cell or phage display is two successfully adapted selection techniques so 
far, one has advantages and disadvantages rely on different criteria over the other. 
For example, cell surface display has greater efficiency, in generating peptide 
sequences due to simply amplification and replication of genomic DNA process, than 
phage display. Besides, there is a still need improvement in the selection of peptides 
since solid materials are quite different from protenacous ligands for which the 
combinatorial selection techniques were originally developed [16, 348, 375, 349]. 
Solvent conditions in biopanning, which may have intrinsic effects on surface 
modifications need to be taken consideration. In addition, display technologies are 
also limited the form of solid substrate. For instance, in case of cell surface display; 
any centrifugal force used in biopanning step could disrupt and shear off the flagella 
form the cells and result in loss of tightly bound clones from the pool. Therefore, 
utilization of cell surface for selection of peptides against to inorganic powders and 
nanostructures are not feasible [368, 9]. 
In general, a consensus binding motive is common in protein-protein interactions 
[345, 340, 343]. However, to obtain clear binding sequence in case of inorganic-
peptide interaction is difficult. This probably reflects the heterogeneity of inorganic 
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surfaces and occurrence of possible binding mechanisms [16, 348]. Consequently, 
further binding analysis is required in selection of material specific peptides. 
Generally, in a biopanning experiment, 50 clones characterize with different methods 
developed Sarikaya group to indicate degree of binding strength. In our group, initial 
peptide binding characterization has been performed using semi-quantitative 
methods such as direct colony counting while peptide displayed on cell or surface 
coverage of phage on inorganic surface by fluorescence microscopy to assess the 
affinity levels of individual clones.  The affinities of the clones are sorted from 
“strong” to “weak” based on the number of bound cells or the surface coverage ratio 
The FM technique also enables characterization of binding specificities of selected 
clones which are tested on various different inorganic solid surfaces.  Further 
quantitative characterization methods such as quartz crystal microbalance (QCM), 
surface plasma resonance spectroscopy (SPR) and atomic force microscopy (AFM) 
have been applied to understand binding strength and assembly of peptides on 
inorganic surfaces [376, 377]. In our approach, set of peptide sequence of 
experimentally selected clones from an initial random library is referred to as the first 
generation peptides. This first generation of peptides can be further engineered by 
computational approaches incorporating bioinformatics to produce second and higher 
generation of more functional peptides [360, 378]. 
1.8.2 Theoretical design and molecular binding characterization of GEPIs 
With the accumulating knowledge on the utility of GEPI in nanotechnology and 
bionanotechnology, there is a need for improvement in the selection of peptides with 
better affinity and material selectivity.  First generation of peptides are restricted the 
size of library that is not enough to cover all possibilities to obtain the best sequence 
through directed evolution [375]. Therefore various molecular tailoring strategies 
such as site directed mutagenesis, bioinformatics and molecular conformations will 
offer way to improve peptide affinity and specificity to inorganic surfaces.  Examples 
were shown the effect of molecular restrictions on peptide affinity by utilizing 
various surfaces such as Pt, Au, TiO2, and SiO2 [356, 354, 359, 379]. Besides, some 
studies were accomplished based on use of multiple repeats of peptides and site-
specific changes of amino acids within the sequence to understand peptide binding 
domain and affinity correlation [353, 380-383].  
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In addition to genetic tailoring strategies, computational studies may introduce novel 
perspectives for the design of new peptides bearing improved affinity as well as 
material-specificity. A successful strategy for the design of GEPI was developed by 
Sarikaya and his co-workers. The basic principle in this strategy based on degree of 
sequence similarity among the selected peptides [360].  
The interaction between and solids that already exists in nature has been studied to 
understand the molecular recognition as well as binding mechanism of the proteins in 
biomineralization, fabrication of hybrid materials, directed assembly of functional 
materials [384-386]. These studies indicated that the proteins in the nature that 
exhibit similar functions also have aa sequence similarity to each other [387]. 
According to this observation, Sarikaya Group proposed theory that peptide, have an 
ability to recognize one surface, should hold sequence similarity [360]. To examine 
this theory, protein sequence alignment is one the tool to detect key functional 
residues inferring the evolutionary history of protein families. Based on this 
knowledge, different sequences were aligned using optimization procedure to find 
out the most possible relative arrangement of the sequences [388-390]. To align 
sequences, a scoring matrix is used to obtain the score that can consider as a measure 
of the similarity between sequences. Sarikaya group developed methodology 
combining sequence alignment techniques to produce unique material –specific 
scoring matrices through bioinformatics tool [360, 349]. The method starts sequence 
selection based on experimentally selected, characterized and categorized inorganic 
binding peptides into three groups; strong, moderate and weak for specific materials. 
The sequence alignment methods [388] and the standard scoring matrices [389] are 
applied to the experimentally selected sequences to generate a new material-specific 
sequence scoring matrix that can determine the aa pattern among the strong with a 
certain score. To design new peptides with higher affinity, the resultant sequence 
scoring matrix that is specific to certain material is applied to millions of aa sequence 
that are generated by computer and similarity score for each generated peptide is 
calculated. Among them, the peptides with highest or lowest similarity score are 
define as “strongest” or “weakest”, respectively, comparing to experimentally 
selected strong binders [360]. The first successful example was shown to generate 
new quartz-binding sequences. As described above, with the combination of different 
sequence alignment techniques, they produce material-specific scoring matrices 
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using the experimentally observed sequence similarities of quartz binders (Figure 
1.27 (lower)). From these matrices, they randomly generated new quartz-binding 
sequences. Thereafter, they have chosen six strong (high-scored) and four weak 
(low-scored) predicted quartz binders and tested their binding affinities to quartz. 
Experimental results were in consistency with the predicted results. As a 
consequence, second generation GEPI sequences were acquired by using the existing 
knowledge of the first generation GEPI sequences [360].  
A detailed understanding of peptide recognition and assembly process is required to 
develop better tailoring strategies for novel peptides with enhanced binding and 
specificity capabilities. There are various techniques that open windows to 
understand binding mechanism. The most applicable quantitative methods are QCM 
and SPR which allow us to monitor adsorption and desorption process of peptides 
providing molecular binding kinetic parameters [356, 354, 359, 381, 379]. In 
addition these techniques, a better knowledge mechanism(s) of the quantitative 
adsorption may become possible through high resolution surface microscopy (e.g 
AFM, STM), molecular spectroscopy (X-ray photoelectron spectroscopy (XPS), time 
of flight secondary ion mass spectroscopy (TOF-SIMS, fourier transform infrared 
spectroscopy) [391, 392] Since the molecular conformation of the peptides is a key 
for understanding the binding mechanism on the inorganic surface, solid  and liquid 
state of nuclear magnetic resonance (NMR) spectroscopy can provide quantitative 
information on molecular conformations of peptides but the contribution of solid-
NMR method is limited due to the interface coming from the solid surface [393]. 
Due to NMR limitations, utilization of circular dichroism (CD) is another way to 
understand the effect of secondary structure on peptide adsorption.   
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Figure 1.27: Design of second generation GEPI using bioinformatic approach.     
Experimentally selected and categorized peptide sequences (upper) are 
used to calculate similarity scoring matrices (lower) [360]. 
Combination of SPR, QCM and CD measurements is useful to understand structure-
molecular conformations relations on adsorption behavior of inorganic binding 
peptides [356, 354]. Additionally, atomic force microscopy (AFM) is powerful 
technique to gain insights into assembly and diffusion of the peptide on solid surface. 
Collective utilization of these techniques will open way for a better understanding of 
GEPI-inorganic interactions. On the other hand, the knowledge obtained from 
experimental studies should be supported with theoretical models to see whole 
picture of GEPI-inogranic interactions. Molecular simulation studies especially 
molecular dynamics (MD) simulations is very promising to reveal information about 
structural behavior of GEPI on solid surfaces [394-396].  Oren et al. was performed 
noticeable study in this area. They observed that out that platinum binding 
septapeptides conform into multiple protrusions, referred as polypods, which 
spatially match with the crystallographic metal surface [378]. Recently, similar 
match of surface and GEPI orientation was observed by So et. al. for another GEPI, 
namely a gold binding peptide 3rGBP1. In that work, molecular simulation and 
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geometrical docking studies were coupled with experimental AFM observations 
resulting in integrated information [397].   
It is difficult to answer all fundamental questions by only utilizing current 
techniques; however advances in molecular spectroscopic techniques and analytical 
approach including combination of appropriate methods will provide more 
quantitative information on peptide assembly. As the knowledge on the peptide 
recognition and assembly processes increases, novel peptides with tailored binding 
and higher material-specificity will be designed for the control of solid-peptide 
interface, leading to fabrication of new hybrid materials [375]. 
1.8.3 Current and Potential Applications of GEPIs in Bionanotechnology  
What functions make GEPIs as an useful tools for bionanotechnology? Among the 
myriad functions allocated to natural proteins/peptides, some of those that become a 
focus in bionanotachnology are specific recognition, biomineralization, self-
assembly and self-organization [398, 374, 399, 349, 347, 400]. In the broadest sense 
of expression, specific recognition is the foundation of all biological phenomena, 
while biomineralization, self assembly and self organization reflect specific 
recognition between proteins/peptides and themselves or other molecules.  Due to 
GEPIs` material selectivity and self assembly properties, they can be utilized as 
molecular linkers, assemblers and erectors in targeted immobilization [401-409], as 
synthesizers and nano-organizers in fabrication of inorganic materials [362, 367, 
410-412, 357, 413]. They have also advantage to enhance their applicability with 
desired functionality in nanoscale when inserted into permissive sites of several 
biomacromolecules (proteins, enzymes, viruses etc.) applying genetic engineering 
techniques [414-416, 352]. 
On the other hand, GEPI can provide a new platform for high performance of 
implants and hard tissue engineering via immobilization of biomolecules with 
controlled attachment and assembly on solid surfaces [417, 418, 400].  In this 
section, only three examples will be demonstrated to give basic perspective for 
promising potential of GEPI in implantation and hard tissue engineering.  In the first 
example, capability of GEPIs as a synthesizer in biomineralization process will be 
given. Biomineralization has been attracted attention in the field of bio-
nanotechnology because firstly, biomineralization reactions proceed under mild 
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conditions than conventional industrial methods and secondly, the hard tissues 
obtained through biomineralization often have elaborately designed nanostructures. 
The unique morphological, structural, and functional properties of inorganic 
materials synthesized by biological organisms have been controlled towards proteins. 
This phenomenon has led to development of biomimetic approaches for utilization in 
designing and engineering of functional materials. The traditional approach involves 
extracting and purifying proteins from organism of interest and utilizing them for in 
vitro material synthesis [419-421]. Although there are exciting examples, performing 
biomineralization using isolated proteins is limited because of the difficulties 
involved in extraction and purification of these proteins from biological systems. 
Another approach is prediction of functional sequence by using computational 
methods called as de novo design, based on identified protein sequence proved role 
in biomineralization. Usually, there may be a large number of proteins with various 
temporal and spatial distribution involved in a given biological mineralization 
process. Practical biomineralization through extracted proteins or de novo designed 
peptide sequence remains elusive due to impractical identification of all proteins and 
their sequence. GEPIs offer unique and a more practical approach in 
biomineralization. Given that the GEPIs recognize and bind to solid materials, there 
may also be inherent capability within the sequences to influence fabrication process 
of these inorganic solids as well. Gungormus et. al. was shown exploring the 
possibility of HA-binding peptides to regulate calcium phosphate formation in vitro. 
They found that a strong- binding peptide HABP1 affects formation of calcium 
phosphate mineral in several aspects (Figure 1. 28). The addition of HABP1 slowed 
the rate of initial mineralization, resulting in the formation of much larger plate-like 
particles compared to control samples (weak binding peptide, HABP2 and no peptide 
containing solutions) and increased the rate of transformation of the amorphous 
phase to the crystalline phase [367]. This conversion may involve interactions of 
HABP1with the amorphous mineral surface, which in turn stabilizes the crystal 
structure by lowering the surface energy, therefore resulting in a growth- dominated 
mineralization pathway. 
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Figure 1.28: (A) Rate of Ca2+ consumption in the presence of peptides; inset: the 
consumption rate during the first 6 h. (B) Ca/P ratio of the mineral phase 
at different time points. The final morphology of the minerals after 96 
hours of mineralization in the presence of (C) no peptide, (D) weak 
binding control peptide and (e) strong binding peptide, HABP1 [367]. 
The second example is related capability of GEPIs in a variety of immobilization 
applications uniquely suited for modifications of biomaterial surfaces. Several 
articles have already been published demonstrating bioactive or bioinert surfaces via 
peptide linkers on a number of materials [422, 371].  Another example was presented 
by Sarikaya and his group present. Four different materials (gold, platinum, glass and 
titanium) as a proof of concept substrate were used to show applicability of GEPIs in 
implant surface modifications. Gold and platinum were chosen because of ideal 
chemical stability for bioinert applications in implantation that are in direct contact 
with blood. Two different peptide linkers (3RGBP1 and PtBP1) were used to 
functionalize these surfaces with PEG anti-fouling polymer. Two step-targeted 
assembly processes in which the peptides are first immobilized on the surface and 
then chemically conjugated with the activated polymer by Schiff- base chemistry 
(Figure 1.29B) were employed. The surfaces that are able to resist cell adhesion were 
obtained as well as those formed by oligo (ethyleneglycol) thiol SAM on gold 
(Figure 1.30A). In the same study, bioactive surface modifications were achieved 
with immobilization of RGD integrin- binding sequence on glass surface via QBP1 
(glass binding peptide) and titanium surface TiBP1 (titanium binding peptide). 
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Figure 1.29: (A) Directed assembly—GEPI is conjugated with the active molecule 
before immobilization on the substrate. (B) Targeted assembly—GEPI is 
immobilized on the substrate alone then conjugated with the active 
molecule by secondary means, such as Schiff base chemistry [346]. 
This modification is accomplished through single step directed assembly process 
(Figure 1.29A). The resulting samples increase adhesion and spreading of the cells, 
exhibiting increase only when both parts of the construct are present (Figure 1.30B 
and C). Although employing GEPIs as linkers in biomaterial applications are 
significant, the path to clinical application has not been covered yet. Understanding 
the mechanism of binding in a number of peptide-solid systems may allow the design 
of new sequences that combine different functional domains.  
Immobilization of cytokines on the implat surface via peptide linker was given as a 
third example. Shiba and his group proposed a similar approach that we described in 
previous examples for immobilizing cytokines on material surfaces. In this method, 
material binding artificial peptide is used to mediate reversible interaction between 
the cytokine and material surface. In their experimental design, they embedded the 
minTBP-1 motif such that the proteins could be used to coat a Ti surface with 
crystals of calcium phosphate. Some of the proteins created in that experiment 
contained multiple copies of minTBP-1 in their sequences. Among them, they 
focused on #56, which contains three copies of minTBP-1, and used it as a Ti-
binding protein in the present experiment. As controls, we also used #55 and #69, 
neither of which contain a minTBP-1 motif, but the amino acid composition of #55 is 
more hydrophobic than that of #69. In Figure 1.31 shows the each contructs 
mineralization efficiency on the surface of titanium via alkanine phosphatase 
activity. 
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Figure 1.30: (A) Light optical microscopy images of NIH3T3 fibroblast cells (3x10
5
 
cells, 1.5 hrs, 200X) on gold substrate modified with GEPI-PEG 
conjugate; (B) Scanning electron microscopy (SEM) images of NIH3T3 
(5 3 103 cells, 24 hrs) on glass substrate modified with GEPI-RGD 
conjugate; (C) SEM images of NIH3T3 (8x10
4
 cells, 24 hrs) on titanium 
surface modified with GEPI-RGD conjugate [346]. 
 
Figure 1.31: ALP activity was assessed by staining with BCIP/NBT [407]. 
All examples indicate us GEPIs enormous potential in wide range applications 
especially they can provide the ways for genetic control on bimeralization, 
funtionilization of implant surfaces with diffrenet purposes in tissue restoration and 
regeneration. 
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2. MATERIALS AND METHODS 
2.1. Combinatorial Selection Methods  
2.1.1. Cell surface display selection  
2.1.1.1. Target material preparation 
cp Grade 4 and cp Grade 1 titanium implant surfaces were kindly gifted Gronowicz 
et.al. 0.78 cm
2
 round implant disks were cleaned before performing any experiments. 
Disks were first soaked in 1% SDS for overnight and then sonicated for 1 hour. 
Following, they were washed in double distilled water several times before and after 
passivation in 30% nitric acid for 1 hour, and then sterilized 15 min under ultraviolet 
light for both sides to achieve sterility prior to any cell experiments.  
2.1.1.2. FliTRx random peptide display library  
FliTrx Library (Invitrogen, K1125-01) was used for selection of titanium binding 
peptides.  The library was designed displaying peptides on the surface of E. coli 
using the major bacterial flagellar protein (FliC) and thioredoxin A (TrxA) diverse 
library of random dodecapeptides was inserted into the active site loop of 
thioredoxin, which is itself inserted into the dispensable region of the flagellin gene 
(fliC). Construction of library in the thioredoxin active site loop constrains the N- 
and C- terminal ends of the peptide resulting in a well-defined structural context. The 
Flitrx library has an estimated diversity of 1.77x108 different random dodecamer 
sequences. The peptide fusion construct is expressed from the bactreriophage lambda 
major leftward promoter (PL). When induced, the fusion protein Flitrx is exported 
and assembled into flagella on the bacterial cell surface, allowing display of 
constrained peptide. The figure below shows schematically how the peptide library is 
constructed and displayed (Figure 2.1). 
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Figure 2.1: Schematic of library construction and displayed peptide on the surface of 
E. coli [354].  
2.1.1.3. Cell surface display   
Before applying basic panning procedure for selection of titanium binding peptides,  
one vial of the FliTrx peptide library were grown in 50 mL IMC media (1XM9 Salts, 
0.2% casamino acids, 0.5% glucose, 1mM MgCl2) containing 50 µg/mL carbenicillin   
(no tryptophan) with shaking (225-250 rpm) for 15 hours (overnight) at 25°C until 
reach OD600 = ~3 to proceed panning experiment. Then, number of cells in the 
culture were determined by measuring optical density at 600 nm (1 OD600 = ~1 x 10
9
 
cells for a 1 mL sample).  Following, FliTrx Library expression was induced by 
adding 1 x 10
10
 cells (~3 ml) of the overnight culture into 50 mL IMC Medium 
containing (50 µg/mL carbenicillin and 100 µg/mL tryptophan).  Induced culture was 
grown at 25°C with shaking (225-250 rpm) for 6 hours. Meanwhile, titanium target 
in a sterile petri dish was incuabated with freshly prepared blocking sloution (IMC 
media, 150 mM NaCl, 1% BSA, 1% α-methyl mannoside) for 1 hr with gently 
agitation (50 rpm) at room temperature. At  the end of the induction period, 10 mL 
induced library in IMC containing 1% BSA, 150 mM NaCl, 1% α-methyl mannoside 
were exposed to titanium surface after decanting blocking solution from the surface 
and incubated with gently agitation at 50 rpm for 1min at room temperature. 
Subsequently, the surface and induced library was let to interaction for 1 more hour 
without any agitation. Following, titanium target was washed 5X times using IMC 
media containing 1% α-methyl mannoside. After 5 washing steps, adhering bacterial 
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cells were sheared off by vortexing for 3 min; released cells were then grown 
overnight in IMC media at 25°C and shaking at 225 rpm. At the end of incubation, 
Glycerol stocks (20%) of the grown cells (4 mL) were prepared. 1 x 10
10
 cells (~3 
mL) were induced in 50 mL IMC Medium containing (50 µg/mL carbenicillin  and 
100 µg/mL tryptophan) to continue for the next round.  After each selection round, 
serial dilutions of overnight cultures were plated onto RMG plates (RM media: 
1XM9 Salts, 2% casamino acids, 1% glycerol, 1 mM MgCl2, 50 µg/mL carbenicillin 
and 1.5% agar) and incubated overnight at 30°C for positive clone selection. (Figure 
2.2)  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Schematic representation of selection of titanium binding peptides by 
cell surface display. 
For DNA isolation, individual colonies were grown overnight at 30°C with shaking 
at 225 rpm in RM media. Plasmid DNA was isolated using Miniprep Spin Kit 
(Qiagene, USA). Nucleotide sequences of positive clones were determined using an 
automated DNA sequencer (ABI Prism 310 Genetic Analyzer, Perkin-Elmer Life 
Sciences, USA) using BigDye 3.1 terminator kit (Applied Biosystems, USA) and 5’-
TAACCCAGCTTCAATTGAGG-3’ and/or 5’-ACAGTGCACCCACTTTGG-3’ 
designed primers (Invitrogen, USA). 
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2.1.1.4 Initial binding characterization of selected clones via fluorescence 
microscopy 
Fluorescence microscopy characterization was applied to investigate binding affinity 
of selected titanium binding clones. Firstly, titanium substrates were prepared by 
directly coating 25 nm thick titanium layer on both sides of glass slides using a 
GATAN Precision Etching Coating System (GATAN, Inc., USA). Then the coated 
substrates were quickly cleaned by ultrasonication first in 1:1 acetone: methanol, 
then isopropanol and lastly in water. The substrates were used immediately after 
sputtering and cleaning procedure. Meanwhile, each selected individual clones were 
first grown in RM media (1XM9 Salts, 2% casamino acids, 1% glycerol, 1 mM 
MgCl2, 50 µg/mL carbenicillin) 16-24 hours at 30
0
C, shaking 225 rpm.   
 
Figure 2.3: The optical microscope dedicated for fluorescence and dark field 
imaging. 
Next, cells were induced in IMC media (50 µg/mL carbenicillin and 100 µg/mL 
tryptophan) for 6-16 hours at 37
0
C shaking 225 rpm until mid-log phase (OD600nm= 
0.4). 1ml aliquots of induced-cell clones were labeled with 500 µL (2.5 µM in DI 
water) nucleic-acid fluorescent dye SYTO9 (Molecular Probes, USA) for 20 min by 
gently mixing. Labeled cells were incubated with a 12 mm diameter titanium surface 
for 20 min with rotating in the dark.  Following, substrates were washed with DI 
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water two times, bound cells were visualized on the titanium surface using a Nikon 
Eclipse TE-2000U Florescent Microscope (with Hamamatsu ORCA-ER cooled CCD 
camera) (Figure 2.3) using a FITC filter (exciter 460-500, dichroic 505, emitter 510-
560) (Figure 2.3) and METAMORPH Software (Universal Imaging, USA) Number 
of cell on the titanium surface was counted by using METAMORPH Software. As a 
negative control, E.coli GI826 (Invitrogen, 50-0091) plasmid-free cells were also 
grown in same conditions as described above except adding any carbenicillin in 
specified media and used for FM. All measurements were carried out in triplicate 
experiments; this led to the identification of three binding groups - strong, moderate 
and weak (Figure 2.4.).   
 
Figure 2.4: Initial binding characterization of titanium binding peptides via 
fluorescence microscopy. 
2.2 Solid State Peptide Synthesis  
An automated solid-phase peptide synthesizer (CS336X, CS-Bio Inc., Menlo Park, 
USA, Figure 2.5) was utilized to synthesize GEPIs through Fmoc-chemistry. In this 
approach, modified amino acids (Chempep, USA), where N-terminus and side chain 
of amino acids were protected by a Fmoc group and an appropriate protecting group, 
respectively, were used. In the reaction vessel, the Wang resin (Novabiochem, USA) 
pre-loaded with F-moc protected first amino acid was treated with 20% piperidine in 
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DMF to remove the Fmoc group, which was monitored by UV-absorbance at 301 
nm. The incoming amino acid separately activated with HBTU (Sigma Aldrich, 
USA) in DMF was transferred into the vessel and incubated with the resin for 45 
min. After washing the resin with DMF, the same protocol was applied for addition 
of the next amino acids. Following the synthesis, the peptide-resin conjugate was 
applied to the cocktail containing 90:5:3:2 TFA:thioanisole:EDT:anisole under 
nitrogen for 3 h to remove peptide from the resin as well as blocking agents from the 
side chains of the peptide. The peptide solution was then filtered to separate the resin 
and the peptide. The cleaved peptide was precipitated in cold ether followed by 
lyophilization (Virtis Benchtop K, SP Industries, Inc, USA) to get crude product. The 
purification was carried out by HPLC (Waters, USA) using C-18 column (Gemini, 
USA) under reverse-phase conditions (see Figure 2.6). Firstly, lyophilized peptide 
powder was dissolved in ~25/75 % (v/v) Acetonitrile:DI water mixture and injected 
into HPLC. At the column, isocratic gradient of Acetonitrile was maintained for 2 
min and then 60 linear gradient of DI water with 1%/min for analytical (at a rate of 1 
ml/min) and 0.5%/min for semi-prep scales (at a rate of 10 ml/min) was employed. 
Each peak monitored by the UV detector at 280 nm and 215 nm was collected and 
characterized by MALDI-TOF mass spectrometry with reflectron (RETOF-MS) on 
an Autoflex II (Bruker Daltonics, USA) mass spectrometer located in Department of 
Medicinal Chemistry at University of Washington. Synthesized peptides were listed 
in Table 2.1. The MW and pI parameters for each peptide were calculated through 
ExPASy Proteomics Server. 
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Figure 2.5: Image of CS-Bio peptide synthesizer. 
 
Figure 2.6: Image of Waters HPLC. 
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Table 2.1: Sequence, MW, pI and net charge of synthesized peptides. 
 
Name 
 
Sequence 
 
MW 
 (g/mol) 
 
pI 
 
Net 
Charge  
at pH 7.4 
 
TiBP1 
 
RPRENRGRERGL 
 
1495.67 
 
 
11.82 
 
+ 
 
TiBP2 SRPNGYGGSESS 1197.18 
 
5.72 
 
0 
 
TiBP60 VGRVTSPRPQGR 
 
1309.49 
 
12.3 
 
+ 
 
TiBP1-RGDS RPRENRGRERGL 
GGGRGDS 
2082.23 11.70 + 
 
TiBP2-RGDS 
 
SRPNGYGGSESS 
GGGRGDS 
 
1783.75 
 
5.79 
 
+ 
 
RGDS 
 
RGDS 
 
433.42 
 
5.84 
 
+ 
 
TiBP1-AMP 
 
RPRENRGRERGLGGG 
LKLLKKLLKLLKKL 
 
3341.14 
 
11.85 
 
+ 
 
TiBP2-AMP 
 
SRPNGYGGSESSGGG 
LKLLKKLLKLLKKL 
 
 
3042.66 
 
10.39 
 
+ 
AMP LKLLKKLLKLLKKL 1692.34 10.70 + 
 
TiBP2-cHABP1 
 
SRPNGYGGSESS 
GGGCMLPHHGAC 
 
2318.5 
 
6.65 
 
 
0 
 
TiBP2-ADP5 
 
Under Patent Pending  
 
3815.99 
 
 
6.48 
 
 
0 
 
TiBP2-ADP7 
 
Under Patent Pending  
 
5995.64 
 
 
7.08 
 
 
0 
 
cHABP1 
 
CMLPHHGAC 
 
968 
 
 
6.90 
 
 
0 
 
ADP5 
 
Under Patent Pending  
 
2465.6 
 
 
7.16 
 
 
0 
 
ADP7 
 
Under Patent Pending  
 
4645.3 
 
 
7.28 
 
 
0 
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2.3 Molecular Structure and Modeling Methods  
2.3.1 Circular dichroism spectroscopy (CD) 
A solution containing 30 µM peptide, 100 mM Tris-HCl at pH 7.4 and various 
amounts of 2, 2, 2-trifluoroethanol (99.8% purity) was prepared for circular dichroic 
analysis. The spectrum, which is the average of 8 scans from 185 – 260 nm with a 
0.5 nm/s scan rate, was collected at 20 ° C using an AVIV Stopped Flow 202SF CD 
Spectropolarimeter. The averaged spectrum, which was then subtracted with the 
appropriate buffer background, was smoothened using the Savitzky-Golay algorithm. 
A section of the smoothened spectrum (from 190 – 240 nm) was compared to the 
five component reference spectra [(1) a helix, (2) b sheet, (3) b turn, Type-I, (4) b 
turn, Type-II, and (5) random coil] compiled by Reed, et al.  using a constrained 
least-squares fit [423]. Note that the standard spectra do not consider any aromatic 
nor disulfide dichroic contributions. This is appropriate because the analyzed 
peptides do not contain significant non-structural features. (TiBP2 contains only one 
peptide with an aromatic residue, Y.) The secondary structure estimates are reported 
as the fractional weight ± the standard deviation. All spectral smoothing and 
secondary structure estimation were executed using commercial graphing software 
(IGOR Pro. 6.0). The CD machine was carefully calibrated using (1S)-(+)-10-
camphorsulfonic acid (Aldrich, 99%). Ellipticity is reported as mean residue 
ellipticity, q M (deg cm
2
 dmol
-1
).  
2.3.2 Molecular modeling  
Six different peptides (TiBP1, TiBP2, TiBP60, AMP, TiBP1-AMP, TiBP2-AMP as 
in Table 2.1) were modeled to determine molecular conformation of peptides. To 
model peptides, we built linear forms using the HyperChem’s molecular modeling 
software (Hyperchem 7.5, USA). The energy minimization of these peptides was 
carried out under implicit solvent conditions using the conformational analysis 
program. The conformational search module finds the minimum-energy structures by 
varying the chosen dihedral angles. To perform energy minimization, it changes 
dihedral angles randomly and creates new initial structures. In each round of energy 
minimization, unique low-energy conformations are stored, and high-energy and 
duplicate structures are discarded. Using the conformational search module, we 
found 1000 different local minima on the potential energy surface, and we chose the 
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lowest one as the global minimum or the lowest-energy conformation [424, 378] 
Then, the lowest energy conformations are solvated with TIP3P water explicitly; and 
finally the overall system is energy minimized using the Polak-Ribiere conjugate 
gradient method until convergence of the gradient (0.01 kJ/mol) was reached using 
the CHARMM 27 force field [425]. The final configurations and the corresponding 
Ramachandran Plots were generated using the VMD (Visual Molecular Dynamics) 
software. 
2.4 Quantitative Peptide Binding Characterization Methods  
2.4.1 Quartz crystal microbalance (QCM) 
In QCM-D systems the peptides or protein were flown through the flow cell onto the 
quartz crystal system. The mass loaded onto the quartz crystal was followed in real 
time. During the analysis of adsorbed layer of GEPI, dissipation change during the 
adsorption of the peptides was also monitored. The mechanic properties were 
followed as the change in the dissipation of the adsorbed layer and layers. The 
operating principle of the QCM-D system is represented in Figure 2.7
 
Figure 2.7: (A) The quartz crystal used in the QCM-D. (B) Applying of the direct 
current to the crystal (C) Applying alternative current to the quartz 
crystal (D) The change in the frequency upon adsorption of a layer onto 
the quartz crystal. (E) The change in the dissipation upon adsorption of a 
viscoelastic layer on to the quartz crystal (reproduced form the user 
guide of QCM-D apparatus, Q-Sense AB, Sweden) [382]. 
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Figure 2.8: The picture of the Quartz Crystal System. The temperature of the QCMD 
system is controlled with Peltier embedded systems coupled with a 
temperature controller. 
In this study, QCM-D was used to determine quantitative peptide binding affinity to 
solid surfaces. We monitored the interaction between inorganic surfaces and peptides 
(as listed in Table 2.1) using titanium, silica, gold and hydroxapaptite surfaces. The 
photograph of the QCM-D system in our lab is shown in Figure 2.8.  
2.4.1.1 Quantification of peptide binding affinity via QCM   
First, to quantify binding strength of peptides on titanium surface, five-megahertz 
quartz crystals (Q-Sense) were coated with 25nm of titanium via physical vapor 
deposition.  Commercial SiOx and hydroxapatite (HA) crystals (Q-Sense) were used 
to analyze peptide binding affinity on other surfaces. In the beginning of experiment, 
the crystals were placed in a KSV QCM-D Z500 parallel flow system, which 
monitors frequency change over time. PBS buffer were flown through the flow cell 
until the surface reach the steady state. Meanwhile, peptides were diluted in PBS 
buffer at various concentrations and introduced to the crystal surface by a flow cell. 
The flow was stopped and the peptides were allowed to bind to the surface until 
reaching equilibrium. Each concentration was flowed several times avoid depletion 
of the peptide in the flow cell. Binding was observed by the frequency shift, which is 
directly related to the wet mass of the adsorbed peptide. To determine the 
dissociation constant (Kd) of each peptide on titanium, the equilibrium frequency 
shift caused by peptide binding was measured at several concentrations. These values 
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were then fit using the Langmuir adsorption model. Initially, peptide concentrations 
of 0.1 to 2 µM and 2 µM to 15 µM were used for all binders. These concentrations 
were then adjusted as necessary to be in a similar range as the Kd value of each 
peptide. After testing, titanium and SiOx surfaces were cleaned using a surfactant 
solution (1% SDS, 1N NaOH), HA surfaces were kept and cleaned in ethanol 
solution overnight, and all surfaces were ozone cleaned for 15 minutes before reuse.  
2.4.1.2 In vitro monitoring for peptide-mediated mineralization via QCM 
To determine the kinetics of hydroxyapatite mineralization and formation, QCM 
measurements were carried out. Firstly, titanium surface was equilibrated with PBS 
solution until reach steady state. Then 10 µM, 1 mL Peptide (TiBP2-cHABP1, 
TiBP2-ADP5, TiBP2-ADP7, TiBP2, ADP5, ADP7, cHABP1) solution that is 
dissolved in PBS was injected to the flow cell three times in 10 min time interval. 
Once the bifunctional peptide was observed to bind to the titanium substrate, a 
calcium-phosphate solution was introduced into the flow cell as a mixture (1:1 ratio) 
of 4.8 mM calcium chloride and 2.8 mM potassium phosphate. By using QCM, 
formation of Hydroxylapatite on top of the bifunctional peptide layer was monitored 
24 hours. Then the substrate was gently washed with deionized water and was dried 
with pressurized nitrogen gas to ensure that any unbound hydroxyapatite minerals 
were removed. Following peptide mediated mineralized film were characterized 
under SEM and TEM. 
2.5 Material Surface Characterization Methods 
2.5.1 Scanning electron microscopy (SEM) 
SEM was used first to determine surface morphology and chemistry of cp Grade1, cp 
Grade4 and titanium foil surfaces. Then bacteria, osteoblast and fibroblast adhered 
titanium surfaces was monitored under SEM. The last peptide–mediated 
hydroxyapaptite mineralization on titanium surfaces were characterized by applying 
SEM. All experiments were carried out and scanned under JSM-7000F (JEOL, 
Japan) coupled with the attachments for Energy-dispersive X-ray (EDX) 
spectroscopy (Figure 2.9).  
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Figure 2.9: JEOL JSM-7000F Scanning Electron Microscope with EDX detector. 
In case of determination surface properties of cp Grade1, cp Grade4 and titanium 
foils, samples were directly mounted onto aluminum cylinder using carbon tape. 
Images and EDS spectra were taken at 9 keV using a LaB6 filament. EDS spectra 
were collected for 100 seconds at approximately 1500 counts per second (cps). In 
case of monitoring cell- adhered titanium and hydroxapatite mineralized surfaces, the 
samples were coated with thin layer of platinum and then directly placed on the 
aluminum mouth. 
2.5.2 Atomic force microscopy (AFM)  
Surface morphology and roughness of cp Grade1 and cp Grade4 titanium implant 
surfaces were obtained by using AFM. Root mean square roughness (Rrms) of cleaned 
implant disks and topographic features were examined by using a Nanoscope 
III/MMAFM system (Veeco Instruments, Inc., Santa Barabra, CA). (Figure 2.10) 
Scans of 30 µm by 60 µm were made in contact mode using standard SiN contact 
mode AFM tips.  Rrms values were calculated from these scans using the onboard 
software. 
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Figure 2.10: The image of the Atomic Force Microscope in the chamber for acoustic 
and mechanical isolation. 
2.5.3 Transmission Electron Microscopy (TEM) 
Philips EM420 TEM (Figure 2.11) was used to observe crystal structure or X-ray 
pattern of peptide mediated–hydroxapatite mineralized surfaces. Prior to 
characterization, nanoparticles were rinsed with DI water to remove the salt and then 
drop-coated on copper TEM grid coated with carbon film (Ted Pella, USA). Excess 
of the nanoparticle solution was removed using tissue paper and then the grid was 
allowed to dry under vacuum. 100 kV were used as accelerating voltage. The 
projection of the nanoparticles was printed on photographic negatives (Kodak, USA) 
that were then developed in the dark room. 
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Figure 2.11: Philips EM420 Transmission Electron Microscope. 
2.6 Preparation of PDMS Stamps for µCP  
2.6.1 Master preparation  
The silicon wafer was prepared through cleaning procedure in which the wafer was 
sonicated in acetone for 5 min, then incubated in methanol for a min, and, lastly, 
dried under stream of nitrogen. The cleaned substrate was spin-coated with negative 
photoresist, SU-8 2035 (Microchem, USA) through two subsequent steps; 500 rpm 
for 5 sec and 3000 rpm for 45 sec. Photoresist-coated wafer was incubated for 3 min 
on hotplate that was set to 65
0
C, and then kept for 6 min following ramping up to 
95
0
C. Soft-baked wafer was then exposed to UV light (λ= 365 nm) for 20 sec 
through a photomask where the micropatterns were printed on. For the post exposure 
baking, UV-exposed wafer was kept at 65
0
C for 1 min and then at 95
0
C for 6 min on 
hotplate. Micropatterns produced on the photoresist were developed through 
incubating the photoresist coated silicon wafer in SU-8 200 developer (Microchem, 
USA) for 5 min. Finally, the wafer (master) was incubated at 200
0
C for hard baking.  
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2.6.2 PDMS stamp preparation  
A small petri dish with one droplet of tridecafluoro-1,1,2,2-tetrahydrooctyl)-1-
trichlorosilane was placed into the bottom of the desiccator whereas the master was 
located at upper part of it. Desiccator was closed and left for 30 min under vacuum. 
This treatment step makes the master surface hydrophobic so that the PDMS sticking 
on the master is avoided. The modification can be controlled by putting a drop of 
water on the master to see if the droplet is formed. If it is formed, master is ready to 
use. CAUTION: the silane molecule is toxic and the fume hood is necessary.  
Viscous pre-polymer and the curing agent (Sylgard 184 Elastomer kit, Dow Corning, 
USA) were mixed with ratio of 10:1 (w/w) and poured onto the treated master. 
Following degassing for removing the formed air bubbles, the viscous mixture 
spread on the master was cured at 70°C for overnight. The PDMS and master were 
separated and the elastomer stamp was cut into the smaller pieces. The stamps were 
then washed several times with ethanol and dried with nitrogen before use. 
2.7 Cytotoxicity Assays for Peptide Functionalized Titanium Surfaces 
2.7.1 Cell culture maintenance  
 MC3T3-E1 preosteoblast (ATCC, CRL-2593™) and NIH3T3 (ATCC, CRL- 
1658™) were cultured in Minimum Essential Medium (MEM) Alpha Medium 
(Gibco, 12561) supplemented with 10% fetal bovine serum (Gibco, 16250), 2mM 
glutamine (Gibco, 25030-164) and 1% antibiotic solution (Gibco, 15140). Cells were 
incubated at 37°C in 5% CO2 for one week. After one week, cells were 
enzymatically detached from the surface of the petri-dish using 0.25% trypsin-EDTA 
solution (Gibco, 25200) and precipitated by centrifugation (2000 rpm for 5min). 
Following, certain number of cells was used to proceed further experiments. 
2.7.2 Cell viability (MTT assay) 
First, peptides (TiBP1 and TiBP2) were dissolved and diluted to 200 µM in 1X PBS 
(Gibco, 14200). Then, 750 µL each peptide solution was incubated with sterilized cp 
Grade1 and Grade4 implant surfaces  and as a positive control, each type of implant 
surfaces were also incubated 1X PBS for 4 hours at 37°C in 5% CO2. Following 
incubation with the various solutions, all samples were washed two times in 1X PBS 
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to remove unbound peptides. 8x10
5
 cells/mL (2 mL) cells in 12-well plates were 
exposed to samples and as a negative control in other wells. The cultures were 
maintained in serum-free Minimum Essential Medium (MEM) Alpha Medium with 
1% antibiotic solution at 37°C in 5% CO2 and incubated for 24 hours. Following 
incubation time, 200 µL media was removed from each well, 200 µL of an MTT 
(Sigma M5655) solution (5 mg/mL) (1:10 ratio) was added into each well and 
incubated 3 hours. At the end of incubation time, purple formazan crystals were 
observed under inverted microscope. All implant surfaces were transferred into clean 
wells and formazan crystals were dissolved and incubated with 1.5 mL DMSO and 
0.1 M Glycine, NaCl pH 10.5 (10:1) ratio for 5 min. Absorbance of converted dye 
was measured at a wavelength of 570 nm with background subtraction at 630-690 
nm. Relative cell viability (%) was calculated based on bare titanium surfaces for 
each group. 
2.7.3 Cell adhesion and spreading 
In this section, cp Grade4, cp Grade1 titanium implant surfaces and glass coated 
titanium were functionalized with peptides (TiBP1, TiBP2, TiBP1-RGDS, TiBP2-
RGDS, RGDS) as described above. Following each peptide modified surfaces were 
inoculated with 10
4 
cells in 1 mL serum free media for 2 hours at 37
o
C and 5% CO2. 
Following the 2 hours incubation, the cells were fixed in 500 µL of 2% 
glutaraldehyde (Ted Pella, USA) solution in PBS for 20 minutes at room temperature 
and dehydrated with a series of increasing ethanol solutions. (10-30-60-90-100% 
ethanol, 10 minutes in each). The implant disks were then rinsed twice with PBS. 
Previously prepared methanolic stock solution of Alexa Fluor488-Phalloidin 
(Invitrogen Co., U.S.A.) was diluted 200 times in water to obtain an approximately 
33 nM working solution. 500 µL of the final working solution was added on top of 
each sample and kept at room temperature protected from light for 20 minutes. The 
samples where then rinsed twice with distilled water and dried under N2, then 
observed using a TE 300L microscope (Nikon, Japan). Metamorph (Universal 
Imaging, USA) and Image J Software (NIH) were used to analyze number of cell, 
cell spreading and circularity factor. 
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2.8 Antimicrobial Assays for Peptide Functionalized Titanium Surfaces 
2.8.1 Bacterial maintenance and culturing 
Three bacteria - Escherichia coli ATCC® 25922™, Streptococcus mutans ATCC® 
25175™, and Staphylococcus epidermidis ATCC® 29886™ - were used in the 
present study.  All bacteria were cultured according to ATCC® protocol using the 
following media: Tripticase Soy Broth (TSB) for E. coli, Brain Heart Infusion (BHI) 
Broth (Sigma Aldrich, 53286) for S. mutans, and Nutrient Broth (NB) (Difco, 0003) 
for S. epidermidis.  For all three bacterial species, the bacterial pellet obtained from 
ATCC was rehydrated in 0.5 mL of the above specified media, and several drops of 
the suspension were immediately placed and streaked on an agar slant of the 
specified media.  The agar was then incubated aerobically at 37°C for 24 hours (and 
in the presence of 5% CO2 in the case of S. mutans).  S. mutans overnight cultures 
were made by aseptically transferring a single-colony forming unit into 10mL of 
BHI, followed by aerobic incubation at 37°C in the presence of 5% CO2 for 16 hours 
under static conditions.  Overnight cultures of S. epidermidis and E. coli were made 
by aseptically transferring a single-colony forming unit into 10 mL of NB or TSB 
(respectively), followed by aerobic incubation at 37°C with constant agitation (200 
rpm) for 16 hours.   
2.8.2 In solution antimicrobial activity of TiBP-AMP conjugates  
The in-solution antimicrobial activities of the peptides were analyzed against S. 
mutans, S. epidermidis, and E. coli spectrophotometrically. For each bacteria species, 
peptide solutions (AMP, TiBP1-GGG-AMP, and TiBP2-GGG-AMP) were added in 
specified media to reach final concentrations of 10 µM-200 µM, and inoculated with 
the bacteria to a final concentration of 10
7 
cells/mL.   Bacterial growth at 37°C was 
monitored over the course of 24 hours by optical density measurements at 600 nm on 
a Tecan Safire Spectrophotometer No. I 112 913.  For each experiment, a positive 
control consisting of solely 10
7 
cells/mL of bacteria in the specified media, and a 
negative control consisting of solely media was monitored as well.  Additionally, 
bacterial growth of the three bacteria in the presence of TiBP1 and TiBP2 was 
monitored to determine if the titanium-binding peptides exhibited any antimicrobial 
effects. 
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2.8.3 Titanium substrate preparation and peptide immobilization   
0.5 mm thick, 99% titanium foil (AlfaAesar, 43677) was cut into 1 cm x 1 cm 
squares.  The titanium substrates were cleaned by sonicating them for 15 minutes 
each in a 1:1 acetone:methanol mixture, then isopropyl alcohol, and finally de-
ionized water.  Following all bacterial-adhesion experiments, substrates were first 
soaked overnight in a 1:1 mixture of 20% bleach: 70% ethanol before being cleaned 
by the above regimen.  Cleaned 1cm
2
 titanium foil substrates were transferred into a 
pre-sterilized 24-well plate.  The substrates were then sterilized under UV light for 
15 minutes on each side.  Substrates were subsequently incubated aerobically at 37˚C 
under constant agitation (200 rpm) with 500 µL of 1X PBS (positive control), AMP, 
TiBP1-GGG-AMP, or TiBP2-GGG-AMP solutions for 4 hours.  (200 µM peptide 
solutions were used for S. mutans experiments, while 50 µM peptide solutions were 
used for S. epidermidis and E. coli experiments as these were determined to be the 
minimal inhibitory concentrations for each of the bacteria. Following the 4 hours of 
incubation with peptides, the peptide solutions were removed from each well.  1 mL 
of sterile 1X PBS was then added to each well, pipetted up-and-down twice, and 
removed from the well.  A second 1 mL of sterile 1X PBS was then added to each 
well, pipette up-and-down once, and removed from the well.  Using sterile forceps, 
each titanium substrate was moved to a clean well, free of any peptides.    
2.8.4 Mid-log culture and preparation of 10
8 
cells/mL cell suspension 
To proceed with bacterial adhesion experiments, overnight cultures for each bacteria 
were prepared as described above.  Bacteria from the overnight cultures were used to 
inoculate fresh media to a final concentration of 10
7 
cells/mL.  Cultures were then 
incubated in the same manner as the overnight cultures were (see bacterial 
maintenance and culturing), until they reached the mid-log phase as determined by 
optical density measurement at 600nm.  (S. mutans O.D.≈0.4, S. epidermidis 
O.D.≈0.25, and E. coli O.D.≈1.0.)  Cultures were then centrifuged at 4000 rpm for 5 
minutes in a Sorvall® RC 5B Plus Centrifuge.   The supernatant was removed and 
the bacterial pellet was re-suspended in 500 µL of specified media.  This suspension 
was then transferred to a 2 mL centrifuge tube and centrifuged at 5500 rpm for 3 
minutes in a Fischer Scientific accuSpin™ Micro Centrifuge.  The supernatant was 
carefully removed and the bacterial pellet was re-suspended in sterile 1X PBS to a 
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final concentration of 10
8 
cells/mL.  Then, 1mL of the 10
8 
cells/mL cell suspension 
was added to each well containing a peptide-modified titanium substrate, and 
incubated for 2 hours.  For S. mutans experiments, incubation was carried out 
aerobically at 37°C in the presence of 5% CO2 under static conditions; for S. 
epidermidis and E. coli experiments, incubation was carried out aerobically at 37°C 
under constant agitation (200 rpm).  After 2 hours incubation, first the bacterial 
suspension was removed and the surfaces were washed two times with 1 mL of 1X 
PBS by pipetting. 
2.8.5 Fixation of adhered bacteria to peptide-modified titanium surfaces   
Cells adhering to Titanium substrates were fixed with 500 µL of 2% Glutaldehyde 
(in 50 mM Tris Buffer, pH 7.4) for 30 minutes, followed by dehydration in a series 
of increasing alcohol baths. (50% ethanol for 10 minutes, 70% ethanol for 10 
minutes, 90% ethanol for 10 minutes, followed by a 1mL wash with 100% ethanol.)   
2.8.6 Micro-contact printing of TiBP1-AMP with S. mutans 
To establish the dramatic effects of TiBP1-GGG-AMP, the peptide was stamped 
onto a clean titanium-substrate in a manner previously described.  The patterned side 
of the polydimethylsiloxane (PDMS) stamp was incubated in 200 µM of TiBP1-
GGG-AMP for 5 minutes and then the peptide solution was removed by pipette from 
the surface of the stamp. The stamp was dried with inert gas, followed by a brief 
washing with 1X PBS. The titanium substrate was then applied to the surface of the 
stamp and pressed using force for 10 seconds and left on the stamp for 1 minute. 
Then the substrate was removed from the stamp, washed twice with 1X PBS and was 
then subjected to the above procedures (except the incubation with peptides) for S. 
mutans only.  
2.8.7 Visualization and quantification of bacterial adhesion on GEPI-modified 
titanium substrates   
500 µL of 5 µM SYTO 9 dye was added onto bacteria adhered and fixed titanium 
surfaces, protected from light, and incubated for 20 minutes.  Substrates were then 
washed 3 times with 1 mL of 1X PBS by pipetting the PBS up-and-down two times.  
Substrates were then secured onto a clean microscope slide and viewed under a 
Nikon Eclipse TE2000-U Fluorescent Microscope.  Five random images of each 
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surface were taken and analyzed for percent surface coverage using Meta Morph 
(Version 6.r6) software.  Two independent analyses were conducted and averaged for 
each image.  For each substrate, the averaged value for each of the five images were 
averaged together and subjected to statistical analysis. 
2.9 Statistical Analysis 
One way Anova Test was used to determine the significant difference p<0.05 
between the samples. 
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3. RESULTS AND DISCUSSION  
3.1 Selection and Characterization of Titanium Binding Peptides (TiBPs) as a 
Molecular Linker  
3.1.1 Biocombinatorial selection and characterization of TiBPs  
Biocombinatorial methods such as phage and cell surface display have been widely 
used to identify peptide sequence with high affinity and specificity for inorganics. In 
here, we first applied cell surface display technique [341] onto cp Grade 4 titanium 
dental implant [426] to select TiBPs as a potential molecular linker for titanium 
implant surface functionalization. Then, detail peptide characterization were 
performed in the frame of binding affinity, specificity and peptide structure that will 
allow us precise control on utilization of peptide as a potential molecular linker for 
implant surface functionalization. In the cell surface display selection, after four 
successive rounds of biopanning, 60 random clones with equal distribution from each 
round were selected and subjected to sequence analysis. Among peptide sequence, 
consensus binding motive wasn`t obtained as in general protein-protein interaction. 
To identify clear consensus binding motive is difficult in selection of inorganic 
binding peptides because of inorganic surface heterogeneity [9]. Consequently, 
further binding analysis via fluorescence microscopy (FM) was applied to assess the 
affinity levels of individual clones semi-quantitatively.  In this method, binding 
affinity levels for each clone was achieved by incubating the selected clones with a 
titanium surface, followed by staining with Syto9 dye.  The Syto 9 dye, which binds 
to nucleic acids, allowed for the visualization and quantification of bound clones; the 
bound cells expressing titanium-binding sequences were visualized as fairly 
uniformly distributed bright green rods on a dark background, as opposed to GI826 
plasmid free control cells, which did not adhere to the titanium substrate (Figure 3.1).  
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Figure 3.1: Florescence microscopy images of titanium binding peptides with 
various binding affinities. 
The binding affinity of selected titanium-binding clones was estimated by 
enumerating adhered cells in three random regions in triplicate experiments.  This led 
to categorization of binders into three different groups: strong, moderate and weak 
binders (Figure 3.2).  
 
Figure 3.2: Categorization of titanium binding clones via fluorescence microscopy. 
Following this categorization, to determine the role of amino acid distribution on 
binding affinity of clones on titanium surface, we compared the observed amino acid 
distribution among strong and weak binder groups of selected TiBPs with the native 
(unpanned) library to calculate the relative abundances of amino acids among them. 
Based on amino acid distribution analysis of the TiBPs, expression level of polar 
amino acids (Ser, Asn), and basic (Arg) amino acids were noticeable (Figure 3.3).  
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Figure 3.3: Relative abundance of amino acids in strong and weak binding groups of 
titanium binding peptides. 
Physico-chemical properties of both inorganic surfaces and peptides need to 
investigate to bring approaches on peptide recognition and binding on solid surfaces. 
Especially, the role of amino acid composition versus amino acid sequence order and 
the role of peptide net charge versus local charge distribution have been studying to 
understand binding mechanism of peptides to desired surface. Number of studies in 
the literature has been focus on probing interactions peptides and metal, metal-oxide 
and mineral surfaces based on amino acid type and position relations.  For example, 
mineral (e.g hydroxapatite) binding sequences are rich in acidic residues (aspartate, 
glutamate and serine) resulting in a net negative charge that promotes binding to 
positively charged calcium at apatite crystal faces. Hydroxyl rich and cysteine 
residues present in metal (e.g gold) binding sequences. In metal-oxide (e.g titanium 
and silica) binders case, peptides enriched with charged and polar amino acid 
residues (Lys, Arg, His, Asp and Glu) have high affinity to most of the negatively 
charged metal–oxide surfaces, because of their positive charge in an aqueous 
environment at neutral pH [380, 359, 381].  
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In this study, amino acid distribution among strong binders indicate us different trend 
from literature. Expression level of Ser is remarkable compare to His, Lys and Arg 
expression that have role peptide binding on metal–oxide. Besides, expression levels 
of Asp and Glu are similar to previous studies (Figure 3.3). Although there is general 
categorization for amino acid type in binding sequences to metal, metal-oxide and 
mineral surfaces, to understand and indicate clear contribution of each residue based 
on their effect on peptide net charge and local charge distribution is challenging. 
There are key limitations factors such as target surface properties, selection 
technique and solution pH to reveal this difference. In the literature, there are a 
number of peptides that were selected utilizing phage display against different forms 
and various sizes of titanium oxide powders, such as anatase, titania and titanium 
particles [359, 411, 380]. Features of phage and cell surface library and their adapted 
protocols are a constraint in terms of their design criteria based on different amino 
acid distribution percentage, peptide generation efficiency, and random sequence 
diversity. Consequently, to draw conclusion about peptide binding affinity to metal 
oxide surfaces in the frame of this parameter is difficult so different critical design 
parameters should also be evaluated. 
In here, to refine peptide binding affinity to titanium and other implantable (e.g Silica 
and HA) surfaces and to show peptide capability as a molecular linker more in detail, 
we chose three peptides, TiBP1 and TiBP2 have very similar high titanium binding 
affinity with their distinct physicochemical properties; TiBP60 has the lowest affinity 
exhibiting similar physicochemical properties with TiBP1 (Table 3.1) based on initial 
FM characterization. The first reason for choosing these sequences is that evaluation 
of their adsorption behavior on titanium surface by combining their molecular 
structure. The second reason is that analyzing binding affinity and selectivity 
properties of TiBP1 and TiBP2 on other implantable surfaces such as silica and HA 
to indicate their potential capability as a molecular linker. The third is that to show 
the difference in physicochemical properties of TiBP1 and TiBP2 may allow us 
flexibility to control their efficient immobilization on implant surfaces while 
conjugating them with biomolecules. 
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Table 3.1: Amino acid sequence and physicochemical properties of TiBP1, TiBP2 
and TiBP60.  
3.1.2 Conformational properties of TiBPs  
Molecular conformation is one of the challenging design parameter to understand 
peptide binding behavior to desired surface. Its challenge comes from a number of 
polypeptides which interact with inorganic solids exhibit some degree of intrinsic 
disorder or unfolded structure. [383, 427, 354, 367, 428, 429] In addition, it has been 
shown that folding propensity, or the ability of an unfolded polypeptide sequence to 
fold into an ordered structure, is another molecular characteristic that distinguishes 
functionally different inorganic binding protein sequences from one another [367, 
428] From this, we first synthesized TiBPs by solid phase synthesis and then  
investigated two properties : First, we assayed for the presence of ordered or 
disordered structure within each sequence, and second, we determined the folding 
propensity of each sequence in the presence and absence of the structure-stabilizing 
solvent, 2, 2, 2-trifluoroethanol (TFE).  As shown in Figure 3.4, at 0% TFE in 
aqueous media each peptide exhibits a strong (-) ellipticity band representing the pi – 
pi* transition[428, 423] For TiBP1 and TiBP2 this band is centered near 198 nm and 
is characteristic of random coil conformation in equilibrium with other secondary 
structures such as alpha-helix and beta turn that are featured in these sequences 
(Table 3.2) [428, 354, 423, 367, 429] The presence of beta turn structures may arise 
from the Arg, Gly and Ser residues in TiBP1 and TiBP2 that would promote turn or 
loop-like regions in either sequence [428, 430, 431]. In addition, TiBP2 possesses a 
second, slightly (+) ellipticity band centered near 218 nm, representing the n-pi* 
transition.  Under the same conditions the TiBP60 peptide sample features a pi-pi* 
band centered near 200 nm and this reflects a shift away from random coil 
Peptide 
Name 
AA Sequence MW pI Charge 
TiBP1 RPRENRGRERGL 1495.67 11.82 +3 
TiBP2 SRPNGYGGSESS 1197.18 5.72 0 
TiBP60 VGRVTSPRPQGR 1309.49 12.3 +3 
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conformation towards other secondary structures.  As shown in Table 3.2, TiBP60 
possess more beta strand structure and reduced beta Type II content compared to 
either TiBP1 or TiBP2 and this may be due to the presence of a extended beta strand 
forming tetramer sequence cluster, -PRPQ-, [432] located near the middle of the 
TiBP60 sequence. 
Table 3.2: Secondary structure classifications of TiBP1, TiBP2 and TiBP60. 
  
TiBP1 
 
TiBP2 
 
TiBP60 
 
Alpha helix 
 
 
% 0  TFE 
 
0 
 
0 
 
0 
 
% 75 TFE 
 
0.02 ± 0.01 
 
0 
 
0.01 ± 0.004 
 
Beta sheet 
 
 
% 0  TFE 
 
0 
 
0 
 
0.26 ± 0.03 
 
% 75 TFE 
 
0.07 ± 0.03 
 
0.06 ± 0.04 
 
0.22 ± 0.02 
 
Beta turn Type I 
 
 
% 0  TFE 
 
0.13 ± 0.03 
 
0.12 ± 0.03 
 
0.04 ± 0.02 
 
% 75 TFE 
 
0.11 ± 0.02 
 
0.13 ± 0.03 
 
0.08 ± 0.01 
 
Beta turn Type 
II 
 
 
% 0  TFE 
 
0.30 ± 0.07 
 
0.37 ± 0.07 
 
0.13 ± 0.04 
 
% 75 TFE 
 
0.30 ± 0.05 
 
0.35 ± 0.06 
 
0.21 ± 0.03 
 
Random coil 
 
 
% 0  TFE 
 
0.57 ± 0.08 
 
0.51 ± 0.07 
 
0.57 ± 0.04 
 
% 75 TFE 
 
0.50 ± 0.05 
 
0.47 ± 0.07 
 
0.48 ± 0.03 
 
Thus, this tetramer sequence may be inducing a more linear, extended beta strand-
like region within TiBP60 that is not found in the random coil/beta turn structures of 
TiBP1 or TiBP2. From this data, we conclude that each TiBP peptide exhibits 
intrinsic disorder, with TiBP1 and TiBP2 adopting a combination of coil, turn, or 
loop structures in solution, whereas TiBP60 adopts a more linear conformation under 
the same conditions. With the addition of TFE, we note that for each peptide the pi-
pi* transition ellipticity band is reduced in intensity as a function of TFE addition 
and undergoes a 7-8 nm red shift in absorption wavelength.  This red shift is 
indicative of a shift in secondary structure population away from random coil 
towards other secondary structures, and thus like other intrinsically disordered 
inorganic binding sequences each TiBP peptide undergoes some degree of 
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conformational reordering in the presence of TFE.  This is reflected in Table 3.1, 
where the percentage of random coil structure is observed to decrease for each 
peptide at 75% v/v TFE as compared to 0% v/v TFE.   
 
 
Figure 3.4: CD spectra of 30 µM TiBPs (TiBP1, TiBP2, TiBP60) in the presence of 
varying volume percentages of TFE in 100 µM Tris–HCl, pH 7.4. Arrow 
indicates increasing sample TFE concentration (0, 10, 20, 30, 40, 50, 75 
%). 
In addition, we note that TiBP60 exhibits an isochromic transition point [423] 
centered at 215 nm, and this is not observed for either TiBP1 or TiBP2.  We infer 
from this transition point that the conformational transition for TiBP60 differs from 
that of TiBP1 and TiBP2, and we believe that this difference may arise from the 
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presence of the extended -PRPQ- sequence in TiBP60. These observed differences in 
conformational transition may play a role in the ability of these sequences to adapt to 
titanium surfaces. The structural models of the three different titanium-binding 
peptides, two of them strong (TiBP1 and TiBP2) and one of them weak (TiBP60), 
have been obtained using CHARMM force field parameters for the peptide and 
TIP3P parameters for the solvent. All three peptides mainly have turn and random 
coil conformations, lacking regular secondary structure elements such as an alpha 
helix or beta sheet (Fig. 3.5).  
This finding is in accord with the CD analysis and indicates that all three peptides 
exhibit some degree of intrinsic disorder or unfolded structure.[383, 427, 354, 367, 
428, 429] The plots in Figure 3.5 shows the structure of the peptides in water, which 
is omitted for clarity, and reflects the CD experiments in the absence of the structure-
stabilizing solvent (TFE). These plots indicate that, TiBP1 and TiBP2 have slightly 
more compact structures than TiBP60, which may explain the differences in 
conformational transition studied via CD experiments in TFE conditions. 
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Figure 3.5: a) Overlapped ribbon and CPK models of the predicted structures of the 
(a) TiBP1, (b) TiBP2 and (c) TiBP60. The residues are colored 
according to residue type (Basic: blue, Acidic: red, Polar: green, 
Nonpolar: gray). The backbone is colored according to secondary 
structure (Turn: cyan, Random Coil: Gray, Isolated Bridge: Tan). Water 
is omitted for clarity. 
3.1.3 Adsorption behavior of TiBPs on titanium and other implantable surfaces    
Understanding the exact nature of peptide binding mechanism on solid surfaces has 
been elusive for practical applications. Various peptides that can mediate cell 
adhesion were adsorbed or covalently attached onto biomaterial surfaces. However, 
these cell adhesive sequences were not designed based on preferential affinity 
towards a specific material. Weakly attached molecules can be redistributed by cells 
  
110 
 
attempting to attach the surface. In this case, effective formation of focal adhesion 
that influences cell attachment will not occur. This demonstrates that the need to 
design a peptide including both material specific and cell adhesive domains. To 
investigate adsorption behavior of peptide on titanium surfaces provides us not only 
adjusting initial peptide concentration required to promote cell adhesion but also 
evaluation of molecular structure and peptide binding mechanism relations.  
In here, we tested the adsorption behavior of TiBP1, TiBP2 and TiBP60 
quantitatively via QCM on titanium-coated quartz crystals. Frequency shift (∆F) data 
from QCM was used to determine the dissociation constants (Kd) for each peptide. 
Kd values represent the concentration necessary to achieve 50% surface coverage on 
a given surface. Thus the lower the Kd value the stronger the peptide binds to that 
surface. The Kd values were calculated by fitting data to Langmuir’s adsorption 
model. This was done using the following relationship: 
 
-∆F = ∆FmaxC/(C + Kd)                                                                                            3.1          
 
where ∆Fmax is the frequency shift when the surface is saturated and C is the 
concentration of the bulk solution. The unknown constants ∆Fmax and Kd were fit to 
the data using a least squared regression. The dissociation constant is also related to 
the free energy of adsorption by the following relationship: 
 
∆Gads = RT ln(Kd)                                                                                                   3.2                   
 
The TiBP1, TiBP2 and TiBP60 showed vast difference in their binding affinity. In 
the case of TiBP1 and 2, shown to be a strong binder in FM analysis, the peptide 
saturated the surface at relatively low concentrations (Figure 3.6), yielding Kd values 
of 0.90 µM and 018 µM, respectively in Table 3.3. Both of these peptides can be 
characterized as strong binders from these Kd values when compared to other 
titanium binding peptides in the literature [380].  
 Figure 3.6: Surface coverage of TiBP1, TiBP2 and TiBP60 on titanium via QCM
On the other hand, TiBP60 showed much weaker binding on titanium with 14.76 µM 
Kd value (Figure 3.6 and Table 3.3
approximately one hundred times higher concentration in solution to achieve the 
same surface coverage as TiBP2 (Figure 3.6 and Table 3.3
difference in binding strength between the strong binding peptides. TiBP2 showing 
five times lower Kd value than TiBP1.
Table 3.3: Observed K
 
Peptide
Name
TiBP1
TiBP2
TiBP60
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), confirming FM results. TiBP60 requires an
). There is a significant 
 
d and ∆G values of TiBP1, TiBP2 and TiBP60
 
QCM Analysis 
 
 
KD 
(µM ) 
∆G 
(kcal/mol) 
 0.90 ± 0.12 -8.25 ± 0.08 
 0.18 ± 0.03 -9.19 ± 0.11 
 14.76 ± 2.74 -6.59 ± 0.12 
 
. 
 
. 
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The reason of this difference in Kd could be the cause of various parameters between 
the two peptides that we mentioned above. TiBP2 has high binding affinity with its 
hydroxyl (Ser) rich amino acid content and with its neutral charge.  Although TiBP1 
and TiBP60 have high Arg content with their net positive charge, their binding 
strength is an order of magnitude different than each other. The thermodynamic 
effect of this difference is not so significant, as shown in the ∆Gads values in Fig. 4b. 
In case of TiBP60, it has higher binding energy (-6.59 ± 0.12 kcal/mol) compared to 
TiBP1 and TiBP2 respectively (-8.25 ± 0.08, -9.19±0.11 kcal/mol). In the literature, 
the assumption on peptide binding adsorption basically relies on oxide layer and 
charged group interactions. Identified peptides possessed strong enrichment in 
histidine residues, hydroxyl-containing residues and with high cationic charge [411, 
358].  However, The trend on adsorption behavior of TiBPs indicate us, it is not only 
results of electrostatic interactions, hydrogen, hydrophobic, dipole or combination of 
these forces but also more complex binding mechanism involved in peptide inorganic 
interactions beyond simple binding affinity, amino acid content and  peptide net 
charge correlation. The observed differences in their binding affinity may be 
attributed to the similarities in their molecular architecture so conformational 
transition may play a critical role in the ability of these sequences to adapt to 
titanium surfaces. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7: Surface Coverage and K
surfaces (SiO
On the other hand, to explain material selectivity of any inorganic binding peptides 
based on only their adsorption behavior on particular surface is difficult through the 
effect of many unknown parameters. However, it is imperative to fully characterize 
peptide specificity onto substrate material to understand its applicability boundary in 
implantation. Consequently, we evaluated adsorption behavior of TiBPs on two 
different implantable materials to indicate their material selectivity as a molecular 
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D (µM ) of TiBPs on various implantable 
x and Hydroxapatite). a) TiBP1 (b) TiBP2. 
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tool for any implant surface modifications. Silica was chosen as suitable material to 
demonstrate proof of concept due to the applicability of glass and glass-based 
materials as coating substrate for implants and its widespread use in cell culture 
experiments as control group because of its hydrophilic surface character in 
comparison of new implant surface modifications efficiency. HA is also preferable 
material for implant coating due to its similarity with the mineral phase in bone and 
teeth. 
To evaluate material selectivity, each peptide on two substrates was tested five 
different selected concentrations ranging from 0.1 µM through 2 µM and 5 µM to 15 
µM via QCM. The calculated surface coverage values relative to peptide 
concentrations for each peptide on two surfaces were shown in Figure 3.7. TiBP1 
displays fairly high affinity with 0.90 µM Kd value to silica surface as well as 
titanium in Figure 3.7a and Table 3.4. TiBP2 exhibits 10 fold low Kd value (2.46 
µM) to silica surfaces compare to its binding affinity to titanium surface (0.18 µM) 
as in Figure 3.7b and Table 3.4.  
 While evaluating peptide adsorption on other metal-oxide (silica) surface for TiBP1 
and TiBP2 depending on the role of charged group interaction, we may speculate that 
TiBP1 may bind to silica and titanium as two native oxide surfaces because of its 
high number of cationic charged groups; however TiBP2 has low affinity to silica 
comparable to titanium with its net neutral charge.In HA case, TiBP1 and TiBP2 
shows low binding affinity with low Kd values (10.57 µM and 5.8 µM) respectively 
as in Figure 3.7 and Table 3.4. For practical applications to utilize peptides as multi-
purpose molecular linkers, TiBP1 generally tend to high affinity to both titanium and 
silica surfaces while it has no affinity to HA. TiBP2 has more distinctive material 
selectivity properties on among silica, titanium and HA surfaces.  
Although analysis of their binding affinity and selectivity properties can required for 
their possible application, an appropriate cellular response to peptide–functionalized 
surfaces should also be evaluated.  Therefore, we first examined effect of TiBPs in 
term of cytotoxicity, cell adhesion and spreading on  two different dental implants 
(cp Grade 1 and cp Grade 4) with their various surface topography and similar in 
composition. Then their conjugates with RGD as a cell adhesive motive were 
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designed to show capability of TiBPs as molecular linker for bioactive surface 
modification of implants. 
Table 3.4: QCM analysis of TiBP1and TiBP2 on SiOx and Hydroxapatite. 
  
TiBP1 
 
TiBP2 
 
Various Surfaces 
 
KD 
(µM ) 
 
∆G 
(kcal/mol) 
 
KD 
(µM ) 
 
∆G 
(kcal/mol) 
 
 
On Titanium 
 
 
0.90 ± 0.12 
 
 
-8.25 ± 0.08 
 
 
0.18 ± 0.03 
 
 
-9.19 ± 0.11 
 
On Silica 
 
0.66 ± 0.13 
 
-8.40 ± 0.11 
 
2.46 ± 0.29 
 
-7.64 ± 0.7 
 
On Hydroxapatite 
 
10.57± 0.08 
 
-6.90 ± 0.06 
 
5.80 ± 0.30 
 
-6.74 ± 0.7 
 
3.1.4 Surface topography of cp Grade 4 and cp Grade 1 titanium dental implant 
materials   
The biocompatibility of biomaterials is closely related to cellular functions 
particularly cell viability and adhesion in early stage of cell-surface interactions 
[197]. This interaction is limited and depended on surface characteristics of materials 
such as topography, chemistry, surface energy. Both material composition and 
surface morphology influence protein adsorption and the resulting cell adhesion and 
proliferation. On the other hand, adsorption behavior of TiBPs may also be affected 
surface roughness properties.  Due to the possible role of surface morphology for 
appropriate cellular response and peptide adsorption, we first examined the surface 
roughness of cp Grade 4 and cp Grade 1 titanium dental implants by applying AFM.  
The results revealed that the cp grade 4 surface was relatively smoother than cp 
grade 1 surface.  The Rrms values were 170 nm with a peak to valley range of 1.6 µm 
and 300 nm with peak to valley range of 2.6 µm, respectively for cp grade 4 and 
grade 1 surfaces.  A depiction of the difference surface groove depth is shown in by 
the 30 µm by 30 µm cut-out of the AFM scans in 3D view in Fig 3.8 a and b.   
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8: AFM scans in 3D view with the 30 µm by 30 µm cut
(b) cp Grade 1. 
In SEM images, we also showed the general view of surface properties. 
clearly has deeper grooves than Grade 4.  Larger SEM scans revealed that the groove 
patterns are similar between the two grades of Ti disk with Grade 4 ha
smoother surface (Figure 3.9 a).  
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Figure 3.9: SEM scans titanium implant surfaces (a) cp Grade 4 (b) cp Grade 1. The 
inset represents EDS spectra of each surfaces. 
EDS spectra revealed an interesting surface chemistry.  Grade 1 was found to carry 4 
wt % of Si compared to 2 wt % in that of Grade 4 (see spectra in insets of Figure 3.9 
b). The detected Si was likely due to surface contamination resulted from roughening 
process which typically involve grinding and/or sand blasting using Si based media.  
The higher Si content in Grade 1 was likely due to a more intense surface roughening 
treatment than that of cp Grade 4. 
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 3.1.5 Cell viability (MTT assay) 
It was required that to test cytotoxicity properties of TiBPs before performing any 
conjugation with biomolecules to utilize as a molecular linker. In here we first tested 
cell viability on peptide-functionalized two dental implant surfaces (cp Grade4 and 
cp Grade1) with MTT assay to evaluate changes in cell viability and growth 
inhibition. Following peptide self assembly on two implant surfaces, MC3T3-E1 
cells were exposed to peptide modified surfaces to proceed MTT assay (Figure 3.10).  
 
Figure 3.10: Schematic representation of peptide functionalized dental implant 
surface. 
The results of experiment demonstrate that cell viability and growth have not been 
affected in the presence of TiBP1 and TiBP2 modified surfaces compare to control 
groups (Figure 3.11 and 3.12). 
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Figure 3.11: TiBP1 and TiBP2 functionalized cp Grade 4 titanium implant surface. 
 
 
Figure 3.12: TiBP1 and TiBP2 functionalized cp Grade 1 titanium implant surface. 
In this part of this work, detailed selection and characterization in terms of binding 
affinity, specificity, molecular structure and cytotoxicty were accomplished. Firstly, 
selection of TiBPs against cp Grade 4 titanium implant surface to generate set of 
sequences that could offer a route for implant surface functionalization as a 
molecular linker were reported.  Following, three TiBPs (TiBP1, 2 and 60) were 
identified based on initial fluorescence microscopy (FM) characterization for further 
investigations. Two (TiBP1 and TiBP2) that exhibited high affinity, one (TiBP60) 
with lowest binding affinity to titanium were subjected to determine their 
quantitative binding characteristics on titanium with the contribution of primary and 
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secondary structural properties. We were also interested in learning material 
selectivity properties of TiBP1 and TiBP2 on various implantable surfaces such as 
silica and HA via QCM due to requirement of new molecular linkers with their 
recognition and specificity capabilities in implantation. Then, we attempt to show 
cellular response against TiBPs (TiBP1 and TiBP2) functionalized surfaces via MTT 
assay. 
 
3.2. TiBPs as a Molecular Linker for Bioactive Implant Surface 
Functionalization  
3.2.1. Biocompatibility of TiBPs functionalized titanium dental implant surface 
Following fully characterization of TiBPs, we aimed to show the effect of peptide-
functionalized dental implant surfaces on cell adhesion. MC3T3-E1 cells were 
exposed to peptide functionalized cp Grade1 and Garde4 surfaces including positive 
control groups. After 2 hours incubation, the cytoskeleton of MC3T3-E1 was 
visualized with phalloidin labeling under FM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13: FM micrographs of phalloidin stained MC3T3
and Grade 1   titanium implant surfaces
To test effect of peptide on cell adhesion and spreading, FM images were processed 
with Image J soft ware (NIH) by using at least three different images from one 
experiment. The results were plotted after repeating the experiments three times. 
hours, in control groups, the number of cells on both surfaces was not significantly 
different than each other (Figure 3.13, first line
on cp Grade1 and Grade 4 surfaces (Figure 3.13, first line
had spread on cp grade 4 than grade1.  The cells on cp Grade1 were more elongated 
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). Significantly, more cells 
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and on Grade 4 surfaces flattened. In case of  TiBP functionalized cp Grade 4 
surfaces, the number of cells on control and peptide-functionalized surfaces was very 
similar  (Figure 3.14) conversely, the spreading of cells are on peptide functionalized 
surfaces significantly different than control group. A slight increase in the cell 
spreading was observed on the cp Grade 4 titanium surfaces modified with TiBP1 
and TiBP2 (Figure 3.15). In case of TiBP functionalized cp Grade 1 surfaces, there 
are no significant chances cell number and spreading among control and peptide-
functionalized surfaces. The difference in cell behavior among two peptide modified 
dental implant surfaces can be related surface roughness.  Although cp Grade 4 
surface smoother than cp Grade 1, cells like especially peptide functionalized cp 
Grade4 surfaces. 
 
 
Figure 3.14: The number of adhered MC3T3-E1 cells per mm
2 
in serum free 
conditions on two titanium implant surfaces. 
Surface roughness may have an effect on not only cell attachment and spreading, but 
also peptide binding. Effect of surface nano or micro topography on peptide binding 
mechanism or peptide functionality on the surface and effect of peptide binding on 
surface physcochemical properties needs to investigate. 
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Figure 3.15: Average cell spreading per µm
2
 on TiBP1 and TiBP2 functionalized cp 
Grade1 and cp Grade4 titanium dental implant surfaces. 
3.2.2 TiBP-RGDS mediated bioactive surface modifications 
The RGD sequence is by far the most effective and most often employed peptide 
sequence for stimulated cell adhesion on synthetic surfaces. This is based upon its 
widespread distribution and use throughout the organism, its ability to address more 
than one cell adhesion receptor, and its biological impact on cell anchoring, behavior 
and survival. The process of integrin mediated cell adhesion comprises a cascade of 
four different partly overlapping events: cell attachment, cell spreading, organization 
of actin cytoskeleton, and formation of focal adhesions. This cascade also effect 
further cell differentiation and proliferation which are important steps for implant- 
tissue integration. In here, bi-functional peptide was designed in conjugation with 
titanium binding peptide (TiBP) and integrin binding domain RGD via GGG flexible 
linker for bioactive surface modifications. Bi-functional peptide effect on cell 
viability, adhesion and spreading were examined on cp Grade 4 titanium implant 
surfaces and titanium coated glass surfaces in the presence of osteoblast and 
fibroblast.  Firstly, the efficiency of bi-functional peptides (TiBP1-RGDS and 
TiBP2-RGDS) on cell adhesion and spreading were shown on cp Grade 4 titanium 
dental implant surface including one negative (bare surface), one positive control 
(RGDS) in the presence of MC3T3-E1which show and an RGD-dependent adhesion 
through integrins.  There is a 1.5 fold difference in case of adhered cell number 
among bi-functional peptide treated cp Grade4 surfaces and negative (bare), positive 
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control group (RGDS) as shown in FM micrographs and plotted graph (Figure 3.16 
and Figure 3.17). There is a significant difference in cell spreading data among two 
bi-functional peptide behaviors as shown in Figure 3.18. TiBP1-RGDS has ~ 2.5 fold 
higher spreading then the others.  The difference may reveal because of various 
reasons.  The one is structural conformation of peptide may allow us exposing of 
RGDS domain more freely with resulting effect of cell adhesion and spreading. The 
other one is peptide charge and hydrophilicity may affect surface chemistry that can 
alter cell behavior.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.16: FM micrographs of phalloidin stained MC3T3-E1 cells on RGDS, 
TiBP1-RGDS and TiBP2-RGDS functionalized cp Grade 4 titanium 
dental implant surfaces. 
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Figure 3.17: The number of adhered MC3T3-E1 cells per mm
2 
in serum free 
conditions on peptide functionalized cp Grade 4 titanium dental implant 
surfaces.  
 
 
Figure 3.18: Average cell spreading per µm
2
on peptide functionalized cp Grade 4 
titanium dental implant surfaces. 
In this experimental set up, depending on previous results with cp Grade 4 titanium 
dental implant surface, titanium coated glass substrate due to its different surface 
0
50
100
150
200
250
300
350
Bare RGDS TiBP1-RGDS TiBP2-RGDS
N
u
m
b
er
 o
f 
ce
ll
s/
m
m
2
0
100
200
300
400
500
600
700
800
900
Bare RGDS TiBP1-RGDS TiBP2-RGDS
A
v
er
ag
e 
ce
ll
 a
re
a/
µ
m
2
  
126 
 
roughness, NIH3T3 mouse fibroblast and only TiBP1-RGDS substrate were used to 
examine peptide effect on cell adhesion and spreading with varied parameters. Thus, 
in case of titanium coated glass surface, adhesion of the NIH3T3 cells on titanium 
surfaces modified with RGD chimeric peptides were increased by 3.5 to 5 fold 
compared to unmodified negative controls (Figure 3.19 and 3.20).  No significant 
change was observed in the adhesion on the surfaces incubated with RGD alone. 
Conversely, a slight increase in the adhesion was observed on the surfaces modified 
with TiBP1 alone.  
 
Figure 3.19: FM micrographs of phalloidin stained NIH3T3 cells on titanium coated 
glass surfaces.  
Although within the margin of error, this effect may be due to the inherent chemical 
properties of the peptides. Consequently, when amphiphilic molecules on the cell 
membrane, such as proteins, interact with the non-polar residues, an increase in non-
specific adsorption on the surface may be observed. To test whether the RGD 
chimeric peptides results in any enhancement of the cell viability, cell spreading was 
evaluated in addition to the cell adhesion. An increase about 1.6 fold in the cell 
spreading was observed on both materials modified with chimeric RGD peptides 
compared to bare surfaces (Figure 3.21).  
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Figure 3.20: The number of adhered NIH3T3 cells per mm
2 
in serum free conditions 
on peptide functionalized titanium coated glass surfaces. 
 
Figure 3.21: Average cell spreading per µm
2 
on peptide functionalized titanium 
coated glass substrate.  
A similar increase was observed on fibronectin modified surfaces. The results 
indicate that the presence of both material binding and RGD domains in the designed 
bi-functional molecular construct is necessary to promote cell adhesion and 
spreading.  
In this part of dissertation, the utility and versatility of TiBPs for controlling cell-
surface interactions through immobilization of functional molecules on various 
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implant surfaces especially on titanium were demonstrated. We also identify basic 
design criteria for the choice of the most suitable peptides for specific potential 
applications. Directed assembly, on the other hand, is preferred for the 
immobilization of small molecules via synthesizing a single chimeric molecule with 
bi-functional domains. Our results demonstrated that the engineered peptide-based 
surface modification is an adaptable platform to meet the specific requirements that 
may arise due to the inherent properties of the materials used for a particular 
application, the need of the use variety of functional molecules to be conjugated, and 
the molecular characteristics of the solid-binding peptides themselves. Single-step 
surface modification using solid-binding peptides conjugated to desired medically 
relevant molecules may prove to be a robust, biocompatible approach in the 
functionalization of complex devices in clinical applications. 
3.3 GEPI Mediated Antimicrobial Titanium Implant Surface Modifications  
Implant-associated infections are a primary cause of early implant failures. Such 
infections have been difficult to treat due to the unique (and complex) 
biomicroenvironment inside the human body. The success of implants depends not 
only on the bone–implant integration, but also on the presence of a sterile 
environment around the implant that will prevent bacterial infection. The generally 
prescribed oral antibiotics, e.g., for dental implants, are not always effective in 
combating implant-associated infections for a variety of reasons including the 
inability to reach the infection site in bone tissue, and an increase in bacterial 
resistance. A novel class of peptides, the antimicrobial peptides (AMPs), is useful for 
their utility as therapeutic agents mainly because of the difficulty for microorganisms 
to develop resistance towards them.  
In the present study, we use a novel bi-functional peptide based approach for implant 
surface functionalization. Specifically, we use Titanium-binding peptides that have 
been selected using biocombinatorial approach, via a flagella display method, and 
well characterized in binding and material selectivity properties. The selected AMP 
was chosen for its broad range of activity against both gram-positive and gram-
negative bacteria, including but not limited to E. coli
 
[316], K. pneumonia, S. aureus, 
and B. subtilis, and its demonstrated ability to remain bacteriacidal when covalently 
bound to a water-insoluble resin [315, 316]. 
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3.3.1 Designing of TiBP-AMP bi-functional conjugates  
In the current study, two set of bi-functional peptides were designed and synthesized 
based on three parameters including structural, charge and binding affinity on 
titanium surface. In design of bi-functional peptide; firstly, each domain activity 
should retained and then desired activity should be revealed by utilizing other 
domain capability. Depending on targeted goal, we first evaluated peptide retained 
binding affinity to titanium surface. Following, the effect of other parameters on the 
antimicrobial activity and selectivity was analyzed by combination with CD, 
molecular modeling and biological studies. These parameters affect antimicrobial 
potency and spectrum of peptides. 
Many of the antimicrobial peptides characterized to date display a net positive 
charge, ranging from +2 to +9, and may contain highly defined cationic domain(s). 
Cationicity is undoubtedly important for the initial electrostatic attraction of 
antimicrobial peptides to negatively charged phospholipid membranes of bacteria 
and other microorganisms, and mutual electro affinity likely confers selective 
antimicrobial targeting relative to host tissues. Besides their cationic properties, 
three-dimensional topology of peptides appears predominant and peptides have been 
categorized accordingly. The two largest groups are the α-helical and β-sheet 
peptides, whereas the majority of remaining peptides can be classified as those that 
are enriched in one or more amino acid residues [e.g., proline-arginine or tryptophan-
rich].  
According to charge and structural properties, the first designed bi-functional 
peptide, AMP with α helical and +6 cationic charge were combined TiBP1 with +3 
cationic charge, Arg rich peptide and close α helical structure via GGG flexible 
linker. For the second one, the same AMP was conjugated with TiBP2 with net 
neutral charge.  
Designed bi-functional peptides and AMP with their physicochemical properties 
were listed in Table 3.5.  
 
 
 
 
 
  
130 
 
Table 3.5: Sequence, MW, pI and net charge of TiBP-AMP bi-functional peptides 
 
Peptide Name 
 
Sequence MW pI Charge 
 
AMP 
 
LKLLKKLLKLLKKL 
 
1692.34 
 
10.70 
 
 
+6 
 
 
TiBP1-GGG-AMP 
 
 
RPRENRGRERGL 
GGGLKLLKKLLKLLKKL 
 
3341.14 
 
 
11.85 
 
+9 
 
 
TiBP2-GGG-AMP 
 
 
SRPNGYGGSESSGGG 
LKLLKKLLKLLKKL 
 
3042.66 
 
 
10.39 
 
+6 
 
3.3.2 Adsorption behavior of TiBP-AMP bi-functional peptides on titanium  
One of the goals of this study was determine whether the binding abilities of 
antimicrobial peptides to titanium surfaces were enhanced by conjugation with 
titanium binding peptides. Before testing our approach applicability on implant 
surfaces as a candidate for prevention of implant infections, we first evaluated 
adsorption behavior of AMP and bi-functional conjugates to titanium surface.  
Frequency shift data obtained by QCM analysis was converted to wet mass data and 
fit to a Langmuir adsorption model in order to obtain KD values for AMP, TiBP1-
GGG-AMP, and TiBP2-GGG-AMP.  The two bifunctional peptides were found to 
have stronger binding affinities to titanium than the AMP alone (Table 3.6).  TiBP1-
GGG-AMP exhibits a 2.85-fold higher KD value than AMP, while TiBP2-GGG-
AMP exhibits a 1.5-fold higher KD value than AMP.  TiBP1-GGG-AMP has the 
strongest binding affinity of the three peptides, exhibiting a 1.85-fold higher KD 
value than TiBP2-GGG-AMP. 
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Table 3.6: Binding affinity analysis of AMP and TiBP-AMP bi-functional peptides 
on titanium via QCM. 
 QCM Analysis 
Peptide 
Name 
KD 
(µM ) 
∆G 
(kcal/mol) 
AMP 0.40 ± 0.04 -8.78 ± 0.22 
TiBP1-GGG-AMP 0.14 ± 0.06 -9.00 ± 0.35 
TiBP2-GGG-AMP 0.26 ± 0.06 -9.01 ± 0.11 
3.3.3 Conformational properties of TiBP-AMP bi-functional peptides  
 Peptide secondary structure was evaluated to understand one of the design parameter 
affect AMP activity and TiBP binding affinity. CD experiments were carried out 
only in PBS buffer to mimic the environment for active peptide. This finding is in 
accord with the CD analysis and indicates that all three peptides exhibit some degree 
of intrinsic disorder or unfolded structure [383, 427, 354, 367, 428, 429] or all of the 
peptides negligible secondary structure. However, structural difference can also 
observe among peptides structure (Figure 3.22). In case of AMP and TiBP1-GGG-
AMP, alpha helical content and β turns are more distinct. Besides, the increase was 
observed on terms of alpha helical content in case of TiBP1-GGG-AMP. There is no 
observed difference for alpha helical content among AMP and TiBP2-GGG-AMP 
(Table 3.7).  
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Figure 3.22: CD Spectra of 50 µM AMP, TiBP1-GGG-AMP and TiBP2-GGG-AMP 
bi-functional peptides in the presence PBS. 
Table 3.7: Secondary structure classifications of AMP, TiBP1-AMP, TiBP2-AMP. 
  
AMP 
 
TiBP1-GGG-AMP 
 
TiBP2-GGG-AMP 
 
Alpha helix 
 
0.165 ± 0.01 
 
0.35 ± 0.03 
 
0.18 ± 0.01 
 
Beta Sheet 
 
0.140 ± 0.01 
 
0.08 ± 0.01 
 
0.12 ± 0.01 
 
Beta Turn 
 
0.241 ± 0.15 
 
0.21 ± 0.02 
 
0.27 ± 0.02 
 
Random coil 
 
0.455 ± 0.02 
 
0.36 ± 0.03 
 
0.42 ± 0.03 
 
The finding in CD analysis is also correlated modeling studies. The plots in Figure 
3.23 show the structure of peptide in water. These plots indicate that AMP has 
distinct alpha helical structure that can affect its antimicrobial activity.  We see alpha 
helical structure in case of TiBP1-GGG-AMP bi-functional peptide. Peptide structure 
of TiBP1 may also affect occurrence or dominancy of alpha helical structure in bi-
functional peptide. In case of TiBP2-GGG-AMP, we can`t observe extended alpha 
helical structure because of TiBP2 more distinct unfolded structural properties. 
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Figure 3.23: Models of the predicted structures of the a) AMP, b) TiBP1-GGG-
AMP, c) TiBP2-GGG-AMP. 
3.3.4 In solution antimicrobial activity of TiBP-AMP bi-functional peptides  
In this section, the efficiency of TiBP-AMP bi-functional peptides in solution was 
evaluated in vitro against three bacteria S. mutans, S. epidermidis, and E. coli.  which  
are common for oral and orthopedic implants, and the growth was analyzed in 
solution by optical density measurement.  To observe the minimum inhibitory 
concentration of peptides to prevent for S.mutans growth at least 8 hours,  the 
experiment were conducted including positive (S. mutans only) and negative control 
(only AMP) in the presence of various concentrations (10-100 µM) at different time 
points (Figure 3.24 a, b, c, d). In case of 10 µM peptide concentration in solution 
between 0 to 8 hours, nice growth were observed in the presence of all bi-functional 
peptides including positive and negative control (Figure 3.24a). The peptide 
concentration were increased until 25 µM, there was no growth until 10 hours in the 
presence of AMP where until 4 hours in the presence of TiBP1-GGG-AMP. No 
antimicrobial effect was observed in case of TiBP2-GGG-AMP at 25 µM 
concentration. We continued to gradually increase the peptide concentration until 
reach minimum inhibitory concentration for two bi-functional peptides (Figure 
3.24b). Thus at 50 µM peptide concentration, we observed very similar trend for 
peptide antimicrobial behavior in case of 25 µM peptide concentration. (Figure 
3.24c). The increase in peptide concentration wasn`t enough to prevent bacterial 
growth, in case of 100 µM, there was no growth until 12 hours in the presence of 
AMP, until 8 hours in the presence of TiBP1-GGG-AMP (Figure 3.24d).There 
wasn`t significant difference in growth in case of TiBP2-GGG-AMP. Although 
antimicrobial properties of TiBP2-GGG-AMP is not as good as TiBP1-GGG-AMP, 
sharp increase wasn`t observed in the S.mutans growth in the presence of TiBP2-
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GGG-AMP. However, there is a sharp increase in the growth curve after certain hour 
in case of TiBP1-GGG-AMP and AMP. This result may reveal that, TiBP2-GGG-
AMP may suppress the growth in some extent but its efficiency is not as good as 
TiBP1-GGG-AMP and the trend in antimicrobial behavior for AMP and TiBP1-
GGG-AMP is very similar each other. 
The same experimental set up was utilized against to other two bacteria that already 
described (S. epidermidis and E.coli). In case of S. epidermidis, 10 µM was chosen 
as initial peptide concentration, AMP was very efficient to preventing bacterial 
growth until 12 hours, following very slow growth were obtained. In the presence of 
TiBP1-AMP and TiBP2-GGG-AMP, there was no growth until 12 hours, following 
there is a sharp growth that reach same growth with positive control at the end of 24 
hours period (Figure 3.25a). Again the peptide concentration was increased to 25 
µM. In case of TiBP1-GGG-AMP and TiBP2-GGG-AMP, there was very slow 
growth at the end of 24 hours (Figure 3.25b). 
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Figure 3.24:  In solution antimicrobial activity of bi-functional peptides (TiBP1-
AMP, TiBP2-AMP) in the presence of  gradually increased peptide 
concentrations a) 10 µM, b) 25 µM c) 50 µM, d) 100 µM including 
positive (only S. mutans), negative control (only AMP).  
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Figure 3.25: In solution antimicrobial activity of bi-functional peptides (TiBP1-
GGG-AMP, TiBP2-GGG-AMP) in the presence of gradually increased 
peptide concentrations a) 10 µM, b) 25 µM including positive (only S. 
epidermidis), and negative control (only AMP). 
The antimicrobial efficiency of two bi-functional peptides was tested against to 
E.coli as an example of gram negative bacteria in the presence of various 
concentrations as performed for other bacteria types. At 10 µM, there was no growth 
in the presence of AMP at the end of 24 hours, where 8 hours for TiBP1-GGG-AMP 
and 4 hours for TiBP2-GGG-AMP. In case of 25 µM, both of bi-functional peptide 
antimicrobial efficiency was longer until approximately 12 hours. The trend their 
antimicrobial behavior of two bi-functional peptides was similar to S.mutans case.  
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Figure 3.26: In solution antimicrobial activity of bi-functional peptides (TiBP1-
GGG-AMP, TiBP2-GGG-AMP) in the presence of gradually increased 
peptide concentrations a) 10 µM, b) 25 µM including positive (only E. 
coli) and negative control (only AMP). 
In solution antimicrobial activity results of two bi-functional peptides revealed that 
high peptide concentration were required and efficiency of TiBP1-GGG-AMP is 
higher than TiBP2-GGG-AMP against to S.mutans. In the presence of S. epidermidis, 
the trend in the antimicrobial behavior of two bi-functional peptides is very similar 
which is different than S.mutans case. At 4X lower peptide concentrations than in 
case of S. mutans is required to get the same antimicrobial activity. In case of E.coli, 
there is a difference antimicrobial behavior of two bi-functional peptides which is 
similar to S. mutans case. Although the trend is similar, required peptide 
concentration is 4X lower as same as in case of S. epidermidis. 
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Figure 3.27: Minimum growth inhibition concentration of AMP, TiBP1-GGG-AMP, 
TiBP2-GGG-AMP in the presence of various bacteria type a) 
Streptococcus mutans, b) Staphylococcus epidermidis, c) Escherichia 
coli.   
Following, bi-functional peptides antimicrobial activity including was tested in 
presence of various concentrations against all there bacteria types. The “minimum 
working-concentration,” as determined by stability of the peptides for at least 8 hours 
after the bacteria had entered the mid-log phase, was found to be 200 µM for S. 
mutans, 50 µM for S. epidermidis and 50 µM for E. coli. 
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Figure 3.28: In solution antimicrobial activity of TiBP1 and TiBP2 at minimum 
inhibitory concentration of their bi-functional conjugates against a) 
Streptococcus mutans, b) Staphylococcus epidermidis, c) Escherichia 
coli.   
Afterwards, all in solution experiments to find out antimicrobial activity of bi-
functional peptide, the only antimicrobial activity of TiBP1 and TiBP2 in the 
presence of E.coli, S.epidermidis and S.mutans were tested as a second negative 
control (Figure 3.28).  In these experiments, required peptide concentration was 
chosen rely on the minimum inhibitory concentration. 200 µM for S.mutans (Figure 
3.28a), 50 µM for S. epidermidis (Figure 3.28b) and 50 µM for E.coli (Figure 3.28c) 
was used in these experiments.  
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3.3.5 On the surface antimicrobial activity of TiBP-AMP bi-functional peptides  
After determining best working concentrations for each bacteria. Peptide 
antimicrobial efficacy was tested on the titanium surface. Certain concentration of 
peptides for bacteria type depending on our in-solution activity results were self 
assembled to titanium surface and incubated 4 hours at 37
0
C with agitation and the 
end of the incubation period, surface was washed two times to remove excess 
amount of peptide. Meanwhile, each bacterium was grown until their mid-log phase 
and 10
8 
cells/mL from mid-log phase were exposed to peptide modified titanium 
surface an incubated 2 hours. At the end of the incubation time, cells are fixed and 
labeled with Syto 9 and visualized under fluoresce microscopy. Based on FM results, 
the amount of adhered bacteria on the bare titanium surface among three bacteria is 
significantly different than each other (Figure 3.29, first row).  In case of S.mutans, 
the difference in adhered bacteria on peptide functionalized surface is significant. 
Especially, there is ~45 fold difference among TiBP1-GGG-AMP modified titanium 
surface and positive control (bare titanium) where ~20X difference with negative 
control (only AMP) (Figure 3.29, left column and Figure 3.30 a). On the surface 
antimicrobial activity of TiBP2-GGG-AMP was not as high as TiBP1-GGG-AMP 
however it’s higher than negative control. The difference in surface coverage ratio 
among TiBP2-GGG-AMP modified surface and negative control is ~2 fold where ~4 
fold difference with positive control (Figure 3.30a). In the presence of S. 
epidermidis, the similar 2 fold decrease in bacterial adhesion as in S. mutans was 
observed among positive control (bare titanium) and negative control (AMP). 
However, on the surface antimicrobial behavior of TiBP1-GGG-AMP and TiBP2-
GGG-AMP was very similar in case of S. epidermidis. The efficiency of TiBP2-
GGG-AMP is higher against to S.epidermidis than S.mutans (Figure 3.29 middle 
column and Figure 3.30b).  In case of E.coli, AMP was very efficient to prevent 
bacterial adhesion on titanium surface. The difference in surface coverage ratio 
among AMP and TiBP1-GGG-AMP is very low.  Although TiBP2-GGG-AMP had a 
significant decrease on cell adhesion compare to positive control, the difference rely 
on surface coverage ratio is not higher than AMP (negative control) (Figure 3.29 left 
column and Figure 3.30c). 
 Figure 3.29: Bacterial adh
peptide modified titanium surfaces against 
column), Staphylococcus epidermidis 
(right column)
In summary, in case of three bacteria,
more bacterial adhesion on average than titanium treated with TiBP1
TiBP2-GGG-AMP, or AMP. 
found to significantly reduce bacterial adhesion again
compared to adhesion on pristine titanium and AMP.  
TiBP2-GGG-AMP were found to have less bacterial adhesion on average than 
substrates modified with AMP when incubated with 
however, they were interestingly found to have more bacterial adhesion on average 
than substrates modified with AMP when incubated with 
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esion on AMP, TiBP1-GGG-AMP and TiBP2
Streptococcus mutans 
(middle column), Escherichia coli 
. 
 bare titanium was found to have significantly 
Surfaces modified with our bi-functional peptides were 
st all three bacteria when 
Substrates modified with 
S. mutans and S. epidermidis
E. coli.  Surfaces modified 
 
-GGG-AMP 
(left 
-GGG-AMP, 
; 
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with TiBP1-GGG-AMP were found to reduce bacterial adhesion of S. mutans and E. 
coli better than surfaces modified with TiBP2-GGG-AMP.   
 
Figure 3.30: Surface coverage analysis on AMP, TiBP1-GGG-AMP and TiBP2-
GGG-AMP peptide modified titanium surfaces against a) Streptococcus 
mutans, b) Staphylococcus epidermidis, c) Escherichia coli   
3.3.6 Micro-contact printing of TiBP1-AMP on titanium surface   
To examine the striking difference in bacterial adhesion between pristine titanium 
and titanium treated with TiBP1-GGG-AMP, PDMS Stamping of TiBP1-GGG-AMP 
was performed against to S.mutans (Figure 3.31).   
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Figure 3.31: a) Schematic representation for PDMS patterning of TiBP1-GGG-AMP 
on titanium. b)  Adhesion of S.mutans (10
8 
cell/mL) from log-phase on 
peptide modified surfaces after 2 hours incubation. c) FM images of 
Syto9 labeled S.mutans on patterned peptide array. 
Depending on all experimental findings, AMP efficiency is higher especially higher 
against to E.coli as a gram negative bacterium than gram positive bacteria examples 
such as S.mutans and S.epidermidis. Different mechanisms were hypothesized to 
understand the mode of action of cationic antimicrobial peptides on gram positive 
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and gram negative bacteria. The general principle of this mechanism is relying on the 
bacterial membrane structure and properties. In general, the bacterial membranes are 
rich in the acidic phospholipids. Especially, the outer surface of Gram negative 
bacteria contains lots of negatively charged lipopolysaccharides (LPS). Therefore the 
net positive charge of the antimicrobial peptides facilitates their perturbing activity 
towards bacterial membrane. Although electrostatic interactions between cationic 
peptide and negatively charged bacterial cell envelope components are important, 
there is not always a direct correlation between LPS and antimicrobial activity. In 
comparison, gram positive bacteria lack an outer membrane of LPS, however their 
cell envelopes are enriched in negatively charged teichoic and teichuronic acids. This 
charge also increases sensitivity to killing the bacteria by positively charged 
antimicrobial peptides. Some of the studies also report efficiency of antimicrobial 
peptides on gram positive and gram negative bacteria by considering the kinetics of 
membrane permeabilization and of bacterial inactivation. Rely on their results; gram 
negative bacteria have faster permeabilization and killing kinetics respect to gram 
positive bacteria and this also confirm the conclusion of previous studies that double 
membrane of this gram negative bacterium is a less efficient barrier than the single 
membrane and thick peptidoglycan layer of the gram-positive species. This study is 
also revealed that chosen AMP is more efficient on E.coli in solution and on the 
surface antimicrobial activity than S.mutans and S.epidermidis.  All in solution 
activity cases; AMP is the most efficient antimicrobial activity at constant 
concentration with the other bi-functional counterparts. However, bi-functional 
peptides have more improved antimicrobial activity on the surface in case of three 
bacteria. Among two bi-functional peptides, TiBP1-GGG-AMP is the most efficient 
one against three bacteria. AMP has less antimicrobial activity against gram positive 
S.mutans both in solution and on the surface. TiBP1-GGG-AMP has especially 
improved activity on the surface. The similar trend was shown in case of 
S.epidermidis. However, the ratio among the all positive, negative and bi-functional 
ones is not high as in case of S.mutans. The AMP modified surface has a high 
resistance against to E.coli.  The difference in bacterial resistance is not significant in 
the presence of bi-functional conjugates. These results may rely on bi-functional 
peptide design criteria. Especially, its efficiency can also be related two important 
parameters, the one is increased charge and the other one is structural 
properties.TiBP1-GGG-AMP has +9 cationic charge which is increased positive 
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charge. Its molecular model reveals that it has turns that similar to alpha helical 
structure of AMP. Although TiBP2-GGG-AMP has the same +6 charge with AMP, it 
has more unfolded structure than AMP. This unfolded structure may affect its 
antimicrobial efficiency. Although we compare the structure, charge and 
functionality relations depending on comparison in solution, on the surface 
antimicrobial activity and in solution structural properties, the exact peptide 
conformation on the titanium surface is not known.  There are not only mechanism 
interplay related to antimicrobial peptide activity against to three bacteria species but 
also peptide binding mechanism on titanium surface including sequence, structure 
and charge parameters.  
3.4. In situ Mineralization of Hydroxapatite Films on Titanium Surface via Bi-
functional Peptide 
The formation of hydroxyapatite layers is an important process in biological 
organisms, which possess complex catalytic systems for mineralizing, absorbing and 
repairing hard tissues.  These processes have drawn interest from the research 
community, where the ability to mimic the control shown in biological systems 
would represent a significant advancement processing technology.  The key area of 
interest is the formation of thin films to facilitate the osseointegration of structural 
implants and the regeneration of damaged hard tissues [433, 434, 107].  Thin films of 
hydroxyapatite have been formed on titanium and other implant material surfaces 
using a variety of chemical and physical methods including among others, 
spontaneous formation in electrolyte solutions [435, 436], electrochemical methods 
[437], sol-gel methods [438], plasma-spray coating [439], and hybrid methods [440].  
These studies aim to attach the film of hydroxyapatite to the implant and control the 
morphology.  Biological approaches have also been used, especially with the use of 
natural proteins such as amelogenin for the control of HaP nucleation and 
morphology [441, 442].  Genetically engineered peptides (GEPIs) selected through 
combinatorial approaches, have also been used to control the formation of HaP 
[367].  A study by Gungomus et al. has shown the ability of these peptides to not 
only control growth rates but also crystal structure.  In this case crystals were formed 
in aqueous solution at room temperature and neutral pH.  Besides GEPIs efficacy in 
controlling mineralization processes, they also have the added advantage of being 
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easily modified to add additional functionalities.  This includes being attached to 
larger proteins sequences of with other peptide sequences, creating multifuncional 
molecules.  Here we utilize these attributes of GEPIs to mineralize an attached HAP 
layer on a titanium surface, using  previously selected TiBPs and designed ADPs 
peptide sequences [367].  
In the following section in this part of dissertation; first, designing strategy of ADPs, 
then binding and biomineralization characteristic of ADPs were explained briefly. 
Afterwards, designed and synthesized bi-functional peptide with conjunction of 
TiBP2-ADP in a single peptide chain was used to examine their mineralization 
capability. The resulting bi-functional peptide TiBP2-ADP (various types) was 
characterized both for its ability to bind to titanium and mineralize hydroxyapatite.  
The binding and mineralization process was monitored in real-time using quartz 
crystal microbalance (QCM).  Both peptide adsorption and HAP film formation 
cause a mass change that is easily detected via QCM.  Mineralization was run in 
solution with several concentrations of calcium and phosphate ions to examine the 
mineralization kinetics.  The resulting film was characterized via electron 
microscopy.  A series of control experiments verify the significance of the findings.  
3.4.1. Bioinformatics design of peptides derived from natural proteins:  
          Amelogenin case study 
The peptides used in biomimetic materials formation are selected using 
combinatorial biology techniques based on the developments during last two 
decades. Although the nature of peptide-inorganic interaction is not yet well 
understood, many short peptide sequences specific to metals, oxides and 
semiconductorshave been discovered as potential utility for future engineering 
materials and have been used in the proof-of-principle synthesis, morphogenesis and 
assembly studies.  
In nature, proteins that perform functions similar to each other usually have similar 
sequences due to biochemical, biophysical and evolutionary constraints [387]. 
Founded on this observation, Oren et al. showed that the inorganic binding peptides, 
generated by in vivo selection, recognizing same material have alike sequences, 
much as evolutionarily related proteins do [360].  To use in this bioinformatics-based 
approach we showed a way to derive novel sequence similarity scoring matrices 
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which capture the relationships within the strong binders while differentiating them 
from the weak-binding peptides for a given material system. A scoring matrix is used 
to obtain the score for aligning two amino acids (match or mismatch) in an alignment 
of two protein sequences, and the overall score can be considered as a measure of the 
similarity between sequences.  
We have selected amelogenin as a proof of concept study. Amelogenin is a protein 
found in developing tooth enamel. The function of amelogenin is believed to be 
interacting with the developing tooth mineral and organizing enamel rods during 
tooth development [443-445].  Despite the obvious importance of the amelogenin 
during the teeth development, the function of the protein and its cleavage fragments 
is not completely understood. It has been shown that the amelogenin is a modular 
protein having domains and cleavage products with multiple functionalities [446, 
447]. Therefore, it is important to be able to identify what functionalities the certain 
domains of amelogenin may carry. We hypothesize the amelogenin may have 
sequence similarities with the phage display [367] selected HABPs, much as 
evolutionarily related proteins do. To test this hypothesis, two similarity scoring 
matrices (HAPI and HAPII) were generated using two different sets of HABPs (7 
and 12 a.a. long) selected by phage display. Once the scoring matrices were created, 
we compared amelogenin sequence with the two sets of experimentally selected 
hydroxyapatite binding peptides using the appropriate scoring matrices and detected 
high similarity regions for both sets. Then we have chosen the 4 regions with the 
highest similarity as the putative functional regions and 3 regions with the lowest 
similarity as control groups. The sequences and the positions of the ADPs are 
depicted in Figure 3.32. This allowed us to compare putative functional regions of 
the amelogenin with the predicted structure of the protein. Based on the previously 
predicted structures, we have shown that the regions predicted to have the highest 
similarity scores are water accessible and may have to ability to interact with the HA 
mineral and modify the nucleation and growth during enamel formation. These 
putative functional regions were named as Amelogenin derived peptides (ADPs). All 
the ADPs were then synthesized and their binding and mineralization properties were 
investigated. 
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Figure 3.32: Mouse amelogenin sequence (P63277|AMELX_MOUSE) and 
predicted high (red) and low (teal) similarity sequence domains [448]. 
3.4.1.1 Binding characterization of ADPs 
The binding affinity of the peptides on hydroxyapatite was determined via quartz 
crystal microbalance (QCM). Lyophilized peptides were diluted in a phosphate-
carbonate buffer at concentrations ranging from 0.1 µM to 50 µM. The peptide 
solutions were introduced to the surface of a hydroxyapatite-coated quartz crystal, 
and the resonance frequency was allowed to equilibrate. As the decrease in resonance 
frequency is directly related to the mass of peptide on the surface, the net frequency 
shift at different concentrations was used to determine the dissociation constant (KD) 
of each peptide. The KD values were determined using the relationship –∆F = 
∆FmaxC/(C+KD), where Fmax is the maximum frequency shift at surface saturation, 
and C is the concentration. The hydroxyapatite-coated crystals were rinsed with 
ethanol then cleaned in an ozone chamber between uses as prescribed by the 
manufacturer. KD is an equilibrium constant that represents the concentration 
necessary to achieve fifty percent surface coverage. These values can vary over many 
orders of magnitude. The results obtained from the QCM analysis showed that the 
prediction of binding strength was accurate for the amelogenin derived peptides. The 
peptides that were predicted to have a high binding affinity (ADP1, ADP2, ADP4 
and ADP7) had a relatively strong KD value on the order of 1 µM. In fact, the 
binding affinities of the strong ADPs were higher than the experimentally selected 
HABP1. Likewise, the peptides predicted to have low binding affinity (ADP3, 
ADP5, ADP6) resulted in Kd values varying from 5-14 µM, which was comparable 
with the experimentally selected weak binding peptide HABP2. The relative binding 
affinities derived from the Kd values are shown were indicated us ADP5 has high 
binding affinity, ADP7 has very low binding affinity to HA surface. The binding 
affinity analyses show that the similarity scoring matrices work pretty well for the 
binding affinities [448]. However, binding affinity is not always correlated with 
biomineralization activity. To test the relationship between the binding affinity and 
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the mineralization activity, kinetics and morphological analyses were performed as 
described in the previous section. 
3.4.1.2 Biomineralization characteristics of ADPs 
To investigate the effects of the ADPs on calcium phosphate mineralization, an 
alkaline phosphatase (AP) based mineralization model was used. Ca
+2
 consumption 
was monitored for 24 hours and noted that complete conversion of Ca
+2
 ions had 
occurred for all cases. However, varying conversion rates were observed in presence 
of different peptides. Ca
+2
 consumptions were observed for the first 90 minutes. We 
noted that the majority of the weak binders exhibited similar reaction kinetics to that 
of mineralization without peptide while majority of the strong binders exhibited 
faster kinetics. Namely, kinetics of two of the three weak binders were similar to that 
of no peptide case, with reaction constants for the first 60 minutes of -3.3x10
-3
/min, -
3.4x10
-3
/min and -3.3x10
-3
/min for ADP3 (weak), ADP6 (weak) and no peptide, 
respectively. In addition, three of the four strong binders exhibited faster kinetics 
compared to that of no peptide case, with reaction constants of -5.1x10
-3
/min, -
5.0x10
-3
/min and -4.9x10
-3
/min for ADP1, ADP2 and ADP4, respectively. However, 
One strong (ADP7) and one weak (ADP5) binders were exhibited opposite kinetic 
trends, in which ADP7 (strong) exhibited the slowest kinetics (-9x10
-4
/min) and 
ADP5 (weak) exhibited the fastest (-6.7x10
-3
/min). The reaction kinetic in the 
presence of amelogenin, the protein which ADP’s were derived from, was relatively 
fast compared to that of no peptide reaction with a rate constant of -5.2x10
-3
/min 
[448].  
Microstructural analyses were performed by SEM and TEM. Samples at 24 hours 
revealed that mineralization reactions exhibiting similar kinetics showed a high 
correlation in crystal morphology. For example, as shown in Figure 3.33, reactions in 
the presence of strong binders, ADP1, ADP2, and HABP1 where reactions were 
relatively fast compared to no peptide, yielded minerals with similar structural 
morphology. In particular, microstructure in all three cases revealed spherulites of 
~3-5 μm diameter crystal plate of ~200 nm wide fully populating their surfaces. On 
the other hand, reactions in the presence of weak binders ADP3, ADP6 and no 
peptide yielded minerals that formed in spherulites but with no apparent plate-like 
structures on their surfaces. However, we noted that in the case of strong binding 
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ADP7, where reaction kinetics was the slowest, the microstructure was similar to that 
of full amelogenin with needle like crystals forming bundle like structures. 
Interestingly, minerals formed in the presence of ADP5 exhibited very different 
crystal morphologies. There were no spherulites, only plate-like crystals that were 
larger than that of other minerals 10 fold. 
 
 
 
 
 
 
 
 
 
Figure 3.33: SEM micrographs of the minerals formed by the ADPs. The 
morphologies ADP5 and ADP7 yielded [448]. 
 
Figure 3.34: TEM micrographs of the minerals formed by ADP7 and the full length 
recombinant amelogenin, and a literature [449]  comparison to a mineral 
formed by the same full length amelogenin. The control mineral was 
formed in the presence of no peptide [448]. 
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The significant morphological differences suggest that the final phase of the resulting 
mineral might be different as well. The plate like structures and the spherulites are 
the characteristic morphologies of OCP observed in similar experimental conditions. 
However, the needle-like morphologies obtained from amelogenin and the ADP7 are 
characteristic with HA formed in wet-precipitation reactions. 
Mineralization characterizations, on the other hand, have shown that some of the 
ADPs emulate the function of the full amelogenin in different aspects. Amelogenin 
has shown high binding affinity to HA, resulted in HA crystals forming the 
characteristic bundle structures and has resulted in high mineralization rate. ADP7 
has shown very high binding affinity to HA, higher than the amelogenin and formed 
minerals with very similar morphology to those formed by amelogenin. However, 
ADP7 failed to emulate the high mineralization kinetics observed in the full 
amelogenin. ADP5, on the other hand, resulted in mineralization kinetics very 
similar to the full amelogenin but failed to reproduce the mineral phase and 
morphology observed in the full amelogenin. This data indicate that the ADP5 and 
ADP7 might be two different functional domains on the amelogenin, ADP5 being the 
region controlling the mineralization kinetics and ADP7 being the region controlling 
the binding, morphology and the mineral phase (Figure 3.34). 
 
3.4.2. Designing of TiBP-ADP(s) bi-functional conjugates for 
hydroxyapatite mineralization on titanium  
One of the major characteristics of inorganic binding peptides is their ability to 
mineralize materials from solution as mentioned in previous section.  This has been 
an area of interest in several studies that have assessed the effects of peptides on the 
biomineralization of such materials as gold, silver, silica, HAp and others.  This 
phenomenon represents a major area of future applications of GEPIs, making them 
not only material linkers and modifiers, but also material synthesizers.  Thus far, 
GEPIs have been used to form films [450], nanoparticles [357, 355, 343] and 
nanorods [451] as well as multiple-material hybrids [452, 453].  Despite the interest 
the area this phenomenon is yet poorly understood.  This lack of understanding is due 
to the fact that the mineralization process can be affected by peptides in a number of 
ways that cannot easily be observed.  Peptides can be responsible for ion binding, 
chemical reduction of ions (in the case of metals), stabilization of nuclei, surface 
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energy modification, or steric hindrance of crystal growth, or some combination of 
these factors. Depending on described features of GEPIs with the examples, the goal 
was to design multifunctional construct or bi-functional peptide carrying with TiBPs` 
molecular linker and ADPs` mineralization capability for HA mineralization on 
titanium surface. 
In here, first detailed binding affinity characterization experiment was performed on 
both titanium and hydroxyapatite surfaces via QCM for each domain of bi-functional 
peptide (i.e. TiBP2, ADP5 and ADP7 on titanium and HA) to do possible best design 
with their affinity comparison. In designed peptides, two domains were combined 
with GGG flexible linker and synthesized from C terminus to N terminus (ADP to 
TiBP). Following, each individual domain binding affinity were examined. Figure 17 
represents Kd values of ADP5, ADP7, TiBP2 on titanium and hydroxyapatite. ADP5 
has low affinity with more than 50 µM Kd value to HA surface where ADP7 has 
relatively high binding affinity with 10x lower Kd value. In case of titanium surface, 
ADP5 has high binding affinity to titanium surface with 0.5 µM Kd value where 
ADP7 has relatively low binding affinity with 5X lower Kd value.  For titanium 
binding peptides, TiBP2 is reported previous sections as a best binder were chosen 
for linker domain in bi-functional peptides. It has also really low binding affinity to 
HA surface (Figure 3.35).   
 
Figure 3.35: Binding affinity of TiBP2, ADP5 and ADP7on titanium and HA 
respectively. 
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3.4.3 Adsorption behavior of  TiBP-ADP(s) bi-functional peptides on titanium  
Following testing binding affinity and selectivity properties of peptides for each 
target material (titanium and hydroxyapatite), binding affinity of designed bi-
functional peptide were tested on titanium surface first. As indicated in Figure 3.36, 
TiBP2-ADP7 has high surface coverage at low concentrations compared to TiBP2-
ADP5. There is a 7.3 fold difference among their KD values as shown in Table 3.7. 
Although binding affinity levels of two bi-functional peptides are different then each 
other, both of them are good binders. Binding affinity of TiBP2-ADP7 is almost as 
same as TiBP2.  
 
Figure 3.36: Surface Coverage of TiBP2-ADP5 and TiBP2-ADP7 on Titanium 
Surface 
Table 3.8 KD (µM) values of TiBP2-ADP5 and TiBP2-ADP7 on titanium. 
Peptide 
Name 
KD 
(µM ) 
TiBP1-ADP5 1.32 ± 0.22 
TiBP2-ADP7 0.18 ± 0.02 
 
 
0
0.2
0.4
0.6
0.8
1
0 0.5 1 1.5 2 2.5
S
u
rf
ac
e 
C
o
v
er
ag
e 
Concentration (µM)
TiBP2-ADP5
TiBP2-ADP7
  
154 
 
3.4.4 Kinetics of bi-functional peptides facilitated biomineralization  
QCM experiments were run to show the kinetics of mineral formation induced by 
different immobilized peptide films.  Peptides were first allowed to adsorb to the 
titanium surface at 10 µM. Once the signal stabilized a supersaturated calcium-
phosphate buffer was introduced.  The solution was then left for up to three days to 
mineralize.  In the cases of TiBP2-ADP5 and ADP5 mineralization began almost 
immediately, with the rate of mineralization increasing exponentially until reaching 
an approximately linear growth rate after around four hours.   TiBP2-ADP7 also 
leads to short term mineralization; however, there were several hours of incubation 
before the mineralization rate began increasing exponentially.   TiBP2-ADP7 also 
stabilized with a significantly slower growth rate than the ADP5-based peptides.  
The other peptides, TiBP2 and ADP7, did not cause any mineralization during the 
first 24 hours.  Nothing mineralized on the bare Ti surface during a three day test 
(Figure 3.37).   
 
Figure 3.37: In situ monitoring of bi-functional peptide mediated Ca5(PO4)3OH 
mineralization via QCM. 
3.4.5 Mineralization characteristics of bi-functional peptides on titanium  
Following, the kinetics of mineralization were monitored via QCM. The effect of the 
peptide on the structure of the mineralized film was monitored using SEM first and 
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then TEM.  Titanium surfaces showing no mineralization in QCM were 
indistinguishable from control bare titanium substrates. Two bi-functional peptides 
that did show significant mineralization all had very similar structures to the HAP 
film (Figure 3.38).   No mineralization was observed in case of no peptide, ADP5, 
ADP7 and TiBP2.   Among them, mineralization and binding behavior of ADP5 is 
significant with variety of contrast examples. It has low binding affinity to HA 
surface where high binding affinity to titanium surface. Its mineralization capability 
in solution was significantly different than on titanium surface. It also shows us there 
is no correlation between binding strength and mineralization capability of peptides. 
Their behavior can also be affected depending on occurrence of mineralization 
reaction in the solution or on the surface. This data also may reveal that changes in 
molecular conformation of peptides in solution and on the surface may alter the 
mineralization process.  In case of ADP7, it has really high binding affinity to HA 
surface where binding affinity to titanium surface low. It can form HA like structure 
in solution however any mineral formed on the surface of the titanium. In case of bi-
functional peptides, they both form mineral with similar structure. TEM (Figure 
3.41) data was also indicate us formed mineral structure is very similar to HA 
crystals. 
In conclusion, there are several possible mechanisms for an immobilized peptide 
films have in influencing the nucleation and growth of a mineralizing film.  These 
include binding the relevant ions, leading to a local increase in the concentration; 
and, perhaps most likely, by reducing the surface energy of calcium-phosphate 
nuclei.   Since the peptides are immobilized on the titanium surface and there is a 
very low concentration of peptide in solution, we can only expect that the once the 
peptide is covered with HAp they should no longer have any effect on the way the 
HAp film evolves.  This was shown to be the case in both QCM and SEM data.  
These results isolate the peptides ability as nucleating agents, and show the peptides’ 
ability to form a HAp film in situ, without the need of any surface modification of 
the titanium.  The results are also revealed that peptide mineralization behavior can 
be different in solution and on the surface. 
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Figure 3.38: SEM micrographs of minerals formed by bi-functional peptides 
(TiBP2-ADP5, TiBP2-ADP7) including positive and negative controls. 
 
 
  
Figure 3.39: TEM images of the minerals formed in the presence of TiBP2-ADP5. 
The inset is the corresponding selected area diffraction patterns of the 
minerals. 
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4. CONCLUSION  
Nanotechnology has revolutionized many fields of science including fabrication and 
characterization of various nanostructures. In general, it is experiencing a rapid 
growth period with major advances arriving quickly. According to these advances 
are applied in the biomedical field in numerous diverse ways. Especially, remarkable 
recognition capabilities of biomolecules when combined with the unique properties 
of nanomaterials can lead to novel implant materials with significantly improved 
performances. Nature also provides abundant examples of materials and systems 
with a rich variety of interconnections among materials and biomlecules. The joining 
of biology in the implementation of nanotechnology to design, engineer materials 
help scientist for realization of nanobiotechnology. Due to control of all interfaces 
between materials and tissues by proteins and peptides in biology, molecular 
biomimetics bring approaches into engineering and technological systems by 
utilizing peptides. Based on potentials of peptides, GEPIs as a field of molecular 
biomimetics may serve a platform for achieving the goal of efficient ways for design 
and fabrication of complex materials with multiple functionalities. They can act as 
fundamental building blocks in nanoinorganic assembly for electronics and photonics 
application. They can couple with solid substrates to open new routes in the 
development of advanced biosensors for pathogen detection, drug screening, 
bioseparations systems and diagnostics in medicine (e.g. cancer therapeutics). GEPI 
have short amino acid sequences with material selective binding and self assembling 
properties can also be good candidate as a molecular linker for functionalization of 
material surfaces. Once selected by combinatorial biology techniques, they can be 
further tailored to enhance/modify their binding ability and multifunctionality. The 
multifunctionality could be introduced either two or more material binding peptides 
to create novel ways of making dissimilar materials and coupling material binding 
properties with other bio-functional molecules to modify surfaces with improved 
properties for particular goal. 
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In the scope of this dissertation, the remarkable findings on multifunctional features 
of GEPIs to improve implant material properties with different examples were 
demonstrated. In the following examples, controlling cell-surface interactions were 
demonstrated either designing bioactive, antimicrobial surfaces or inducing mineral 
formation on titanium surface towards peptide-based biomolecule immobilization. 
In the first part, selection and detailed characterization of TiBPs in terms of binding 
affinity, specificity, molecular structure and cytotoxicty were shown.  Selection of 
TiBPs against cp Grade 4 titanium implant surface  via cell surface display to 
generate set of sequences that could offer a route for implant surface 
functionalization as a molecular linker were reported.  Following, three TiBPs 
(TiBP1, 2 and 60) were identified based on initial fluorescence microscopy (FM) 
characterization for further investigations. Two (TiBP1 and TiBP2) that exhibited 
high affinity, one (TiBP60) with lowest binding affinity to titanium were subjected to 
determine their quantitative binding characteristics on titanium with the contribution 
of primary and secondary structural properties. We were also interested in learning 
material selectivity properties of TiBP1 and TiBP2 on various implantable surfaces 
such as silica and HA via QCM due to requirement of new molecular linkers with 
their recognition and specificity capabilities in implantation. Then, we attempt to 
show cellular response against TiBPs (TiBP1 and TiBP2) functionalized surfaces via 
MTT assay.  The findings rely on remarkable high binding affinity, material 
selectivity, cytotoxicity features with distinct physicochemical properties of the two 
TiBPs (TiBP1 and TiBPs) was a potential candidate to tailor their capabilities 
conjugation with other functional molecules for implant surface modifications. 
In the second section,  to address  the utility and versatility of TiBPs for controlling 
cell-surface interactions through immobilization of functional molecules on various 
implant surfaces especially on titanium, bi-functional peptide was designed in 
conjugation with  two titanium binding peptides (TiBP1 and TiBP2) and integrin 
binding domain RGD via GGG flexible linker for bioactive surface modifications.  
Their effects on cell viability, adhesion and spreading were examined on cp Grade 4 
titanium implant surfaces and titanium coated glass surfaces in the presence of 
osteoblast and fibroblast.  Our results demonstrated that peptide-based surface 
modification is an adaptable platform to meet the specific requirements to design 
bioactive surfaces enhancing with cell adhesion and spreading. This also indicate us 
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single-step surface modification using solid-binding peptides conjugated to desired 
medically relevant molecules may prove to be a robust, biocompatible approach in 
the functionalization of complex devices in clinical applications. 
In the third section, we offer a way for development of biomaterial surfaces that 
capable of preventing bacterial infection towards peptide-based surface 
functionalization. We have created two bi-functional peptides composed of a 
genetically engineered peptide for inorganics (GEPI) motif and an antimicrobial 
peptide (AMP) motif; these bi-functional peptides rely on the titanium-binding 
properties of the GEPI to preferentially bind to the biomaterial, freely exposing the 
AMP motif to combat invading bacteria. The efficacy of our bi-functional peptides 
(TiBP1-AMP and TiBP2-AMP) were evaluated both in-solution and on the surface 
of titanium against Streptococcus mutans, Staphylococcus epidermidis, and 
Escherichia coli.  Surfaces modified with our bi-functional peptides were found to 
significantly reduce bacterial adhesion against all three bacteria when compared to 
adhesion on bare titanium.  The results of the presented work indicate that surface 
modification with conjugated molecules consisting of antimicrobial and titanium 
binding peptides is a promising approach to prevent bacterial infection on implant 
surfaces. Although antimicrobial properties of peptide modified implant surfaces 
were shown against to three different bacteria (S.mutans, S.epidermidis and E.coli), 
various peptide can be also designed against to broad range of bacteria by utilizing 
sequence, structure and charge relations of AMPs and material binding peptides. It 
should be noted that controlled binding and release of biomolecules to implant 
surfaces are critical in the development of intelligent implant materials. Detail 
studies are necessary to clarify the underlying mechanism of antimicrobial activity in 
such conjugated peptides and determine the stability of adsorbed peptides in the 
presence of body fluids.  
In the last section, molecular linkers and synthesizers capabilities of GEPIs were 
demonstrated. Depending on described features of GEPIs, the goal was to design 
multifunctional construct or bi-functional peptide carrying with TiBPs` molecular 
linker and ADPs` mineralization capability for HA mineralization on titanium 
surface. Real time monitoring of the CaPO4 biomineralization were successfully 
achieved on the surface of titanium via QCM. The mineral morphology and crystal 
structure were examined with TEM and SEM. This part of work indicates that GEPI 
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may provide the ways for genetic control on biomineralization from tissue restoration 
to regeneration. 
In conclusion, GEPIs are smart molecules selected using combinatorial biology 
protocols such as phage and cell surface display and subsequently characterized by 
different qualitative and semi quantitative methods e.g. AFM, QCM, SPR and FM. 
Their binding affinity and material selectivity properties can also be improved by 
efficacy of the bioinformatics approach. The overall results indicate in here, GEPI 
has potential to become more attractive in implant applications not only molecular 
linker but also synthesizer capability.  Their high binding affinity,  specificity and 
recognition capability for desired surface that allow precise control density, 
functionality, accessibility of biomolecules offers an alternative immobilization 
methods for biological surface modification of implants.  
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TiBP60, TiBP1-GGG-RGDS, TiBP2-GGG-RGDS, RGDS, TiBP1-GGG-AMP, 
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APPENDIX A1 
 
Figure A.1: The MALDI/TOF spectrum of synthesized TiBP1 
 
Figure A.2: The MALDI/TOF spectrum of synthesized TiBP2 
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Figure A.3: The MALDI/TOF spectrum of synthesized TiBP60 
 
Figure A.4: The MALDI/TOF spectrum of synthesized TiBP1-GGG-RGDS 
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Figure A.5: The MALDI/TOF spectrum of synthesized TiBP2-GGG-RGDS 
 
Figure A.6: The MALDI/TOF spectrum of synthesized RGDS 
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Figure A.7: The MALDI/TOF spectrum of synthesized TiBP1-GGG-AMP 
 
Figure A.8: The MALDI/TOF spectrum of synthesized TiBP2-GGG-AMP 
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Figure A.9: The MALDI/TOF spectrum of synthesized AMP 
 
Figure A.10: The MALDI/TOF spectrum of synthesized TiBP2-GGG-ADP7 
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Figure A.11: The MALDI/TOF spectrum of synthesized TiBP2-GGG-ADP5 
 
Figure A.12: The MALDI/TOF spectrum of synthesized ADP5 
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Figure A.13: The MALDI/TOF spectrum of synthesized ADP7 
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